VIICTR
Profiles
ORIT
Pediatrics RRO
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
KONOPLEVA, MARINA
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
MARINA KONOPLEVA
Title
Professor
Institution
MD Anderson
Department
Leukemia
Address
1400 Holcombe Blvd
Houston TX 77030-4008
vCard
Download vCard
Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can
login
to make corrections and additions.
Newest
|
Oldest
|
Most Cited
|
Most Discussed
|
Timeline
|
Field Summary
|
Plain Text
PMC Citations
indicate the number of times the publication was cited by articles in PubMed Central, and the
Altmetric
score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)
Fields
are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation
tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Figueroa M, Ma H, Alfayez M, Morales-Mantilla DE, Wang F,
Lu Y
,
Estecio M
,
King KY
,
Kleinerman ES
,
Moghaddam SJ
, Daver NG,
Andreeff M
, Konopleva MY, DiNardo CD,
Chandra J
, Figueroa M, Ma H, Alfayez M, Morales-Mantilla DE, Wang F, Lu Y, Estecio MR, King KY, Kleinerman E, Moghaddam SJ,
Daver N
, Andreeff M,
Konopleva M
,
DiNardo C
, Chandra J. Cigarette smoke exposure accelerates AML progression in FLT3-ITD models. Blood Adv. 2023 Nov 14; 7(21):6624-6629.
PMID:
37486624
; PMCID:
PMC10628807
.
Citations:
Fields:
Hem
Hematology
Senapati J, Fiskus WC, Daver N, Wilson NR, Ravandi F, Garcia-Manero G, Kadia T,
DiNardo CD
, Jabbour E, Burger J, Short NJ,
Alvarado Y
,
Jain N
, Masarova L, Issa GC, Qiao W,
Khoury JD
, Pierce S, Miller D, Sasaki K, Konopleva M,
Bhalla KN
,
Borthakur G
, Pemmaraju N, Senapati J,
Fiskus WC
,
Daver N
, Wilson NR, Ravandi F,
Garcia-Manero G
,
Kadia T
, DiNardo CD,
Jabbour E
,
Burger J
, Short NJ, Alvarado Y, Jain N, Masarova L, Issa GC, Qiao W, Khoury JD, Pierce S, Miller D, Sasaki K,
Konopleva M
, Bhalla KN, Borthakur G,
Pemmaraju N
. Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies. Clin Cancer Res. 2023 11 01; 29(21):4352-4360.
PMID:
37585491
.
Citations:
Fields:
Neo
Neoplasms
Skwarska A,
Konopleva M
. BCL-xL Targeting to Induce Apoptosis and to Eliminate Chemotherapy-Induced Senescent Tumor Cells: From Navitoclax to Platelet-Sparing BCL-xL PROTACs. Cancer Res. 2023 11 01; 83(21):3501-3503.
PMID:
37824434
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Koller P, Baran N, Harutyunyan K, Cavazos A,
Mallampati S
, Chin RL, Jiang Z, Sun X, Lee HH, Hsu JL, Williams P, Huang X,
Curran MA
,
Hung MC
,
Konopleva M
. PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity. J Immunother Cancer. 2023 10; 11(10).
PMID:
37793852
; PMCID:
PMC10551962
.
Citations:
Fields:
Neo
Neoplasms
The
Therapeutics
Translation:
Humans
Animals
Jia Y, Han L, Ramage CL, Wang Z, Weng CC, Yang L,
Colla S
, Ma H, Zhang W,
Andreeff M
,
Daver N
,
Jain N
,
Pemmaraju N
,
Bhalla K
, Mustjoki S, Zhang P, Zheng G, Zhou D, Zhang Q,
Konopleva M
. Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells. Haematologica. 2023 10 01; 108(10):2626-2638.
PMID:
37078252
; PMCID:
PMC10542840
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
Cells
Aminu M,
Daver N
,
Godoy MCB
,
Shroff G
, Wu C, Torre-Sada LF, Goizueta A,
Shannon VR
,
Faiz SA
, Altan M,
Garcia-Manero G
,
Kantarjian H
,
Ravandi-Kashani F
,
Kadia T
,
Konopleva M
,
DiNardo C
, Pierce S,
Naing A
, Kim ST,
Kontoyiannis DP
, Khawaja F,
Chung C
, Wu J,
Sheshadri A
. Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept. Front Immunol. 2023; 14:1249511.
PMID:
37841255
; PMCID:
PMC10570510
.
Citations:
Fields:
All
Allergy and Immunology
Translation:
Humans
Hammond D,
Loghavi S
, Wang SA,
Konopleva MY
,
Kadia TM
,
Daver NG
,
Ohanian M
, Issa GC,
Alvarado Y
, Short NJ, Sasaki K,
Pemmaraju N
, Montalban-Bravo G, Lachowiez CA, Maiti A,
Garcia-Manero G
,
Jabbour EJ
,
Borthakur G
, Ravandi F,
Takahashi K
, Pierce SR,
Kantarjian HM
,
DiNardo CD
. Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents. Blood Cancer J. 2023 09 21; 13(1):148.
PMID:
37735426
; PMCID:
PMC10514257
.
Citations:
Fields:
All
Allergy and Immunology
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Richard-Carpentier G, Rausch CR, Sasaki K, Hammond D, Morita K,
Takahashi K
, Tang G, Kanagal-Shamanna R,
Bhalla K
,
Dinardo CD
,
Borthakur G
,
Pemmaraju N
,
Shpall EJ
,
Alousi A
,
Daver NG
,
Garcia-Manero G
,
Konopleva MY
, Ravandi F,
Kantarjian HM
,
Kadia TM
. Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2). Haematologica. 2023 09 01; 108(9):2331-2342.
PMID:
36951163
; PMCID:
PMC10483357
.
Citations:
2
Fields:
Hem
Hematology
Translation:
Humans
Kadia TM
, Ravandi F, Molica M, Bataller A,
Borthakur G
,
Daver N
,
Jabbour E
,
DiNardo CD
,
Pemmaraju N
,
Jain N
,
Ferrajoli A
, Ylimaz M,
Bose P
, Tidwell RS, Marx KR, Rausch CR, Kanagal-Shamanna R, Wang S, Islam R,
Champlin R
,
Shpall E
,
Konopleva M
,
Garcia-Manero G
,
Kantarjian H
. Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia. Am J Hematol. 2023 11; 98(11):1711-1720.
PMID:
37635400
.
Citations:
Fields:
Hem
Hematology
Tian Z, Shi C, Yang G, Allen JK, Shi Q, Ai-Shami A, Olson JW, Smith MG, Chang Q, Kaur J, You J, Lofton TE, Gonzalez MA, Zhang Q, Zha D, Tasian SK,
Jain N
,
Konopleva MY
, Heffernan T,
Molldrem JJ
. Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL. Leukemia. 2023 Oct; 37(10):2006-2016.
PMID:
37634013
; PMCID:
PMC10539166
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Narvel H, Vegivinti C, Vikash S, Bazarbachi AH, Pradhan K, Wang S, Hammami MB, Narvel N, Yakkali S, Ansari S, Nabi AG, Mohammed T, Mantzaris I,
Konopleva M
, Goldfinger M, Gritsman K, Cooper D, Shastri A, Shah N, Kornblum N, Verma A, Sica RA. Primary central nervous system lymphoma: treatment access and outcomes in HIV positive patients in a minority rich cohort. Stem Cell Investig. 2023; 10:17.
PMID:
37662874
; PMCID:
PMC10468403
.
Citations:
Shallis RM,
Daver N
, Altman JK, Komrokji RS, Pollyea DA, Badar T, Bewersdorf JP, Bhatt VR, de Botton S, de la Fuente Burguera A, Carraway HE, Desai P, Dillon R, Duployez N, El Chaer F, Fathi AT, Freeman SD, Gojo I, Grunwald MR, Jonas BA,
Konopleva M
, Lin TL, Mannis GN, Mascarenhas J, Michaelis LC, Mims AS, Montesinos P, Pozdnyakova O, Pratz KW, Schuh AC, Sekeres MA, Smith CC, Stahl M, Subklewe M, Uy GL, Voso MT, Walter RB, Wang ES, Zeidner JF, ?ucenka A, Zeidan AM. Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts. Lancet Haematol. 2023 Sep; 10(9):e767-e776.
PMID:
37572683
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Sasaki K, Morita K,
Kantarjian H
,
Garcia-Manero G
,
Jabbour E
, Ravandi F,
Konopleva M
,
Borthakur G
,
Wierda W
,
Daver N
,
Takahashi K
,
DiNardo C
, Bravo GM, Issa GC, Pierce SA, Soltysiak KA, Tingen MS,
Cortes JE
. Geographic Disparity of Outcome in Patients With Cancer Over Decades: The Surveillance, Epidemiology, and End Results. Clin Lymphoma Myeloma Leuk. 2023 11; 23(11):e369-e378.
PMID:
37690903
.
Citations:
Fields:
Neo
Neoplasms
Levitz D, Saunthararajah Y, Fedorov K, Shapiro LC, Mantzaris I, Shastri A, Kornblum N, Sica RA, Shah N,
Konopleva M
, Gritsman K, Braunschweig I, Cooper DL, Pradhan K, Verma A, Feldman EJ, Goldfinger M. A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML. Clin Cancer Res. 2023 Aug 01; 29(15):2774-2780.
PMID:
37341641
.
Citations:
Fields:
Neo
Neoplasms
Gaur T, Poddutoori R, Khare L, Bagal B, Rashmi S, Patkar N, Tembhare P, Pg S, Shetty D, Dutt A, Zhang Q,
Konopleva M
, Platzbeckar U, Gupta S, Samajdar S, Ramchandra M, Khattry N, Hasan SK. Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax. J Exp Clin Cancer Res. 2023 Jul 29; 42(1):186.
PMID:
37507802
; PMCID:
PMC10386772
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Short NJ, Ong F, Ravandi F, Nogueras Gonzalez GM,
Kadia TM
, Daver NG,
DiNardo CD
, Konopleva MY,
Borthakur G
,
Oran B
,
Al-Atrash G
,
Mehta RS
, Jabbour EJ, Yilmaz M, Issa GC, Maiti A,
Champlin RE
,
Kantarjian HM
,
Shpall EJ
,
Popat UR
, Short NJ, Ong F, Ravandi F, Nogueras-Gonzalez G, Kadia TM,
Daver N
, DiNardo CD,
Konopleva M
, Borthakur G, Oran B, Al-Atrash G, Mehta R,
Jabbour EJ
, Yilmaz M, Issa GC, Maiti A, Champlin RE, Kantarjian H, Shpall EJ, Popat U. Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation. Blood Adv. 2023 Jul 25; 7(14):3573-3581.
PMID:
37104058
; PMCID:
PMC10368841
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
Cuglievan B, Connors J, He J, Khazal S,
Yedururi S
, Dai J, Garces S, Quesada AE, Roth M, Garcia M, McCall D, Gibson A, Ragoonanan D,
Petropoulos D
, Tewari P,
Nunez C
, Mahadeo KM, Tasian SK, Lamble AJ, Pawlowska A, Hammond D, Maiti A, Haddad FG, Senapati J,
Daver N
, Gangat N,
Konopleva M
, Meshinchi S,
Pemmaraju N
. Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies. Leukemia. 2023 09; 37(9):1767-1778.
PMID:
37452102
; PMCID:
PMC10457206
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Cells
Friedmann R, Kim YM,
Konopleva M
. Editorial: Microenvironment and therapy-resistance in leukemias. Front Oncol. 2023; 13:1244642.
PMID:
37519784
; PMCID:
PMC10381924
.
Citations:
Bazinet A, Kadia TM, Short NJ,
Borthakur G
, Wang SA, Wang W,
Loghavi S
,
Jorgensen JL
, Patel KP, DiNardo CD, Daver NG,
Alvarado Y
, Haddad FG, Pierce SR, Nogueras Gonzalez GM, Maiti A, Sasaki K, Yilmaz M, Thompson PA,
Wierda WG
,
Garcia-Manero G
, Andreeff M, Jabbour EJ, Konopleva MY, Huang X,
Kantarjian HM
, Ravandi F, Bazinet A,
Kadia T
, Short NJ, Borthakur G, Wang SA, Wang W, Loghavi S, Jorgensen J,
Patel K
,
DiNardo C
,
Daver N
, Alvarado Y, Haddad FG, Pierce S, Nogueras Gonzalez G, Maiti A, Sasaki K, Yilmaz M, Thompson P, Wierda W, Garcia-Manero G,
Andreeff M
,
Jabbour E
,
Konopleva M
, Huang X, Kantarjian H, Ravandi F. Undetectable measurable residual disease is associated with improved outcomes in AML irrespective of treatment intensity. Blood Adv. 2023 07 11; 7(13):3284-3296.
PMID:
36884300
; PMCID:
PMC10336257
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
Chai J, Choudhuri J, Wang Q, Fang Y, Shi Y, Kamel J, Shah N, Sica RA, Kornblum N,
Konopleva M
, Mantzaris I, Shastri A, Gritsman K, Verma A, Goldfinger M, Goel S, Wang Y, Tian X. Acute myeloid leukemias with JAK2/STAT mutations are associated with PD-L1 upregulation. Leuk Lymphoma. 2023 Oct; 64(10):1662-1672.
PMID:
37424335
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Lachowiez CA,
Loghavi S
,
Zeng Z
, Tanaka T, Kim YJ, Uryu H, Turkalj S, Jakobsen NA, Luskin MR, Duose DY, Tidwell RSS, Short NJ,
Borthakur G
, Kadia TM, Masarova L, Tippett GD,
Bose P
, Jabbour EJ, Ravandi F, Daver NG,
Garcia-Manero G
,
Kantarjian H
, Garcia JS, Vyas P, Takahashi K,
Konopleva M
, DiNardo CD, Lachowiez CA, Loghavi S, Zeng Z, Tanaka T, Kim YJ, Uryu H, Turkalj S, Jakobsen NA, Luskin MR, Duose DY, Tidwell RSS, Short NJ, Borthakur G,
Kadia TM
, Masarova L, Tippett GD, Bose P,
Jabbour EJ
, Ravandi F,
Daver NG
, Garcia-Manero G, Kantarjian H, Garcia JS, Vyas P,
Takahashi K
, Konopleva M,
DiNardo CD
. A Phase Ib/II Study of Ivosidenib with Venetoclax ? Azacitidine in IDH1-Mutated Myeloid Malignancies. Blood Cancer Discov. 2023 07 05; 4(4):276-293.
PMID:
37102976
; PMCID:
PMC10320628
.
Citations:
6
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Olesinski EA, Bhatia KS, Mahesh AN, Rosli S, Mohamed JS, Jen WY,
Jain N
, Garcia JS, Wong GC, Ooi MG, Letai A, Konopleva MY, Bhatt S, Olesinski EA, Bhatia KS, Mahesh AN, Rosli S, Mohamed JS, Jen WY, Jain N, Garcia JS, Wong GC, Ooi M, Letai A,
Konopleva M
, Bhatt S. BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia. Blood Adv. 2023 Jun 27; 7(12):2917-2923.
PMID:
36763538
; PMCID:
PMC10285538
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Cells
Bazinet A,
Kantarjian H
, Arani N,
Popat U
, Bataller A, Sasaki K,
DiNardo CD
,
Daver N
, Yilmaz M, Abbas HA, Short NJ, Issa G,
Jabbour E
, Pierce SA, Chen J, Garcia R,
Konopleva M
,
Garcia-Manero G
,
Alousi A
,
Shpall EJ
,
Champlin RE
,
Borthakur G
, Ravandi F,
Kadia T
. Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation. Am J Hematol. 2023 09; 98(9):1383-1393.
PMID:
37334870
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
Desai PN, Wang B, Fonseca A, Borges P, Jelloul FZ, Reville PK, Lee E, Ly C, Basi A, Root J, Baran N,
Post SM
, Deng Q, Sun H, Harmanci AO,
Burks JK
, Gomez JA,
DiNardo CD
,
Daver NG
, Alatrash G,
Konopleva M
, Green MR, Antunes DA,
Futreal A
, Hao D, Abbas HA. Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion. Cancer Immunol Res. 2023 Jun 07; OF1-OF18.
PMID:
37285177
.
Citations:
Fields:
All
Allergy and Immunology
Neo
Neoplasms
Bhattacharya S,
Piya S
, Ma H, Sharma P, Zhang Q, Baran N, Ruvolo VR, McQueen T, Davis RE, Pourebrahim R,
Konopleva M
, Kantarjian H, Cosford NDP, Andreeff M, Borthakur G, Bhattacharya S, Piya S, Ma H, Sharma P, Zhang Q, Baran N, Ruvolo VR, McQueen T, Davis RE, Pourebrahim R, Konopleva M,
Kantarjian H
, Cosford NDP,
Andreeff M
,
Borthakur G
. Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous Leukemia. Mol Cancer Res. 2023 06 01; 21(6):548-563.
PMID:
36787422
.
Citations:
Fields:
Cel
Cell Biology
Mol
Molecular Biology
Neo
Neoplasms
Translation:
Animals
Zhang W, Yu G, Zhang H, Basyal M, Ly C, Yuan B, Ruvolo V,
Piya S
, Bhattacharya S, Zhang Q,
Borthakur G
,
Battula V
,
Konopleva M
, Rice WG,
Andreeff M
. Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy. Haematologica. 2023 06 01; 108(6):1500-1514.
PMID:
36226489
; PMCID:
PMC10230429
.
Citations:
4
Fields:
Hem
Hematology
Translation:
Humans
Animals
Cells
Jain N
, Senapati J,
Thakral B
,
Ferrajoli A
, Thompson P,
Burger J
, Basu S,
Kadia T
,
Daver N
,
Borthakur G
,
Konopleva M
,
Pemmaraju N
, Parry E, Wu CJ,
Khoury J
,
Bueso-Ramos C
,
Garg N
, Wang X, Lopez W, Ayala A, O'Brien S,
Kantarjian H
, Keating M,
Allison J
,
Sharma P
,
Wierda W
. A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL. Blood Adv. 2023 05 23; 7(10):1958-1966.
PMID:
36287248
; PMCID:
PMC10189379
.
Citations:
6
Fields:
Hem
Hematology
Translation:
Humans
Cells
CT
Clinical Trials
Beird H, Yin CC,
Khoury JD
, Pierce S, Abbas HA, Zhao L, Skwarska A,
Qazilbash M
,
Konopleva M
,
Futreal PA
,
Pemmaraju N
. TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm. Blood Adv. 2023 05 23; 7(10):2000-2003.
PMID:
36689729
; PMCID:
PMC10188632
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Cells
Desai PN, Wang B, Fonseca A, Borges P, Jelloul FZ, Reville PK, Lee E, Ly C, Basi A, Root J, Baran N,
Post SM
, Deng Q, Sun H, Harmanci AO,
Burks JK
, Gomez JA,
DiNardo CD
,
Daver NG
, Alatrash G,
Konopleva M
, Green MR, Antunes DA,
Futreal A
, Hao D, Abbas HA. Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion. Cancer Immunol Res. 2023 May 10.
PMID:
37163233
.
Citations:
Fields:
All
Allergy and Immunology
Neo
Neoplasms
Timofeeva N, Ayres ML, Baran N, Santiago-O'Farrill JM, Bildik G,
Lu Z
,
Konopleva M
,
Gandhi V
. Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemia. Front Oncol. 2023; 13:1161254.
PMID:
37228498
; PMCID:
PMC10203524
.
Citations:
1
Senapati J,
Jabbour E
,
Konopleva M
, Short NJ, Tang G,
Daver N
,
Kebriaei P
,
Kadia T
,
Pemmaraju N
,
Takahashi K
,
DiNardo C
, Sasaki K,
Borthakur G
,
Thakral B
, Kanagal-Shamanna R, Patel K, Ravandi F, Roberts K, Mullighan C,
Kantarjian H
,
Jain N
. Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in ABL Class Rearrangements. JCO Precis Oncol. 2023 05; 7:e2200707.
PMID:
37196217
; PMCID:
PMC10309573
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Baran N, Hurrish K, Su Y, Patel S, Ramage C, Carter J, Edwards H, Buck S, Wiley S, H?ttemann M, Polin L, Kushner J, Dzinic S, White K, Bao X, Li J, Yang J, Boerner J, Hou Z, Al-Atrash G,
Konoplev S
, Busquets J, Tiziani S, Matherly L, Taub J, Konopleva M, Ge Y, Hurrish KH, Su Y, Patel S, Ramage CL, Carter JL, Edwards H, Buck SA, Wiley SE, H?ttemann M, Polin L, Kushner J, Dzinic SH, White K, Bao X, Li J, Yang J, Boerner J, Hou Z,
Al-Atrash G
, Konoplev SN, Busquets J, Tiziani S, Matherly LH, Taub JW,
Konopleva M
, Ge Y, Baran N. Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis. Res Sq. 2023 Apr 28.
PMID:
37162954
; PMCID:
PMC10168457
.
Citations:
Yoshimura S, Panetta JC, Hu J, Li L, Gocho Y, Du G, Umezawa A, Karol SE, Pui CH, Mullighan CG,
Konopleva M
, Stock W, Teachey DT,
Jain N
, Yang JJ. Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemia. Leukemia. 2023 06; 37(6):1194-1203.
PMID:
37076694
; PMCID:
PMC10347458
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Animals
Cells
Fedorov K, Maiti A,
Konopleva M
. Targeting FLT3 Mutation in Acute Myeloid Leukemia: Current Strategies and Future Directions. Cancers (Basel). 2023 Apr 15; 15(8).
PMID:
37190240
; PMCID:
PMC10136888
.
Citations:
1
Wright S, Hu J, Wang H, Hyle J, Zhang Y, Du G,
Konopleva MY
,
Kornblau SM
, Djekidel MN, Rosikiewicz W, Xu B, Lu R, Yang JJ, Li C. Interrogating bromodomain inhibitor resistance in KMT2A-rearranged leukemia through combinatorial CRISPR screens. Proc Natl Acad Sci U S A. 2023 04 18; 120(16):e2220134120.
PMID:
37036970
; PMCID:
PMC10120025
.
Citations:
1
Fields:
Sci
Science
Translation:
Humans
Cells
Dufva O, Klievink J, Kuusanm?ki H, V?h?-Koskela M, Lepp? AM, Huuhtanen J, V?nttinen I, Nygren P, Bouhlal J, P?l?nen P, Zhang Q, Adnan-Awad S, Mancebo-P?rez C, Saad J, Miettinen J, Javarappa KK, Aakko S, Ruokoranta T, Eldfors S, Hein?niemi M, Theilgaard-M?nch K, Wartiovaara-Kautto U, Ker?nen M, Porkka K,
Konopleva M
, Wennerberg K, Kontro M, Heckman CA, Mustjoki S. Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia. Blood. 2023 03 30; 141(13):1610-1625.
PMID:
36508699
.
Citations:
5
Fields:
Hem
Hematology
Translation:
Humans
Animals
Cells
Issa GC, Bidikian A, Venugopal S,
Konopleva M
,
DiNardo CD
,
Kadia TM
,
Borthakur G
,
Jabbour E
,
Pemmaraju N
, Yilmaz M, Short NJ, Maiti A, Sasaki K, Masarova L, Pierce S,
Takahashi K
, Tang G,
Loghavi S
,
Patel K
,
Andreeff M
,
Bhalla K
,
Garcia-Manero G
, Ravandi F,
Kantarjian H
,
Daver N
. Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AML. Blood Adv. 2023 03 28; 7(6):933-942.
PMID:
36322818
; PMCID:
PMC10027507
.
Citations:
6
Fields:
Hem
Hematology
Translation:
Humans
Trabal A, Gibson A, He J, McCall D, Roth M, Nu?ez C, Garcia M, Buzbee M, Toepfer L, Bidikian A,
Daver N
,
Kadia T
, Short NJ, Issa GC, Ravandi F,
DiNardo CD
, Montalban Bravo G, Garces S,
Marcogliese A
,
Paek H
, Dreyer Z,
Brackett J
,
Redell M
,
Yi J
,
Garcia-Manero G
,
Konopleva M
,
Stevens A
, Cuglievan B. Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience. Cancers (Basel). 2023 Mar 26; 15(7).
PMID:
37046645
; PMCID:
PMC10093646
.
Citations:
1
Desikan SP, Senapati J,
Jabbour E
,
Abuasab T
, Short N, Tang G, Wang S,
Kebriaei P
,
Kadia T
,
Borthakur G
, Ravandi F, Roberts K, Mullighan C,
Konopleva M
,
Kantarjian H
,
Jain N
. Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia. Am J Hematol. 2023 06; 98(6):E142-E144.
PMID:
36877196
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
Daver NG
, Dail M, Garcia JS, Jonas BA, Yee KWL, Kelly KR, Vey N, Assouline S, Roboz GJ, Paolini S, Pollyea DA, Tafuri A, Brandwein JM, Pigneux A, Powell BL, Fenaux P, Olin RL, Visani G, Martinelli G, Onishi M, Wang J, Huang W, Green C, Ott MG, Hong WJ,
Konopleva MY
,
Andreeff M
. Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial. Blood. 2023 03 16; 141(11):1265-1276.
PMID:
36265087
.
Citations:
8
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Tabe Y,
Konopleva M
. Resistance to energy metabolism - targeted therapy of AML cells residual in the bone marrow microenvironment. Cancer Drug Resist. 2023; 6(1):138-150.
PMID:
37065866
; PMCID:
PMC10099600
.
Citations:
1
Abbas HA, Sun H, Pierce S, Kanagal-Shamanna R, Li Z, Yilmaz M,
Borthakur G
, DiPippo AJ,
Jabbour E
,
Konopleva M
, Short NJ,
DiNardo C
,
Daver N
, Ravandi F,
Kadia TM
. Validation of the ALFA-1200 model in older patients with AML treated with intensive chemotherapy. Blood Adv. 2023 03 14; 7(5):828-831.
PMID:
35405739
; PMCID:
PMC9996355
.
Citations:
Fields:
Hem
Hematology
Nguyen D,
Kantarjian HM
, Short NJ, Qiao W, Ning J, Cuglievan B,
Daver NG
,
DiNardo CD
,
Jabbour EJ
,
Kadia TM
,
Borthakur G
,
Garcia-Manero G
,
Konopleva MY
,
Andreeff M
,
Ravandi-Kashani F
, Sasaki K, Issa GC. Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation. Cancer. 2023 06 15; 129(12):1856-1865.
PMID:
36892949
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Konopleva M
, DiNardo C, Bhagat T, Baran N, Lodi A, Saxena K, Cai T,
Su X
, Skwarska A, Guerra V, Kuruvilla V, Konoplev S, Gordon-Mitchell S, Pradhan K, Aluri S, Collins M, Sweeney S, Busquet J, Rathore A, Deng Q, Green M, Grant S, Demo S, Choudhary G, Sahu S, Agarwal B, Spodek M, Thiruthuvanathan V, Will B, Steidl U, Tippett G,
Burger J
, Borthakur G, Jabbour E, Pemmaraju N,
Kadia T
,
Kornblau S
, Daver N,
Naqvi K
, Short N, Garcia-Manero G, Tiziani S, Verma A, Konopleva M,
DiNardo C
, Bhagat T, Baran N, Lodi A, Saxena K, Cai T, Su X, Skwarska A, Guerra V, Kuruvilla V,
Konoplev S
, Gordon-Mitchell S, Pradhan K, Aluri S, Collins M, Sweeney S, Busquet J, Rathore A, Deng Q, Green M, Grant S, Demo S, Choudhary G, Sahu S, Agarwal B, Spodek M, Thiruthuvanathan V, Will B, Steidl U, Tippett G, Burger J,
Borthakur G
,
Jabbour E
,
Pemmaraju N
, Kadia T, Komblau S,
Daver N
, Naqvi K, Short N,
Garcia-Manero G
, Tiziani S, Verma A. Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: Clinical efficacy and correlative analyses. Res Sq. 2023 Feb 23.
PMID:
36865338
; PMCID:
PMC9980221
.
Citations:
Thongon N, Ma F, Lockyer P, Baran N, Liu J, Jackson C, Rose A, Wildeman B, Marchesini M, Marchica V, Storti P, Giuliani N, Ganan-Gomez I, Adema V, Qing Y, Ha M, Fonseca R, Class C, Tan L, Kanagal-Shamanna R, Nolasco DB, Cerchione C, Montalban-Bravo G, Santoni A,
Bueso-Ramos C
,
Konopleva M
, Lorenzi P,
Garcia-Manero G
, Manasanch E, Viale A, Chesi M,
Colla S
. Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple Myeloma. bioRxiv. 2023 Feb 22.
PMID:
36865225
; PMCID:
PMC9980056
.
Citations:
Pemmaraju N
,
Kantarjian H
, Sweet K, Wang E, Senapati J, Wilson NR,
Konopleva M
, Frankel AE, Gupta V, Mesa R, Ulrickson M, Gorak E, Bhatia S, Budak-Alpdogan T, Mason J, Garcia-Romero MT, Lopez-Santiago N, Cesarman-Maus G, Vachhani P, Lee S, Bhatt VR, Blum W, Walter RB, Bixby D, Gojo I,
Duvic M
, Rampal RK, de Lima M, Foran J, Fathi AT, Hall AC, Jacoby MA, Lancet J, Mannis G, Stein AS, Mims A, Rizzieri D, Olin R, Perl A, Schiller G, Shami P, Stone RM, Strickland S, Wieduwilt MJ,
Daver N
, Ravandi F, Vasu S, Guzman M, Roboz GJ,
Khoury J
,
Qazilbash M
,
Aung PP
, Cuglievan B, Madanat Y, Kharfan-Dabaja MA, Pawlowska A, Taylor J, Tallman M, Dhakal P, Lane AA. North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need. Blood. 2023 02 09; 141(6):567-578.
PMID:
36399715
.
Citations:
3
Fields:
Hem
Hematology
Translation:
Humans
Cells
Yap TA,
Daver N
, Mahendra M, Zhang J, Kamiya-Matsuoka C,
Meric-Bernstam F
,
Kantarjian HM
, Ravandi F, Collins ME, Francesco MED, Dumbrava EE,
Fu S
, Gao S, Gay JP, Gera S, Han J,
Hong DS
,
Jabbour EJ
, Ju Z,
Karp DD
, Lodi A, Molina JR, Baran N,
Naing A
,
Ohanian M
,
Pant S
,
Pemmaraju N
,
Bose P
,
Piha-Paul SA
, Rodon J, Salguero C, Sasaki K, Singh AK,
Subbiah V
,
Tsimberidou AM
, Xu QA, Yilmaz M, Zhang Q, Li Y, Bristow CA, Bhattacharjee MB, Tiziani S, Heffernan TP, Vellano CP, Jones P,
Heijnen CJ
,
Kavelaars A
, Marszalek JR,
Konopleva M
. Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nat Med. 2023 01; 29(1):115-126.
PMID:
36658425
.
Citations:
28
Fields:
Med
Medicine (General)
Mol
Molecular Biology
Translation:
Humans
Animals
Cells
CT
Clinical Trials
Li Y, Moriyama T, Yoshimura S, Zhao X, Li Z, Yang X, Paietta E, Litzow MR,
Konopleva M
, Yu J, Inaba H, Ribeiro RC, Pui CH, Yang JJ. PAX5 epigenetically orchestrates CD58 transcription and modulates blinatumomab response in acute lymphoblastic leukemia. Sci Adv. 2022 12 14; 8(50):eadd6403.
PMID:
36516256
; PMCID:
PMC9750140
.
Citations:
2
Fields:
Sci
Science
Translation:
Humans
Zeng Z
, Maiti A, Herbrich S, Cai T, Cavazos A, Manzella T, Ma H, Hayes K, Matthews J,
DiNardo CD
,
Daver NG
,
Konopleva MY
. Triple combination targeting methyltransferase, BCL-2, and PD-1 facilitates antileukemia responses in acute myeloid leukemia. Cancer. 2023 02 15; 129(4):531-540.
PMID:
36477735
.
Citations:
2
Fields:
Neo
Neoplasms
Translation:
Humans
Bazinet A, Darbaniyan F,
Kadia TM
, Venugopal S, Kanagal-Shamanna R,
DiNardo CD
,
Borthakur G
,
Jabbour EJ
,
Daver NG
,
Pemmaraju N
,
Konopleva MY
, Ravandi F, Sasaki K, Chien KS, Hammond D, Pierce SA,
Kantarjian HM
,
Garcia-Manero G
, Montalban-Bravo G. A retrospective study of cladribine and low-dose cytarabine-based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia. Cancer. 2023 02 15; 129(4):560-568.
PMID:
36458426
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Imahashi N, Basar R, Huang Y, Wang F, Baran N, Banerjee PP, Lu J, Nunez Cortes AK, Uprety N, Ensley E, Muniz-Feliciano L, Laskowski TJ, Moyes JS, Daher M, Mendt M, Kerbauy LN, Shanley M, Li L, Lim FLWI, Shaim H, Li Y,
Konopleva M
, Green M,
Wargo J
,
Shpall EJ
, Chen K, Rezvani K. Activated B cells suppress T-cell function through metabolic competition. J Immunother Cancer. 2022 Dec; 10(12).
PMID:
36543374
.
Citations:
1
Fields:
Neo
Neoplasms
The
Therapeutics
Goradia N, Shastri A, Verma A, Feldman E, Cooper D,
Konopleva M
, Fox S, Gritsman K, Shah N, Mantzaris I, Braunschweig I, Kornblum N, Sica A, Levitz D, Comas M, Goldfinger M. A Co-Management Model for Myeloid Malignancies That Evolved during the COVID-19 Pandemic. Acta Haematol. 2023; 146(2):144-150.
PMID:
36446346
; PMCID:
PMC9892996
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
PH
Public Health
Jabbour E
, Short NJ,
Jain N
, Huang X, Montalban-Bravo G, Banerjee P, Rezvani K, Jiang X, Kim KH, Kanagal-Shamanna R,
Khoury JD
, Patel K,
Kadia TM
,
Daver N
, Chien K,
Alvarado Y
,
Garcia-Manero G
, Issa GC, Haddad FG, Kwari M, Thankachan J, Delumpa R, Macaron W, Garris R,
Konopleva M
, Ravandi F,
Kantarjian H
. Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial. Lancet Haematol. 2022 Nov 16.
PMID:
36402146
.
Citations:
13
Fields:
Hem
Hematology
Neo
Neoplasms
Yennurajalingam S,
Konopleva M
,
Carmack CL
,
Dinardo CD
, Gaffney M, Michener HK, Lu Z, Stanton P,
Ning J
, Qiao W,
Bruera E
. Treatment of Cancer-related-Fatigue in Acute Hematological Malignancies: Results of a Feasibility Study of using Cognitive Behavioral Therapy. J Pain Symptom Manage. 2023 03; 65(3):e189-e197.
PMID:
36384181
.
Citations:
1
Fields:
Pal
Palliative Care
Psy
Psychophysiology
The
Therapeutics
Translation:
Humans
Jabbour E
, Short NJ,
Jain N
, Thompson PA,
Kadia TM
,
Ferrajoli A
, Huang X, Yilmaz M,
Alvarado Y
,
Patel KP
,
Garcia-Manero G
, Macaron W, Garris R,
Konopleva M
, Ravandi F,
Kantarjian H
. Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial. Lancet Haematol. 2022 Dec; 9(12):e878-e885.
PMID:
36279879
.
Citations:
6
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Cells
CT
Clinical Trials
Rivera D, Kim K, Kanagal-Shamanna R,
Borthakur G
, Montalban-Bravo G,
Daver N
,
Dinardo C
, Short NJ, Yilmaz M,
Pemmaraju N
,
Takahashi K
,
Jabbour EJ
, Pierce S,
Konopleva M
,
Bhalla K
,
Garcia-Manero G
, Ravandi F,
Kantarjian H
,
Kadia TM
. Implications of RAS mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypes. Am J Hematol. 2022 Dec; 97(12):1599-1606.
PMID:
36117258
.
Citations:
Venugopal S,
Borthakur G
,
Daver N
,
DiNardo CD
,
Pemmaraju N
, Short NJ, Abbas HA,
Garcia-Manero G
,
Konopleva M
, Ravandi F,
Kadia TM
. Validation of ALFA 1200 score in patients with AML >60 years treated with double nucleoside-based low-intensity therapy. Blood Adv. 2022 10 11; 6(19):5546-5549.
PMID:
35201293
; PMCID:
PMC9647734
.
Citations:
Fields:
Hem
Hematology
Benjamin R,
Jain N
, Maus MV, Boissel N, Graham C, Jozwik A, Yallop D,
Konopleva M
, Frigault MJ, Teshima T, Kato K, Boucaud F, Balandraud S, Gianella-Borradori A, Binlich F, Marchiq I, Dupouy S, Almena-Carrasco M, Pannaux M, Fouliard S, Brissot E, Mohty M, CALM Study Group. UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial. Lancet Haematol. 2022 Nov; 9(11):e833-e843.
PMID:
36228643
.
Citations:
16
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Venugopal S,
DiNardo CD
,
Loghavi S
, Qiao W, Ravandi F,
Konopleva M
,
Kadia T
,
Bhalla K
,
Jabbour E
, Issa GC, Macaron W,
Daver N
,
Borthakur G
, Montalban-Bravo G, Yilmaz M,
Patel KP
, Kanagal-Shamanna R, Chien K, Maiti A,
Kantarjian H
, Short NJ. Differential prognostic impact of RUNX1 mutations according to frontline therapy in patients with acute myeloid leukemia. Am J Hematol. 2022 Dec; 97(12):1560-1567.
PMID:
36087091
.
Citations:
Jonas BA,
DiNardo C
, Fracchiolla N, Pristupa A, Ishizawa K, Jin J,
Konopleva M
, Ofran Y, Montesinos P, Kovacsovics T, Jang JH,
Kantarjian H
, Duan Y, Potluri J, Werner M, Pratz KW. Use of CYP3Ai and impact on outcomes in patients with acute myeloid leukemia treated with venetoclax plus azacitidine in the VIALE-A study. Am J Hematol. 2022 11; 97(11):E422-E425.
PMID:
36053878
; PMCID:
PMC10286746
.
Citations:
Pratz KW,
DiNardo CD
, Selleslag D, Li J, Yamamoto K,
Konopleva M
, Stevens D,
Kantarjian H
, Traina F, Venditti A, Mayer J, Montez M, Jin H, Duan Y, Brackman D, Zha J, Potluri J, Werner M, Jonas BA. Postremission cytopenia management in patients with acute myeloid leukemia treated with venetoclax and azacitidine in VIALE-A. Am J Hematol. 2022 Nov; 97(11):E416-E419.
PMID:
36054316
.
Citations:
Lachowiez CA, Reville PK,
Kantarjian H
,
Jabbour E
,
Borthakur G
,
Daver N
, Issa G, Furudate K, Tanaka T, Pierce S, Tang G,
Patel KP
, Medeiros J, Abbas HA, Haddad F, Hammond D, Short NJ, Maiti A, Yilmaz M, Sasaki K,
Takahashi K
,
Pemmaraju N
,
Konopleva M
,
Garcia-Manero G
, Ravandi F,
Kadia TM
,
Loghavi S
,
DiNardo CD
. Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment. Am J Hematol. 2022 Nov; 97(11):1443-1452.
PMID:
36054614
.
Citations:
Zhao X, Wang P, Diedrich JD, Smart B, Reyes N, Yoshimura S, Zhang J, Yang W, Barnett K, Xu B, Li Z, Huang X, Yu J, Crews K, Yeoh AEJ,
Konopleva M
, Wei CL, Pui CH, Savic D, Yang JJ. Epigenetic activation of the FLT3 gene by ZNF384 fusion confers a therapeutic susceptibility in acute lymphoblastic leukemia. Nat Commun. 2022 09 14; 13(1):5401.
PMID:
36104354
; PMCID:
PMC9474531
.
Citations:
Abbas HA, Ayoub E, Sun H, Kanagal-Shamanna R, Short NJ, Issa G, Yilmaz M, Pierce S, Rivera D, Cham B, Wing S, Li Z, Hammond D,
Jabbour E
,
Borthakur G
,
Garcia-Manero G
,
Andreeff M
,
Daver N
,
Kadia T
,
Konopleva M
,
DiNardo C
, Ravandi F. Clinical and molecular profiling of AML patients with chromosome 7 or 7q deletions in the context of TP53 alterations and venetoclax treatment. Leuk Lymphoma. 2022 12; 63(13):3105-3116.
PMID:
36089905
; PMCID:
PMC9772202
.
Citations:
Short NJ, Macaron W,
Kadia T
,
Dinardo C
, Issa GC,
Daver N
, Wang S,
Jorgensen J
, Nguyen D, Bidikian A,
Patel KP
,
Loghavi S
,
Konopleva M
, Yilmaz M,
Jabbour E
, Maiti A, Abbas HA,
Shpall E
,
Popat U
,
Al-Atrash G
, Pierce S,
Kantarjian HM
, Ravandi F. Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease?(MRD) recurrence following MRD-negative remission. Am J Hematol. 2022 Nov; 97(11):E408-E411.
PMID:
36054774
.
Citations:
Park S, Sater AHA, Fahrmann JF, Irajizad E, Cai Y, Katayama H, Vykoukal J, Kobayashi M, Dennison JB,
Garcia-Manero G
, Mullighan CG, Gu Z,
Konopleva M
,
Hanash S
. Novel UHRF1-MYC Axis in Acute Lymphoblastic Leukemia. Cancers (Basel). 2022 Aug 31; 14(17).
PMID:
36077796
; PMCID:
PMC9455066
.
Citations:
Pemmaraju N
, Wilson NR, Senapati J, Economides MP, Guzman ML,
Neelapu SS
, Kazemimood R, Davis RE,
Jain N
,
Khoury JD
, Sugita M, Cai T, Smith J, Frattini MG, Garton A, Roboz G,
Konopleva M
. CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insights. Leuk Res. 2022 10; 121:106928.
PMID:
35963025
.
Citations:
Konopleva MY
, Cavenagh J, Deeren D, Girshova L, Martinelli G, Ottmann O, Petrini M, Pigneux A, Rambaldi A, Recher C, Taussig D, Vey N, Yoon SS, Ott M, Muehlbauer S, Beckermann BM, Catalani O, Genevray M, Mundt K, Jamois C, Wei AH, R?llig C, Krauter J, Montesinos P, Sch?fer JA, Rodriguez-Veiga R, Fenaux P. Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial. Blood Adv. 2022 07 26; 6(14):4147-4156.
PMID:
35413116
; PMCID:
PMC9327534
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Pemmaraju N
, Sweet KL, Stein AS, Wang ES, Rizzieri DA, Vasu S, Rosenblat TL, Brooks CL, Habboubi N, Mughal TI,
Kantarjian H
,
Konopleva M
, Lane AA. Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm. J Clin Oncol. 2022 09 10; 40(26):3032-3036.
PMID:
35820082
; PMCID:
PMC9462530
.
Citations:
Fields:
Neo
Neoplasms
Chua CC, Hammond D, Kent A, Tiong IS,
Konopleva MY
, Pollyea DA,
DiNardo CD
, Wei AH. Treatment-free remission after ceasing venetoclax-based therapy in patients with acute myeloid leukemia. Blood Adv. 2022 07 12; 6(13):3879-3883.
PMID:
35511730
; PMCID:
PMC9278306
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Short NJ,
Kantarjian H
, Ravandi F,
Konopleva M
,
Jain N
, Kanagal-Shamanna R,
Patel KP
, Macaron W,
Kadia TM
, Wang S,
Jorgensen JL
,
Khoury JD
, Yilmaz M,
Kebriaei P
,
Takahashi K
,
Garcia-Manero G
,
Daver N
, Post SM, Huang X,
Kornblau SM
, Pelletier S, Flores W, Matthews J, Garris R,
Jabbour E
. High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapse. Blood Adv. 2022 07 12; 6(13):4006-4014.
PMID:
35533262
; PMCID:
PMC9278301
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
Wang W, Xu J,
Khoury JD
,
Pemmaraju N
, Fang H,
Miranda RN
, Yin CC, Hussein SE, Jia F,
Tang Z
, Hu S,
Konopleva M
,
Medeiros LJ
, Wang SA. Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers (Basel). 2022 Jul 11; 14(14).
PMID:
35884435
; PMCID:
PMC9324882
.
Citations:
Konopleva M
, Thirman MJ, Pratz KW, Garcia JS, Recher C, Pullarkat V,
Kantarjian HM
,
DiNardo CD
, Dail M, Duan Y, Chyla B, Potluri J, Miller CL, Wei AH. Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Na?ve Acute Myeloid Leukemia. Clin Cancer Res. 2022 07 01; 28(13):2744-2752.
PMID:
35063965
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Pollyea DA,
DiNardo CD
, Arellano ML, Pigneux A, Fiedler W,
Konopleva M
, Rizzieri DA, Smith BD, Shinagawa A, Lemoli RM, Dail M, Duan Y, Chyla B, Potluri J, Miller CL,
Kantarjian HM
. Impact of Venetoclax and Azacitidine in Treatment-Na?ve Patients with Acute Myeloid Leukemia and IDH1/2 Mutations. Clin Cancer Res. 2022 07 01; 28(13):2753-2761.
PMID:
35046058
.
Citations:
2
Fields:
Neo
Neoplasms
Translation:
Humans
Desikan SP, Ravandi F,
Pemmaraju N
,
Konopleva M
,
Loghavi S
,
Jabbour EJ
,
Daver N
,
Jain N
, Chien KS, Maiti A, Montalban-Bravo G,
Kadia TM
, Macaron W, DeLumpa R, Kwari M,
Borthakur G
, Short NJ. A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations. Acta Haematol. 2022; 145(5):529-536.
PMID:
35717939
.
Citations:
Fields:
Hem
Hematology
Kadia TM
, Reville PK, Wang X, Rausch CR,
Borthakur G
,
Pemmaraju N
,
Daver NG
,
DiNardo CD
, Sasaki K, Issa GC,
Ohanian M
, Montalban-Bravo G, Short NJ,
Jain N
,
Ferrajoli A
,
Bhalla KN
,
Jabbour E
,
Takahashi K
, Malla R, Quagliato K, Kanagal-Shamanna R,
Popat UR
,
Andreeff M
,
Garcia-Manero G
,
Konopleva MY
, Ravandi F,
Kantarjian HM
. Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia. J Clin Oncol. 2022 Nov 20; 40(33):3848-3857.
PMID:
35704787
; PMCID:
PMC9671758
.
Citations:
Fields:
Neo
Neoplasms
Desikan SP,
Daver N
,
DiNardo C
,
Kadia T
,
Konopleva M
, Ravandi F. Resistance to targeted therapies: delving into FLT3 and IDH. Blood Cancer J. 2022 06 09; 12(6):91.
PMID:
35680852
; PMCID:
PMC9184476
.
Citations:
Fields:
All
Allergy and Immunology
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Panina SB, Pei J, Baran N, Tjahjono E, Patel S, Alatrash G,
Konoplev S
, Stolbov LA, Poroikov VV,
Konopleva M
, Kirienko NV. Novel mitochondria-targeting compounds selectively kill human leukemia cells. Leukemia. 2022 08; 36(8):2009-2021.
PMID:
35672446
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Cavelier L, Haferlach C,
Konopleva M
, Fioretos T, Smedby KE, W?sterlid T, Fr?hling S, ?stling P, Bullinger L. Application of precision medicine in clinical routine in haematology-Challenges and opportunities. J Intern Med. 2022 08; 292(2):243-261.
PMID:
35599019
; PMCID:
PMC9546002
.
Citations:
Fields:
Int
Internal Medicine
Translation:
Humans
Pabon CM, Abbas HA,
Konopleva M
. Acute myeloid leukemia: therapeutic targeting of stem cells. Expert Opin Ther Targets. 2022 06; 26(6):547-556.
PMID:
35634856
.
Citations:
Fields:
The
Therapeutics
Translation:
Humans
Cells
Carter BZ
, Mak PY, Tao W, Zhang Q, Ruvolo V, Kuruvilla VM, Wang X, Mak DH,
Battula VL
,
Konopleva M
,
Jabbour EJ
, Hughes PE, Chen X, Morrow PK,
Andreeff M
. Maximal Activation of Apoptosis Signaling by Cotargeting Antiapoptotic Proteins in BH3 Mimetic-Resistant AML and AML Stem Cells. Mol Cancer Ther. 2022 06 01; 21(6):879-889.
PMID:
35364607
; PMCID:
PMC9167707
.
Citations:
Fields:
Ant
Antineoplastic Agents
Translation:
Humans
Animals
Cells
Post SM
, Ma H, Malaney P, Zhang X, Aitken MJL, Mak PY, Ruvolo VR, Yasuhiro T, Kozaki R, Chan LE, Ostermann LB,
Konopleva M
,
Carter BZ
,
DiNardo C
,
Andreeff MD
,
Khoury JD
,
Ruvolo PP
. AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill FLT3-ITD acute myeloid leukemia. Haematologica. 2022 06 01; 107(6):1311-1322.
PMID:
34732043
; PMCID:
PMC9152975
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Animals
Cells
Kim K, Bazinet A,
Loghavi S
,
Konopleva M
,
Bhalla K
,
Daver N
,
Khoury JD
,
Kadia T
, Wilson NR,
Curry JL
, Heberton M, Miller D, Pierce S,
Borthakur G
,
Pemmaraju N
. Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine. Leuk Res. 2022 08; 119:106884.
PMID:
35691130
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
DiNardo CD
, Lachowiez CA,
Takahashi K
,
Loghavi S
,
Kadia T
,
Daver N
, Xiao L, Adeoti M, Short NJ, Sasaki K, Wang SA,
Borthakur G
, Issa G, Maiti A,
Alvarado Y
,
Pemmaraju N
, Bravo GM, Masarova L, Yilmaz M,
Jain N
,
Andreeff M
,
Garcia-Manero G
,
Kornblau S
, Ravandi F,
Jabbour E
,
Konopleva MY
,
Kantarjian HM
. Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia. Am J Hematol. 2022 08; 97(8):1035-1043.
PMID:
35583199
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Pemmaraju N
, Wilson NR,
Garcia-Manero G
, Sasaki K,
Khoury JD
,
Jain N
,
Borthakur G
, Ravandi F,
Daver N
,
Kadia T
,
DiNardo C
,
Jabbour E
, Pierce S,
Qazilbash M
,
Konopleva M
,
Kantarjian H
. Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD. Blood Adv. 2022 05 24; 6(10):3027-3035.
PMID:
35061885
; PMCID:
PMC9131912
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Cells
Baran N, Lodi A, Dhungana Y, Herbrich S, Collins M, Sweeney S, Pandey R, Skwarska A, Patel S, Kuruvilla VM, Cavazos A, Kaplan M, Warmoes MO, Veiga DT, Furudate K, Ma H, Harutyunyan K, Daher M, Garcia LM,
Al-Atrash G
,
Piya S
, Ruvolo V, Yang W, Shanmugavelandy SS, Feng N, Gay J, Du D, Yang JJ, Hoff FW, Kaminski M, Tomczak K, Eric Davis R, Herranz D, Ferrando A,
Jabbour EJ
, Emilia Di Francesco M, Teachey DT,
Horton TM
,
Kornblau S
, Rezvani K, Gagea M,
Andreeff M
,
Takahashi K
, Marszalek JR, Lorenzi PL, Yu J, Tiziani S,
Konopleva M
, Tremblay M, Rojas-Sutterin S, Haman A, Gareau Y, Marinier A, Sauvageau G, Hoang T. Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia. Nat Commun. 2022 05 19; 13(1):2801.
PMID:
35589701
; PMCID:
PMC9120040
.
Citations:
Fields:
Bio
Biology
Sci
Science
Translation:
Animals
Cells
Ong F, Kim K,
Konopleva MY
. Venetoclax resistance: mechanistic insights and future strategies. Cancer Drug Resist. 2022; 5(2):380-400.
PMID:
35800373
; PMCID:
PMC9255248
.
Citations:
Tyagi A, Ly S, El-Dana F, Yuan B, Jaggupilli A,
Konopleva M
, Battula VL, Grimm S, B?hring HJ. Evidence supporting a role for the immune checkpoint protein B7-H3 in NK cell-mediated cytotoxicity against AML. Blood. 2022 05 05; 139(18):2782-2796.
PMID:
35231101
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
Animals
Cells
Yilmaz M,
Kantarjian H
, Short NJ, Reville P,
Konopleva M
,
Kadia T
,
DiNardo C
,
Borthakur G
,
Pemmaraju N
, Maiti A,
Jabbour E
,
Jain N
, Issa G,
Takahashi K
, Sasaki K,
Ohanian M
, Pierce S, Tang G,
Loghavi S
, Patel K, Wang SA,
Garcia-Manero G
,
Andreeff M
, Ravandi F,
Daver N
. Hypomethylating agent and venetoclax with FLT3 inhibitor "triplet" therapy in older/unfit patients with FLT3 mutated AML. Blood Cancer J. 2022 05 02; 12(5):77.
PMID:
35501304
; PMCID:
PMC9061716
.
Citations:
Fields:
All
Allergy and Immunology
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Sasaki Y,
Kantarjian HM
, Short NJ, Wang F, Furudate K, Uryu H, Garris R,
Jain N
, Sasaki K, Ravandi F,
Konopleva M
,
Garcia-Manero G
, Little L, Gumbs C, Zhao L, Futreal PA,
Takahashi K
,
Jabbour E
. Correction: Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib. Leukemia. 2022 May; 36(5):1448.
PMID:
35411096
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Lachowiez CA, Reville PK,
Kantarjian H
,
Jabbour E
,
Borthakur G
,
Daver N
,
Loghavi S
, Furudate K, Xiao L, Pierce S, Short NJ, Maiti A, Yilmaz M, Sasaki K,
Takahashi K
,
Konopleva M
,
Pemmaraju N
,
Popat U
,
Shpall E
,
Garcia-Manero G
, Ravandi F,
DiNardo CD
,
Kadia TM
. Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study. Lancet Haematol. 2022 May; 9(5):e350-e360.
PMID:
35483396
; PMCID:
PMC9946440
.
Citations:
1
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Kim K,
Konopleva M
,
DiNardo CD
,
Borthakur G
,
Loghavi S
, Tang G,
Daver N
,
Pemmaraju N
,
Jabbour E
, Rausch CR, Yilmaz M, Sasaki K, Short NJ,
Jain N
, Brandt M, Pierce S,
Garcia-Manero G
, Ravandi F,
Kantarjian H
,
Kadia TM
. Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials. Am J Hematol. 2022 07; 97(7):885-894.
PMID:
35413152
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
Cai T, Black KL, Skwarska A, Naqvi AS, Taylor D,
Zhao M
, Yuan Q, Sugita M, Zhang Q, Galetto R, Cavazos A, Han L, Kuruvilla V, Ma H, Weng C, Liu CG, Liu X,
Konoplev S
, Gu J, Tang G,
Su X
,
Al-Atrash G
,
Ciurea S
,
Neelapu SS
, Lane AA,
Kantarjian H
, Guzman ML,
Pemmaraju N
, Smith J, Thomas-Tikhonenko A,
Konopleva M
, Gouble A, Filipe S. Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells. Nat Commun. 2022 04 28; 13(1):2228.
PMID:
35484100
; PMCID:
PMC9051102
.
Citations:
Fields:
Bio
Biology
Sci
Science
Translation:
Humans
Animals
Cells
Sheshadri A
, Goizueta AA,
Shannon VR
, London D,
Garcia-Manero G
,
Kantarjian HM
,
Ravandi-Kashani F
,
Kadia TM
,
Konopleva MY
,
DiNardo CD
, Pierce S, Zarifa A, Albittar AA, Zhong LL, Akhmedzhanov FO, Arain MH, Alfayez M, Alotaibi A, Altan M,
Naing A
,
Mendoza TR
,
Godoy MCB
,
Shroff G
, Kim ST,
Faiz SA
,
Kontoyiannis DP
, Khawaja F, Jennings K,
Daver NG
. Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: A retrospective cohort study. Cancer. 2022 07 15; 128(14):2736-2745.
PMID:
35452134
; PMCID:
PMC9232977
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Short NJ,
Borthakur G
,
Pemmaraju N
,
Dinardo CD
,
Kadia TM
,
Jabbour E
,
Konopleva M
, Macaron W,
Ning J
, Ma J, Pierce S,
Alvarado Y
, Sasaki K,
Takahashi K
,
Estrov Z
, Masarova L, Issa GC, Montalban-Bravo G,
Andreeff M
,
Burger JA
, Miller D, Alexander L,
Naing A
,
Garcia-Manero G
, Ravandi F,
Daver N
. A multi-arm phase Ib/II study designed for rapid, parallel evaluation of novel immunotherapy combinations in relapsed/refractory acute myeloid leukemia. Leuk Lymphoma. 2022 09; 63(9):2161-2170.
PMID:
35442137
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Sasaki K, Ravandi F,
Kadia T
,
DiNardo C
,
Borthakur G
, Short N,
Jain N
,
Daver N
,
Jabbour E
,
Garcia-Manero G
,
Khoury J
,
Konoplev S
,
Loghavi S
, Patel K, Montalban-Bravo G, Masarova L,
Konopleva M
,
Kantarjian H
. Prediction of survival with intensive chemotherapy in acute myeloid leukemia. Am J Hematol. 2022 07; 97(7):865-876.
PMID:
35384048
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
Haddad FG, Sasaki K, Issa GC,
Garcia-Manero G
, Ravandi F,
Kadia T
, Cortes J,
Konopleva M
,
Pemmaraju N
,
Alvarado Y
, Yilmaz M,
Borthakur G
,
DiNardo C
,
Jain N
,
Daver N
, Short NJ,
Jabbour E
,
Kantarjian H
. Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors. Am J Hematol. 2022 07; 97(7):856-864.
PMID:
35357036
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Maiti A,
Carter BZ
,
Andreeff M
,
Konopleva MY
. Beyond BCL-2 Inhibition in Acute Myloid Leukemia: Other Approaches to Leverage the Apoptotic Pathway. Clin Lymphoma Myeloma Leuk. 2022 09; 22(9):652-658.
PMID:
35490155
.
Citations:
Fields:
Neo
Neoplasms
Kannan S, Irwin ME, Herbrich SM, Cheng T, Patterson LL, Aitken MJL,
Bhalla K
, You MJ,
Konopleva M
, Zweidler-McKay PA,
Chandra J
. Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy. Antioxidants (Basel). 2022 Apr 05; 11(4).
PMID:
35453402
; PMCID:
PMC9027903
.
Citations:
Zhang Q, Riley-Gillis B, Han L, Jia Y, Lodi A, Zhang H, Pan R,
Konoplev SN
, Sweeney SR, Ryan JA, Jitkova Y, Dunner K, Grosskurth SE, Vijay P, Ghosh S,
Lu C
, Ma W, Kurtz S, Ruvolo VR, Ma H, Weng CC, Ramage CL, Baran N, Shi C, Cai T, Davis RE,
Battula VL
, Mi Y, Wang J,
DiNardo CD
,
Andreeff M
, Tyner JW, Schimmer A, Letai A,
Bueso-Ramos CE
, Tiziani S, Leverson J, Popovic R,
Konopleva M
, Ganesan S, Padua RA. Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia. Signal Transduct Target Ther. 2022 Apr 01; 7(1):110.
PMID:
35365596
; PMCID:
PMC8975942
.
Citations:
Fields:
Cel
Cell Biology
Dru
Drug Therapy
Short NJ, Macaron W,
Konopleva M
, Ravandi F,
Jain N
, Issa GC,
Kadia T
, Sasaki K,
Kebriaei P
, Yilmaz M, Thompson PA,
Takahashi K
, Abbas HA,
Wierda WG
, Garris R,
Kantarjian HM
,
Jabbour E
. Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab. Am J Hematol. 2022 06 01; 97(6):E201-E204.
PMID:
35266566
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
Cells
Zhang Q, Riley-Gillis B, Han L, Jia Y, Lodi A, Zhang H, Pan R,
Konoplev SN
, Sweeney SR, Ryan JA, Jitkova Y, Dunner K, Grosskurth SE, Vijay P, Ghosh S,
Lu C
, Ma W, Kurtz S, Ruvolo VR, Ma H, Weng CC, Ramage CL, Baran N, Shi C, Cai T, Davis RE,
Battula VL
, Mi Y, Wang J,
DiNardo CD
,
Andreeff M
, Tyner JW, Schimmer A, Letai A,
Bueso-Ramos CE
, Tiziani S, Leverson J, Popovic R,
Konopleva M
, Ganesan S, Padua RA. Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia. Signal Transduct Target Ther. 2022 02 21; 7(1):51.
PMID:
35185150
; PMCID:
PMC8858957
.
Citations:
3
Fields:
Cel
Cell Biology
Dru
Drug Therapy
Translation:
Humans
Cells
Sasaki Y,
Kantarjian HM
, Short NJ, Wang F, Furudate K, Uryu H, Garris R,
Jain N
, Sasaki K, Ravandi F,
Konopleva M
,
Garcia-Manero G
, Little L, Gumbs C, Zhao L, Futreal PA,
Takahashi K
,
Jabbour E
. Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib. Leukemia. 2022 05; 36(5):1253-1260.
PMID:
35132195
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Cells
Yamatani K, Ai T, Saito K, Suzuki K, Hori A, Kinjo S, Ikeo K, Ruvolo V, Zhang W, Mak PY, Kaczkowski B, Harada H, Katayama K, Sugimoto Y, Myslinski J, Hato T, Miida T,
Konopleva M
, Hayashizaki Y,
Carter BZ
, Tabe Y,
Andreeff M
. Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML. Transl Oncol. 2022 Apr; 18:101354.
PMID:
35114569
; PMCID:
PMC8818561
.
Citations:
Short NJ, Venugopal S, Qiao W,
Kadia TM
, Ravandi F, Macaron W,
Dinardo CD
,
Daver N
,
Konopleva M
,
Borthakur G
,
Shpall EJ
,
Popat U
,
Champlin RE
,
Mehta R
,
Al-Atrash G
,
Oran B
,
Jabbour E
,
Garcia-Manero G
, Issa GC, Montalban-Bravo G, Yilmaz M, Maiti A,
Kantarjian H
. Impact of frontline treatment approach on outcomes in patients with secondary AML with prior hypomethylating agent exposure. J Hematol Oncol. 2022 01 29; 15(1):12.
PMID:
35093134
; PMCID:
PMC8800349
.
Citations:
1
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Venugopal S,
Takahashi K
,
Daver N
, Maiti A,
Borthakur G
,
Loghavi S
, Short NJ,
Ohanian M
, Masarova L, Issa G, Wang X, Carlos BR, Yilmaz M,
Kadia T
,
Andreeff M
, Ravandi F,
Konopleva M
,
Kantarjian HM
,
DiNardo CD
. Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapy. Blood Cancer J. 2022 01 25; 12(1):10.
PMID:
35078972
; PMCID:
PMC8789767
.
Citations:
4
Fields:
All
Allergy and Immunology
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Siddiqui M,
Konopleva M
. Keeping up with venetoclax for leukemic malignancies: key findings, optimal regimens, and clinical considerations. Expert Rev Clin Pharmacol. 2021 Dec; 14(12):1497-1512.
PMID:
34791957
.
Citations:
Fields:
Pha
Pharmacology
Translation:
Humans
Reville PK, Sasaki K,
Kantarjian HM
,
Daver NG
, Yilmaz M,
Dinardo CD
, Short NJ,
Borthakur G
,
Pemmaraju N
,
Mehta RS
, Pierce S,
Konoplev SN
,
Khoury JD
,
Garcia-Manero G
,
Konopleva MY
,
Jabbour E
, Ravandi F,
Kadia TM
. Improved outcomes among newly diagnosed patients with FMS-like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification. Am J Hematol. 2022 03 01; 97(3):329-337.
PMID:
34981570
; PMCID:
PMC8884919
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Maiti A,
Konopleva MY
. How We Incorporate Venetoclax in Treatment Regimens for Acute Myeloid Leukemia. Cancer J. 2022 Jan-Feb 01; 28(1):2-13.
PMID:
35072368
; PMCID:
PMC8785772
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Heuser M, Freeman SD, Ossenkoppele GJ, Buccisano F, Hourigan CS, Ngai LL, Tettero JM, Bachas C, Baer C, Czyz A, Denys B, Dillon R, Feuring-Buske M, Guzman ML, Haferlach T, Han L, Herzig JK,
Jorgensen JL
, Kern W,
Konopleva MY
, Lacombe F, Libura M, Majchrzak A, Maurillo L, Ofran Y, Philippe J, Plesa A, Ravandi F, Subklewe M, Thol F, van de Loosdrecht AA, van der Reijden BA, Venditti A, Wierzbowska A, Valk PJM, Wood BL, Walter RB, Thiede C, Roboz GJ, Cloos J, B?n? MC, B?cklein V, Preudhomme C, Roumier C, D?hner K. 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party. Blood. 2021 12 30; 138(26):2753-2767.
PMID:
34724563
; PMCID:
PMC8718623
.
Citations:
17
Fields:
Hem
Hematology
Translation:
Humans
Gibson A, Trabal A, McCall D, Khazal S, Toepfer L, Bell DH, Roth M, Mahadeo KM,
Nunez C
, Short NJ,
DiNardo C
,
Konopleva M
, Issa GC, Ravandi F,
Jain N
,
Borthakur G
,
Kantarjian HM
,
Jabbour E
, Cuglievan B. Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. Cancers (Basel). 2021 Dec 29; 14(1).
PMID:
35008312
; PMCID:
PMC8750927
.
Citations:
2
Mouhayar EN
, Hammond D,
Lopez-Mattei J
,
Banchs J
,
Konopleva M
,
Pemmaraju N
. Reversible Myocardial Edema Secondary?to Tagraxofusp-Induced Capillary Leak Syndrome. JACC CardioOncol. 2021 Dec; 3(5):752-755.
PMID:
34988487
; PMCID:
PMC8702795
.
Citations:
Richard-Carpentier G,
Kantarjian HM
, Tang G, Yin CC,
Khoury JD
, Issa GC, Haddad F,
Jain N
, Ravandi F, Short NJ,
DiNardo CD
,
Takahashi K
,
Konopleva MY
,
Daver NG
,
Kadia T
,
Garcia-Manero G
, Garris R, O'Brien S,
Jabbour E
. Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience. Blood Adv. 2021 12 14; 5(23):5415-5419.
PMID:
34525185
; PMCID:
PMC9153023
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
Li Y, Xie X, Jie Z, Zhu L, Yang JY, Ko CJ, Gao T, Jain A, Jung SY, Baran N,
Konopleva MY
, Cheng X,
Sun SC
. DYRK1a mediates BAFF-induced noncanonical NF-?B activation to promote autoimmunity and B-cell leukemogenesis. Blood. 2021 12 09; 138(23):2360-2371.
PMID:
34255829
; PMCID:
PMC8832461
.
Citations:
2
Fields:
Hem
Hematology
Translation:
Humans
Animals
Cells
Gangat N,
Konopleva M
, Patnaik MM,
Jabbour E
,
DiNardo C
, Al-Kali A, Foran JM, Granroth GL, Olteanu H,
Kadia T
, Tefferi A,
Pemmaraju N
. Venetoclax and hypomethylating agents in older/unfit patients with blastic plasmacytoid dendritic cell neoplasm. Am J Hematol. 2022 02 01; 97(2):E62-E67.
PMID:
34807470
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Cells
Lv D, Pal P, Liu X, Jia Y, Thummuri D, Zhang P, Hu W, Pei J, Zhang Q, Zhou S, Khan S, Zhang X, Hua N, Yang Q, Arango S, Zhang W, Nayak D, Olsen SK, Weintraub ST, Hromas R,
Konopleva M
, Yuan Y, Zheng G, Zhou D. Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity. Nat Commun. 2021 11 25; 12(1):6896.
PMID:
34824248
; PMCID:
PMC8617031
.
Citations:
5
Fields:
Bio
Biology
Sci
Science
Translation:
Humans
Cells
Yin CC,
Pemmaraju N
, You MJ, Li S, Xu J, Wang W,
Tang Z
, Alswailmi O,
Bhalla KN
,
Qazilbash MH
,
Konopleva M
,
Khoury JD
. Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers (Basel). 2021 Nov 23; 13(23).
PMID:
34884997
; PMCID:
PMC8656770
.
Citations:
2
Abbas HA, Alaniz Z, Mackay S, Cyr M, Zhou J, Issa GC, Alfayez M, Matthews J,
Kornblau SM
,
Jabbour E
,
Garcia-Manero G
,
Konopleva M
,
Andreeff M
,
Daver N
. Single-cell polyfunctional proteomics of CD4 cells from patients with AML predicts responses to anti-PD-1-based therapy. Blood Adv. 2021 11 23; 5(22):4569-4574.
PMID:
34555853
; PMCID:
PMC8759127
.
Citations:
3
Fields:
Hem
Hematology
Translation:
Humans
Cells
Sasaki K,
Kadia T
, Begna K,
DiNardo CD
,
Borthakur G
, Short NJ,
Jain N
,
Daver N
,
Jabbour E
,
Garcia-Manero G
, Bravo GM, Masarova L, Pierce S,
Konopleva M
, Ravandi F, Tefferi A,
Kantarjian H
. Prediction of early (4-week) mortality in acute myeloid leukemia with intensive chemotherapy. Am J Hematol. 2022 01 01; 97(1):68-78.
PMID:
34716921
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
Tanaka T, Morita K,
Loghavi S
, Wang F, Furudate K, Sasaki Y, Little L, Gumbs C, Matthews J,
Daver N
,
Pemmaraju N
,
DiNardo CD
, Sasaki K, Yilmaz M,
Kadia TM
, Ravandi F,
Konopleva MY
,
Kantarjian HM
,
Champlin RE
,
Al-Atrash G
,
Garcia-Manero G
, Wang SA, Futreal PA,
Takahashi K
. Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia. Blood. 2021 11 04; 138(18):1733-1739.
PMID:
34115096
; PMCID:
PMC8569418
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Saito K, Zhang Q, Yang H, Yamatani K, Ai T, Ruvolo V, Baran N, Cai T, Ma H,
Jacamo R
, Kuruvilla V, Imoto J, Kinjo S, Ikeo K, Moriya K, Suzuki K, Miida T, Kim YM, Vellano CP,
Andreeff M
, Marszalek JR, Tabe Y,
Konopleva M
. Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition. Blood Adv. 2021 10 26; 5(20):4233-4255.
PMID:
34507353
; PMCID:
PMC8945617
.
Citations:
7
Fields:
Hem
Hematology
Translation:
Humans
Cells
Ramos Perez JM,
Patel KP
,
Loghavi S
,
Garcia-Manero G
,
Borthakur G
,
Jabbour E
,
Wierda W
, Pierce S, Brandt M,
Kornblau S
,
Kadia T
,
Daver N
,
DiNardo CD
,
Jain N
, Yilmaz M, Short N,
Verstovsek S
,
Ferrajoli A
,
Andreeff M
,
Konopleva M
, Rivera D, McCue D,
Kantarjian HM
, Ravandi F. Value of measurable residual disease monitoring in patients with acute promyelocytic leukemia in the era of frontline 'chemotherapy-free' therapy. Leuk Lymphoma. 2022 03; 63(3):672-675.
PMID:
34668451
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Abbas HA, Hao D, Tomczak K, Barrodia P, Im JS, Reville PK, Alaniz Z, Wang W, Wang R, Wang F,
Al-Atrash G
,
Takahashi K
, Ning J, Ding M, Beird HC, Mathews JT, Little L, Zhang J, Basu S,
Konopleva M
, Marques-Piubelli ML, Solis LM, Parra ER, Lu W, Tamegnon A,
Garcia-Manero G
, Green MR,
Sharma P
,
Allison JP
,
Kornblau SM
,
Rai K
, Wang L,
Daver N
,
Futreal A
. Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy. Nat Commun. 2021 10 18; 12(1):6071.
PMID:
34663807
; PMCID:
PMC8524723
.
Citations:
3
Fields:
Bio
Biology
Sci
Science
Translation:
Humans
Cells
Pemmaraju N
, Wilson NR,
Khoury JD
,
Jain N
,
Daver N
, Pierce S,
Jabbour E
,
Kadia T
,
DiNardo C
,
Garcia-Manero G
,
Qazilbash M
,
Konopleva M
,
Kantarjian H
. Central nervous system involvement in blastic plasmacytoid dendritic cell neoplasm. Blood. 2021 10 14; 138(15):1373-1377.
PMID:
34098573
.
Citations:
2
Fields:
Hem
Hematology
Translation:
Humans
Cells
Bashir Q
,
Popat UR
,
Kebriaei P
,
Hosing C
,
Khouri IF
, Rezvani K,
Nieto Y
,
Oran B
, Srour SA, Saini NY,
Olson AL
,
Ahmed S
,
Al-Atrash G
,
Rondon G
,
Konopleva MY
,
Champlin RE
,
Shpall EJ
,
Qazilbash MH
,
Pemmaraju N
, Milton DR. Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). Bone Marrow Transplant. 2022 01; 57(1):51-56.
PMID:
34629467
; PMCID:
PMC9126091
.
Citations:
5
Fields:
Tra
Transplantation
Translation:
Humans
Cells
Togami K, Chung SS, Madan V, Booth CAG, Kenyon CM, Cabal-Hierro L, Taylor J, Kim SS, Griffin GK, Ghandi M, Li J, Li YY, Seiler M, Buonamici S, Lovitch SB, Louissaint A, Morgan EA, Piccaluga PP, Weinstock DM, Hammerman PS, Yang H,
Konopleva M
,
Pemmaraju N
, Abdel-Wahab O, Koeffler HP, Lane AA, Angelot-Delettre F, Biichle S, Jardin F, Garnache-Ottou F. Sex-Biased ZRSR2 Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis. Cancer Discov. 2022 02; 12(2):522-541.
PMID:
34615655
; PMCID:
PMC8831459
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Niswander LM, Loftus JP, Pondrom M, Hottman DA, Iacobucci I, Mullighan CG,
Jain N
,
Konopleva M
, Tasian SK, Lainey ?, Caye-Eude A, Cav? H, Baruchel A, Rohrlich PS. Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia. Haematologica. 2021 10 01; 106(10):2763-2767.
PMID:
34196168
; PMCID:
PMC8485673
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Cells
Pellagatti A, Boultwood J,
Konopleva M
,
Andreeff M
, West R, Omidvar N, Gorombei P, Guidez F, Ganesan S, Chiquet M, Goursaud L, Tekin N, Beurlet S, Patel S, Guerenne L, Le Pogam C, Setterblad N, de la Grange P, LeBoeuf C, Janin A, Noguera ME, Sarda-Mantel L, Merlet P, Pla M, Ad?s L, Fenaux P, Krief P, Chomienne C, Padua RA. BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome. Int J Mol Sci. 2021 Sep 30; 22(19).
PMID:
34638998
; PMCID:
PMC8508829
.
Citations:
1
Fields:
Bio
Biochemistry
Che
Chemistry
Mol
Molecular Biology
Translation:
Animals
Cells
Issa GC, Zarka J, Sasaki K, Qiao W, Pak D,
Ning J
, Short NJ, Haddad F,
Tang Z
,
Patel KP
, Cuglievan B,
Daver N
,
DiNardo CD
,
Jabbour E
,
Kadia T
,
Borthakur G
,
Garcia-Manero G
,
Konopleva M
,
Andreeff M
,
Kantarjian HM
, Ravandi F. Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements. Blood Cancer J. 2021 09 29; 11(9):162.
PMID:
34588432
; PMCID:
PMC8481264
.
Citations:
2
Fields:
All
Allergy and Immunology
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Marques-Piubelli ML, Solis LM, Parra ER, Castillo LM, Gouni S, Nair R, Chihara D,
Konopleva M
,
Wistuba II
, Iyer SP, Vega F, Strati P. BCL-W expression associates with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified. Blood Cancer J. 2021 09 16; 11(9):153.
PMID:
34531377
; PMCID:
PMC8445996
.
Citations:
Fields:
All
Allergy and Immunology
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Wilson NR,
Bover L
,
Konopleva M
, Han L,
Neelapu S
,
Pemmaraju N
. CD303 (BDCA-2) - a potential novel target for therapy in hematologic malignancies. Leuk Lymphoma. 2022 01; 63(1):19-30.
PMID:
34486917
.
Citations:
1
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Cells
Saxena K,
DiNardo C
,
Daver N
,
Konopleva M
. SOHO State of the Art Updates and Next Questions:Harnessing Apoptosis in AML. Clin Lymphoma Myeloma Leuk. 2022 03; 22(3):133-139.
PMID:
34602371
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Venugopal S, Maiti A,
DiNardo CD
, Qiao W,
Ning J
,
Loghavi S
,
Daver NG
,
Kadia TM
, Rausch CR,
Alvarado Y
,
Ohanian M
, Sasaki K, Short NJ,
Takahashi K
, Yilmaz M, Ravandi F,
Kantarjian HM
,
Konopleva MY
. Prognostic impact of conventional cytogenetics in acute myeloid leukemia treated with venetoclax and decitabine. Leuk Lymphoma. 2021 12; 62(14):3501-3505.
PMID:
34474640
; PMCID:
PMC10423012
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Pemmaraju N
,
Carter BZ
,
Bose P
,
Jain N
,
Kadia TM
,
Garcia-Manero G
,
Bueso-Ramos CE
,
DiNardo CD
, Bledsoe S,
Daver NG
,
Popat U
,
Konopleva MY
, Zhou L, Pierce S,
Estrov ZE
,
Borthakur GM
,
Ohanian M
, Qiao W, Masarova L, Wang X, Mak PY, Cortes J,
Jabbour E
,
Verstovsek S
. Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis. Blood Adv. 2021 08 24; 5(16):3163-3173.
PMID:
34424319
; PMCID:
PMC8405193
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Lu X, Han L, Busquets J, Collins M, Lodi A, Marszalek JR,
Konopleva M
, Tiziani S. The Combined Treatment With the FLT3-Inhibitor AC220 and the Complex I Inhibitor IACS-010759 Synergistically Depletes Wt- and FLT3-Mutated Acute Myeloid Leukemia Cells. Front Oncol. 2021; 11:686765.
PMID:
34490088
; PMCID:
PMC8417744
.
Citations:
2
Alwash Y,
Khoury JD
, Tashakori M, Kanagal-Shamanna R,
Daver N
, Ravandi F,
Kadia TM
,
Konopleva M
,
Dinardo CD
, Issa GC,
Loghavi S
,
Takahashi K
,
Jabbour E
, Guerra V,
Kornblau S
,
Kantarjian H
, Short NJ. Development of TP53 mutations over the course of therapy for acute myeloid leukemia. Am J Hematol. 2021 11 01; 96(11):1420-1428.
PMID:
34351647
; PMCID:
PMC9167467
.
Citations:
2
Fields:
Hem
Hematology
Translation:
Humans
Abbas HA, Reville PK, Geppner A, Rausch CR,
Pemmaraju N
,
Ohanian M
, Sasaki K,
Borthakur G
,
Daver N
,
DiNardo C
,
Bueso-Ramos C
, Pierce S,
Jabbour E
,
Garcia-Manero G
,
Konopleva M
, Ravandi F,
Kantarjian H
,
Kadia TM
. Clinical and molecular characterization of myeloid sarcoma without medullary leukemia. Leuk Lymphoma. 2021 12; 62(14):3402-3410.
PMID:
34380367
; PMCID:
PMC8939853
.
Citations:
1
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Abbas HA, Mohanty V, Wang R, Huang Y, Liang S, Wang F, Zhang J, Qiu Y, Hu CW, Qutub AA, Dail M, Bolen CR,
Daver N
,
Konopleva M
,
Futreal A
, Chen K, Wang L,
Kornblau SM
. Decoupling Lineage-Associated Genes in Acute Myeloid Leukemia Reveals Inflammatory and Metabolic Signatures Associated With Outcomes. Front Oncol. 2021; 11:705627.
PMID:
34422660
; PMCID:
PMC8372368
.
Citations:
1
Maiti A,
DiNardo CD
, Qiao W,
Kadia TM
,
Jabbour EJ
, Rausch CR,
Daver NG
, Short NJ,
Borthakur G
,
Pemmaraju N
, Yilmaz M,
Alvarado Y
, Montalbano KS, Wade A, Maduike RE, Guerrero JA, Vaughan K, Bivins CA, Pierce S,
Ning J
, Ravandi F,
Kantarjian HM
,
Konopleva MY
. Ten-day decitabine with venetoclax versus intensive chemotherapy in relapsed or refractory acute myeloid leukemia: A propensity score-matched analysis. Cancer. 2021 11 15; 127(22):4213-4220.
PMID:
34343352
; PMCID:
PMC8556232
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
Kadia TM
, Reville PK,
Borthakur G
, Yilmaz M,
Kornblau S
,
Alvarado Y
,
Dinardo CD
,
Daver N
,
Jain N
,
Pemmaraju N
, Short N, Wang SA, Tidwell RSS, Islam R,
Konopleva M
,
Garcia-Manero G
, Ravandi F,
Kantarjian HM
. Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial. Lancet Haematol. 2021 Aug; 8(8):e552-e561.
PMID:
34329576
; PMCID:
PMC8884174
.
Citations:
11
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Jain N
, Keating M, Thompson P,
Ferrajoli A
,
Burger JA
,
Borthakur G
,
Takahashi K
,
Estrov Z
, Sasaki K,
Fowler N
,
Kadia T
,
Konopleva M
,
Alvarado Y
, Yilmaz M,
DiNardo C
,
Bose P
,
Ohanian M
,
Pemmaraju N
,
Jabbour E
, Kanagal-Shamanna R, Patel K, Wang W,
Jorgensen J
, Wang SA,
Garg N
, Wang X, Wei C, Cruz N, Ayala A, Plunkett W,
Kantarjian H
,
Gandhi V
,
Wierda WG
. Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia: A Nonrandomized Phase 2 Trial. JAMA Oncol. 2021 Aug 01; 7(8):1213-1219.
PMID:
34110383
; PMCID:
PMC8193546
.
Citations:
8
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Swaminathan M,
Kantarjian HM
, Levis M, Guerra V,
Borthakur G
,
Alvarado Y
,
DiNardo CD
,
Kadia T
,
Garcia-Manero G
,
Ohanian M
,
Daver N
,
Konopleva M
,
Pemmaraju N
,
Ferrajoli A
,
Andreeff M
,
Jain N
,
Estrov Z
,
Jabbour EJ
,
Wierda WG
, Pierce S, Pinsoy MR, Xiao L, Ravandi F,
Cortes JE
. A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Haematologica. 2021 08 01; 106(8):2121-2130.
PMID:
33853292
; PMCID:
PMC8327731
.
Citations:
11
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Lee JB, Khan DH, Hurren R, Xu M, Na Y, Kang H, Mirali S, Wang X, Gronda M, Jitkova Y, MacLean N, Arruda A, Alaniz Z,
Konopleva MY
,
Andreeff M
, Minden MD, Zhang L, Schimmer AD. Venetoclax enhances T cell-mediated antileukemic activity by increasing ROS production. Blood. 2021 07 22; 138(3):234-245.
PMID:
34292323
; PMCID:
PMC8310428
.
Citations:
19
Fields:
Hem
Hematology
Translation:
Humans
Cells
Kim K, Maiti A,
Loghavi S
, Pourebrahim R,
Kadia TM
, Rausch CR, Furudate K,
Daver NG
,
Alvarado Y
,
Ohanian M
, Sasaki K, Short NJ,
Takahashi K
, Yilmaz M, Tang G, Ravandi F,
Kantarjian HM
,
DiNardo CD
,
Konopleva MY
. Outcomes of TP53-mutant acute myeloid leukemia with decitabine and venetoclax. Cancer. 2021 10 15; 127(20):3772-3781.
PMID:
34255353
; PMCID:
PMC10462434
.
Citations:
12
Fields:
Neo
Neoplasms
Translation:
Humans
Zhang L, Cai T, Lin X, Huang X, Bui MH, Plotnik JP, Bellin RJ, Faivre EJ, Kuruvilla VM, Lam LT, Lu X, Zha Z, Feng W, Hessler P, Uziel T, Zhang Q, Cavazos A, Han L, Ferguson DC, Mehta G, Shanmugavelandy SS, Magoc TJ, Rowe J, Goodwin NC, Dorritie KA, Boyiadzis M, Albert DH, McDaniel KF, Kati WM,
Konopleva M
, Shen Y. Selective Inhibition of the Second Bromodomain of BET Family Proteins Results in Robust Antitumor Activity in Preclinical Models of Acute Myeloid Leukemia. Mol Cancer Ther. 2021 10; 20(10):1809-1819.
PMID:
34253595
.
Citations:
1
Fields:
Ant
Antineoplastic Agents
Translation:
Humans
Animals
Cells
Jabbour E
, Patel K,
Jain N
, Duose D,
Luthra R
, Short NJ, Zugmaier G, San Lucas A, Velasco K, Tran Q, Zaman F,
Konopleva M
,
Kantarjian H
. Impact of Philadelphia chromosome-like alterations on efficacy and safety of blinatumomab in adults with relapsed/refractory acute lymphoblastic leukemia: A post hoc analysis from the phase 3 TOWER study. Am J Hematol. 2021 10 01; 96(10):E379-E383.
PMID:
34161631
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Cells
CT
Clinical Trials
Herbrich S, Baran N, Cai T, Weng C, Aitken MJL,
Post SM
, Henderson J, Shi C, Richard-Carpentier G, Sauvageau G,
Baggerly K
,
Al-Atrash G
, Davis RE,
Daver N
, Zha D,
Konopleva M
. Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AML. J Immunother Cancer. 2021 07; 9(7).
PMID:
34326171
; PMCID:
PMC8323398
.
Citations:
4
Fields:
Neo
Neoplasms
The
Therapeutics
Translation:
Humans
Animals
Venugopal S, Shoukier M,
Konopleva M
,
Dinardo CD
, Ravandi F, Short NJ,
Andreeff M
,
Borthakur G
,
Daver N
,
Pemmaraju N
, Sasaki K, Montalban-Bravo G, Marx KR, Pierce S,
Popat UR
,
Shpall EJ
, Kanagal-Shamanna R,
Garcia-Manero G
,
Kantarjian HM
,
Kadia TM
. Outcomes in patients with newly diagnosed TP53-mutated acute myeloid leukemia with or without venetoclax-based therapy. Cancer. 2021 10 01; 127(19):3541-3551.
PMID:
34182597
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
Saxena K, Herbrich SM,
Pemmaraju N
,
Kadia TM
,
DiNardo CD
,
Borthakur G
, Pierce SA,
Jabbour E
, Wang SA,
Bueso-Ramos C
,
Loghavi S
, Tang G, Cheung CM, Alexander L,
Kornblau S
,
Andreeff M
,
Garcia-Manero G
, Ravandi F,
Konopleva MY
,
Daver N
. A phase 1b/2 study of azacitidine with PD-L1 antibody avelumab in relapsed/refractory acute myeloid leukemia. Cancer. 2021 10 15; 127(20):3761-3771.
PMID:
34171128
.
Citations:
6
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Tabe Y,
Konopleva M
. Break the lifeline of AML cells. Blood. 2021 06 24; 137(25):3465-3467.
PMID:
34165546
; PMCID:
PMC9999036
.
Citations:
2
Fields:
Hem
Hematology
Translation:
Humans
Sasaki K,
Kantarjian HM
, Morita K, Short NJ,
Konopleva M
,
Jain N
, Ravandi F,
Garcia-Manero G
, Wang S,
Khoury JD
,
Jorgensen JL
,
Champlin RE
,
Khouri IF
,
Kebriaei P
, Schroeder HM, Khouri M, Garris R,
Takahashi K
, O'Brien SM,
Jabbour EJ
. Hyper-CVAD plus ofatumumab versus hyper-CVAD plus rituximab as frontline therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis. Cancer. 2021 09 15; 127(18):3381-3389.
PMID:
34138471
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Saxena K,
Jabbour E
, Issa G, Sasaki K, Ravandi F, Maiti A,
Daver N
,
Kadia T
,
DiNardo CD
,
Konopleva M
,
Cortes JE
, Yilmaz M, Chien K, Pierce S,
Kantarjian H
, Short NJ. Impact of frontline treatment approach on outcomes of myeloid blast phase CML. J Hematol Oncol. 2021 06 15; 14(1):94.
PMID:
34130720
; PMCID:
PMC8204504
.
Citations:
3
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Salah HT,
DiNardo CD
,
Konopleva M
,
Khoury JD
. Potential Biomarkers for Treatment Response to the BCL-2 Inhibitor Venetoclax: State of the Art and Future Directions. Cancers (Basel). 2021 Jun 14; 13(12).
PMID:
34198580
; PMCID:
PMC8231978
.
Citations:
3
Wilson NR,
Konopleva M
,
Khoury JD
,
Pemmaraju N
. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy. Clin Lymphoma Myeloma Leuk. 2021 11; 21(11):734-740.
PMID:
34226167
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Jain N
, Maiti A, Ravandi F,
Konopleva M
,
Daver N
,
Kadia T
,
Pemmaraju N
, Short N,
Kebriaei P
,
Ning J
, Cortes J,
Jabbour E
,
Kantarjian H
. Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia. Am J Hematol. 2021 08 01; 96(8):1000-1007.
PMID:
33991360
; PMCID:
PMC9096877
.
Citations:
2
Fields:
Hem
Hematology
Translation:
Humans
Cells
DiNardo CD
, Lachowiez CA,
Takahashi K
,
Loghavi S
, Xiao L,
Kadia T
,
Daver N
, Adeoti M, Short NJ, Sasaki K, Wang S,
Borthakur G
, Issa G, Maiti A,
Alvarado Y
,
Pemmaraju N
, Montalban Bravo G, Masarova L, Yilmaz M,
Jain N
,
Andreeff M
,
Jabbour E
,
Garcia-Manero G
,
Kornblau S
, Ravandi F,
Konopleva MY
,
Kantarjian HM
. Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia. J Clin Oncol. 2021 09 01; 39(25):2768-2778.
PMID:
34043428
; PMCID:
PMC8407653
.
Citations:
20
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Kadia TM
, Ravandi F,
Borthakur G
,
Konopleva M
,
DiNardo CD
,
Daver N
,
Pemmaraju N
, Kanagal-Shamanna R, Wang X, Huang X, Pierce S, Rausch C,
Burger J
,
Ferrajoli A
,
Jain N
,
Popat U
,
Estrov Z
,
Verstovsek S
,
Jabbour E
,
Garcia-Manero G
,
Kantarjian H
. Long-term results of low-intensity chemotherapy with clofarabine or cladribine combined with low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia. Am J Hematol. 2021 08 01; 96(8):914-924.
PMID:
33901324
.
Citations:
4
Fields:
Hem
Hematology
Translation:
Humans
Jain N
, Thompson P,
Burger J
,
Ferrajoli A
,
Takahashi K
,
Estrov Z
,
Borthakur G
,
Bose P
,
Kadia T
,
Pemmaraju N
, Sasaki K,
Konopleva M
,
Jabbour E
,
Garg N
, Wang X, Kanagal-Shamanna R, Patel K, Wang W,
Jorgensen J
, Wang S, Lopez W, Ayala A, Plunkett W,
Gandhi V
,
Kantarjian H
, O'Brien S, Keating M,
Wierda WG
. Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations. Leukemia. 2021 12; 35(12):3421-3429.
PMID:
34007049
.
Citations:
3
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Cells
CT
Clinical Trials
Bose P
, McCue D, Wurster S, Wiederhold NP,
Konopleva M
,
Kadia TM
,
Borthakur G
, Ravandi F, Masarova L,
Takahashi K
,
Estrov Z
, Yilmaz M,
Daver N
,
Pemmaraju N
,
Naqvi K
, Rausch CR, Marx KR, Qiao W, Huang X, Bivins CA, Pierce SA,
Kantarjian HM
,
Kontoyiannis DP
. Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study. Clin Infect Dis. 2021 05 18; 72(10):1755-1763.
PMID:
32236406
; PMCID:
PMC8130026
.
Citations:
10
Fields:
Com
Communicable Diseases
Translation:
Humans
CT
Clinical Trials
Wang F, Morita K,
DiNardo CD
, Furudate K, Tanaka T, Yan Y,
Patel KP
, MacBeth KJ, Wu B, Liu G, Frattini M, Matthews JA, Little LD, Gumbs C, Song X, Zhang J, Thompson EJ,
Kadia TM
,
Garcia-Manero G
,
Jabbour E
, Ravandi F,
Bhalla KN
,
Konopleva M
,
Kantarjian HM
, Andrew Futreal P,
Takahashi K
. Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia. Nat Commun. 2021 05 10; 12(1):2607.
PMID:
33972549
; PMCID:
PMC8110775
.
Citations:
12
Fields:
Bio
Biology
Sci
Science
Translation:
Humans
Cells
Morita K, Wang F, Jahn K, Hu T, Tanaka T, Sasaki Y, Kuipers J,
Loghavi S
, Wang SA, Yan Y, Furudate K, Matthews J, Little L, Gumbs C, Zhang J, Song X, Thompson E,
Patel KP
,
Bueso-Ramos CE
,
DiNardo CD
, Ravandi F,
Jabbour E
,
Andreeff M
, Cortes J,
Bhalla K
,
Garcia-Manero G
,
Kantarjian H
,
Konopleva M
,
Nakada D
,
Navin N
, Beerenwinkel N, Futreal PA,
Takahashi K
. Author Correction: Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nat Commun. 2021 May 10; 12(1):2823.
PMID:
33972555
; PMCID:
PMC8110810
.
Citations:
1
Fields:
Bio
Biology
Sci
Science
Isidori A, Cerchione C,
Daver N
,
DiNardo C
,
Garcia-Manero G
,
Konopleva M
, Jabbour E, Ravandi F,
Kadia T
, Burguera AF, Loscocco F, Visani G, Martinelli G,
Kantarjian H
, Romano A, Curti A. Immunotherapy in Acute Myeloid Leukemia: Where We Stand. Front Oncol. 2021; 11:656218.
PMID:
34041025
; PMCID:
PMC8143531
.
Citations:
18
Yilmaz M,
Daver N
,
Borthakur G
,
Kadia T
,
DiNardo C
, Kanagal-Shamanna R,
Loghavi S
,
Oran B
,
Popat UR
, Pierce S,
Jabbour E
, Short NJ, Issa G,
Ohanian M
,
Konopleva M
, Patel K,
Kantarjian H
, Ravandi F. FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burden. Am J Hematol. 2021 08 01; 96(8):E275-E279.
PMID:
33891709
; PMCID:
PMC9154045
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
Mendt M, Daher M, Basar R, Shanley M, Kumar B, Wei Inng FL, Acharya S, Shaim H, Fowlkes N, Tran JP, Gokdemir E, Uprety N, Nunez-Cortes AK, Ensley E, Mai T, Kerbauy LN, Melo-Garcia L, Lin P, Shen Y, Mohanty V, Lu J, Li S, Nandivada V, Wang J, Banerjee P, Reyes-Silva F, Liu E, Ang S, Gilbert A, Li Y, Wan X, Gu J,
Zhao M
, Baran N, Muniz-Feliciano L, Wilson J, Kaur I, Gagea M,
Konopleva M
,
Marin D
, Tang G, Chen K,
Champlin R
, Rezvani K,
Shpall EJ
. Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD. Front Immunol. 2021; 12:631353.
PMID:
34017325
; PMCID:
PMC8130860
.
Citations:
5
Fields:
All
Allergy and Immunology
Translation:
Animals
Cells
Baran N, Kaoma T, Wang F, Carroll M, Selak MA, Nicolay B, Marszalek JR,
Takahashi K
,
DiNardo CD
,
Konopleva M
, Stuani L, Sabatier M, Saland E, Cognet G, Poupin N, Bosc C, Castelli FA, Gales L, Turtoi E, Montersino C, Farge T, Boet E, Broin N, Larrue C, Ciss? MY, Conti M, Loric S, Hucteau A, Zavoriti A, Sahal A, Mouchel PL, Gotan?gre M, Cassan C, Fernando L, Hosseini M, Chu-Van E, Le Cam L, Vey N, Castellano R, Fenaille F, Turtoi A, Cazals G, Bories P, Gibon Y, Ronseaux S, Pancaldi V, Collette Y, Bellvert F, Jourdan F, Linares LK, R?cher C, Portais JC, Sarry JE. Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia. J Exp Med. 2021 05 03; 218(5).
PMID:
33760042
; PMCID:
PMC7995203
.
Citations:
10
Fields:
All
Allergy and Immunology
Med
Medicine (General)
Translation:
Humans
Animals
Cells
Montalban-Bravo G, Kanagal-Shamanna R, Sasaki K, Masarova L,
Naqvi K
,
Jabbour E
,
DiNardo CD
,
Takahashi K
,
Konopleva M
,
Pemmaraju N
,
Kadia TM
, Ravandi F,
Daver N
,
Borthakur G
,
Estrov Z
,
Khoury JD
,
Loghavi S
, Soltysiak KA, Pierce S,
Bueso-Ramos C
,
Patel KP
,
Verstovsek S
,
Kantarjian HM
,
Bose P
,
Garcia-Manero G
. Clinicopathologic correlates and natural history of atypical chronic myeloid leukemia. Cancer. 2021 09 01; 127(17):3113-3124.
PMID:
33914911
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Masarova L,
DiNardo CD
,
Bose P
,
Pemmaraju N
,
Daver NG
,
Kadia TM
, Chifotides HT, Zhou L,
Borthakur G
,
Estrov Z
,
Konopleva M
,
Verstovsek S
. Single-center experience with venetoclax combinations in patients with newly diagnosed and relapsed AML evolving from MPNs. Blood Adv. 2021 04 27; 5(8):2156-2164.
PMID:
33885751
; PMCID:
PMC8095138
.
Citations:
2
Fields:
Hem
Hematology
Translation:
Humans
Lachowiez CA,
Loghavi S
, Furudate K, Montalban-Bravo G, Maiti A,
Kadia T
,
Daver N
,
Borthakur G
,
Pemmaraju N
, Sasaki K,
Alvarado Y
, Yilmaz M, Short NJ, Chien K,
Ohanian M
, Pierce S,
Patel KP
,
Jabbour E
, Ravandi F,
Kantarjian HM
,
Garcia-Manero G
,
Takahashi K
,
Konopleva MY
,
DiNardo CD
. Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax. Blood Adv. 2021 04 27; 5(8):2173-2183.
PMID:
33885753
; PMCID:
PMC8095152
.
Citations:
4
Fields:
Hem
Hematology
Translation:
Humans
Maiti A,
DiNardo CD
, Wang SA,
Jorgensen J
,
Kadia TM
,
Daver NG
, Short NJ, Yilmaz M,
Pemmaraju N
,
Borthakur G
,
Bose P
, Issa GC,
Ferrajoli A
,
Jabbour EJ
,
Jain N
,
Garcia-Manero G
,
Ohanian M
,
Takahashi K
, Montalban-Bravo G, Masarova L,
Burger JA
, Thompson PA,
Verstovsek S
, Sasaki K,
Andreeff M
, Rausch CR, Montalbano KS, Pierce S, Qiao W, Ning J,
Kantarjian HM
,
Konopleva MY
, Ravandi F. Prognostic value of measurable residual disease after venetoclax and decitabine in acute myeloid leukemia. Blood Adv. 2021 04 13; 5(7):1876-1883.
PMID:
33792630
; PMCID:
PMC8045494
.
Citations:
10
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Montalban-Bravo G, Hammond D,
DiNardo CD
,
Konopleva M
,
Borthakur G
, Short NJ, Ramos-Perez J, Guerra V, Kanagal-Shamanna R,
Naqvi K
, Sasaki K,
Jabbour E
,
Pemmaraju N
,
Kadia TM
, Ravandi F,
Daver N
,
Estrov Z
, Pierce S,
Kantarjian H
,
Garcia-Manero G
. Activity of venetoclax-based therapy in chronic myelomonocytic leukemia. Leukemia. 2021 05; 35(5):1494-1499.
PMID:
33846541
.
Citations:
2
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Short NJ,
Konopleva M
,
Kadia T
,
Kebriaei P
,
Daver N
, Huang X, Masarova L, Cook R,
Jain N
,
Jabbour E
,
Kantarjian H
, Ravandi F. An effective chemotherapy-free regimen of ponatinib plus venetoclax for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia. Am J Hematol. 2021 07 01; 96(7):E229-E232.
PMID:
33780038
; PMCID:
PMC9278812
.
Citations:
4
Fields:
Hem
Hematology
Translation:
Humans
Cells
Morita K,
Kantarjian HM
, Sasaki K, Issa GC,
Jain N
,
Konopleva M
, Short NJ,
Takahashi K
,
DiNardo CD
,
Kadia TM
,
Garcia-Manero G
,
Daver N
, Montalban Bravo G,
Cortes JE
, Ravandi F,
Jabbour E
. Outcome of patients with chronic myeloid leukemia in lymphoid blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemia treated with hyper-CVAD and dasatinib. Cancer. 2021 08 01; 127(15):2641-2647.
PMID:
33823073
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Sasaki K,
Kantarjian HM
, Short NJ, Samra B,
Khoury JD
,
Kanagal Shamanna R
,
Konopleva M
,
Jain N
,
DiNardo CD
, Khouri R,
Garcia-Manero G
,
Kadia TM
,
Wierda WG
,
Khouri IF
,
Kebriaei P
,
Mehta RS
,
Champlin RE
, Garris R, Cheung CM,
Daver N
, Thompson PA, Yilmaz M, Ravandi F,
Jabbour E
. Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitors. Cancer. 2021 08 01; 127(15):2648-2656.
PMID:
33793964
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Rausch CR,
DiNardo CD
, Maiti A, Jammal NJ,
Kadia TM
, Marx KR,
Borthakur G
, Savoy JM,
Pemmaraju N
, DiPippo AJ,
Daver NG
, Chew SM, Sasaki K, Issa GC, Short NJ,
Takahashi K
,
Ohanian MN
,
Ning J
, Xiao L,
Alvarado Y
,
Kontoyiannis DP
, Ravandi F,
Kantarjian HM
,
Konopleva MY
. Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia. Cancer. 2021 07 15; 127(14):2489-2499.
PMID:
33793970
; PMCID:
PMC8249340
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
Singh Mali R, Zhang Q, DeFilippis RA, Cavazos A, Kuruvilla VM, Raman J, Mody V, Choo EF, Dail M, Shah NP,
Konopleva M
, Sampath D, Lasater EA. Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia models. Haematologica. 2021 04 01; 106(4):1034-1046.
PMID:
32414851
; PMCID:
PMC8017817
.
Citations:
20
Fields:
Hem
Hematology
Translation:
Humans
Cells
Zeng Z
, Ly C,
Daver N
, Cortes J,
Kantarjian HM
,
Andreeff M
,
Konopleva M
. High-throughput proteomic profiling reveals mechanisms of action of AMG925, a dual FLT3-CDK4/6 kinase inhibitor targeting AML and AML stem/progenitor cells. Ann Hematol. 2021 Jun; 100(6):1485-1496.
PMID:
33787984
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Animals
Cells
Cerchione C,
Daver N
,
DiNardo C
,
Jabbour EJ
,
Konopleva M
,
Ravandi-Kashani F
,
Kadia T
, Martelli MP, Isidori A, Martinelli G,
Kantarjian H
, Romano A. IDH1/IDH2 Inhibition in Acute Myeloid Leukemia. Front Oncol. 2021; 11:639387.
PMID:
33898313
; PMCID:
PMC8063727
.
Citations:
7
Koller P,
Saliba RM
, Ledesma C,
Rondon G
,
Popat U
,
Alousi A
,
Mehta R
,
Oran B
, Olson A,
Hosing C
,
Qazilbash M
,
Khouri I
,
Ciurea S
,
Shpall E
,
Jorgensen J
, Wang S,
Jain N
,
Jabbour E
,
Kantarjian H
,
Champlin R
,
Konopleva M
,
Kebriaei P
. Outcomes in patients with CRLF2 overexpressed acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2021 07; 56(7):1746-1749.
PMID:
33767403
.
Citations:
Fields:
Tra
Transplantation
Translation:
Humans
Saxena K,
Konopleva M
. New Treatment Options for Older Patients with Acute Myeloid Leukemia. Curr Treat Options Oncol. 2021 03 20; 22(5):39.
PMID:
33743079
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Morita K,
Jain N
,
Kantarjian H
,
Takahashi K
, Fang H,
Konopleva M
, El Hussein S, Wang F, Short NJ, Maiti A, Sasaki K,
Garcia-Manero G
,
Konoplev S
, Ravandi F,
Khoury JD
,
Jabbour E
. Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine. Am J Hematol. 2021 05 01; 96(5):589-598.
PMID:
33639000
.
Citations:
7
Fields:
Hem
Hematology
Translation:
Humans
Reville PK,
Kantarjian HM
, Ravandi F,
Jabbour E
,
DiNardo CD
,
Daver N
,
Pemmaraju N
,
Ohanian M
,
Alvarado Y
, Xiao L, Alatrash G,
Loghavi S
, Rausch CR,
Borthakur G
,
Konopleva M
, Cortes J,
Kadia TM
. Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study. Blood Cancer J. 2021 03 17; 11(3):60.
PMID:
33731681
; PMCID:
PMC7969746
.
Citations:
2
Fields:
All
Allergy and Immunology
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Maiti A, Rausch CR,
Cortes JE
,
Pemmaraju N
,
Daver NG
, Ravandi F,
Garcia-Manero G
,
Borthakur G
,
Naqvi K
,
Ohanian M
, Short NJ,
Alvarado Y
,
Kadia TM
,
Takahashi K
, Yilmaz M,
Jain N
,
Kornblau S
, Montalban Bravo G, Sasaki K,
Andreeff M
, Bose P,
Ferrajoli A
, Issa GC,
Jabbour EJ
, Masarova L, Thompson PA, Wang S,
Konoplev S
, Pierce SA,
Ning J
, Qiao W, Welch JS,
Kantarjian HM
,
DiNardo CD
,
Konopleva MY
. Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimens. Haematologica. 2021 03 01; 106(3):894-898.
PMID:
32499238
; PMCID:
PMC7927994
.
Citations:
13
Fields:
Hem
Hematology
Translation:
Humans
Yilmaz M, Alfayez M,
DiNardo CD
,
Borthakur G
,
Kadia TM
,
Konopleva MY
,
Loghavi S
, Kanagal-Shamanna R,
Patel KP
,
Jabbour EJ
,
Garcia-Manero G
,
Pemmaraju N
, Pierce SA, Ghayas I, Short NJ, Montalban-Bravo G,
Takahashi K
, Assi R, Alotaibi AS,
Ohanian M
,
Andreeff M
,
Cortes JE
,
Kantarjian HM
, Ravandi F,
Daver NG
. Correction to: Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML. J Hematol Oncol. 2021 Feb 23; 14(1):34.
PMID:
33618754
; PMCID:
PMC7901199
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Kantarjian H
,
Kadia T
,
DiNardo C
,
Daver N
,
Borthakur G
,
Jabbour E
,
Garcia-Manero G
,
Konopleva M
, Ravandi F. Acute myeloid leukemia: current progress and future directions. Blood Cancer J. 2021 02 22; 11(2):41.
PMID:
33619261
; PMCID:
PMC7900255
.
Citations:
45
Fields:
All
Allergy and Immunology
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Animals
Loghavi S
,
DiNardo CD
, Furudate K,
Takahashi K
, Tanaka T, Short NJ,
Kadia T
,
Konopleva M
, Kanagal-Shamanna R, Farnoud NR, Pierce S,
Khoury JD
,
Jorgensen JL
,
Patel KP
,
Daver N
, Yilmaz M,
Medeiros LJ
,
Kantarjian H
, Ravandi F, Wang SA. Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemia. Br J Haematol. 2021 03; 192(6):1054-1063.
PMID:
33618432
; PMCID:
PMC8944196
.
Citations:
6
Fields:
Hem
Hematology
Translation:
Humans
Cells
CT
Clinical Trials
Venugopal S, Maiti A,
DiNardo CD
,
Loghavi S
,
Daver NG
,
Kadia TM
, Rausch CR,
Alvarado Y
,
Ohanian M
, Sasaki K, Short NJ,
Takahashi K
, Yilmaz M, Ravandi F,
Kantarjian HM
,
Konopleva MY
. Decitabine and venetoclax for IDH1/2-mutated acute myeloid leukemia. Am J Hematol. 2021 05 01; 96(5):E154-E157.
PMID:
33580980
; PMCID:
PMC8237705
.
Citations:
5
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Konopleva MY
. Mechanisms for resistance in AML insights into molecular pathways mediating resistance to venetoclax. Best Pract Res Clin Haematol. 2021 03; 34(1):101251.
PMID:
33762105
.
Citations:
5
Fields:
Hem
Hematology
Translation:
Humans
Daher M, Basar R, Gokdemir E, Baran N, Uprety N, Nunez Cortes AK, Mendt M, Kerbauy LN, Banerjee PP, Shanley M, Imahashi N, Li L, Lim FLWI, Fathi M, Rezvan A, Mohanty V, Shen Y, Shaim H, Lu J, Ozcan G, Ensley E, Kaplan M, Nandivada V, Bdiwi M, Acharya S, Xi Y, Wan X, Mak D, Liu E, Jiang XR, Ang S, Muniz-Feliciano L, Li Y, Wang J, Kordasti S, Petrov N, Varadarajan N,
Marin D
, Brunetti L, Skinner RJ, Lyu S, Silva L, Turk R, Schubert MS, Rettig GR, McNeill MS, Kurgan G, Behlke MA, Li H, Fowlkes NW, Chen K,
Konopleva M
,
Champlin RE
,
Shpall EJ
, Rezvani K. Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells. Blood. 2021 02 04; 137(5):624-636.
PMID:
32902645
; PMCID:
PMC7869185
.
Citations:
52
Fields:
Hem
Hematology
Translation:
Humans
Animals
Cells
Zeng Z
,
Konopleva M
. Concurrent inhibition of IDH and methyltransferase maximizes therapeutic efficacy in IDH mutant acute myeloid leukemia. Haematologica. 2021 02 01; 106(2):324-326.
PMID:
33522781
; PMCID:
PMC7849332
.
Citations:
3
Fields:
Hem
Hematology
Translation:
Humans
Maiti A,
DiNardo CD
,
Daver NG
, Rausch CR, Ravandi F,
Kadia TM
,
Pemmaraju N
,
Borthakur G
,
Bose P
, Issa GC, Short NJ, Yilmaz M, Montalban-Bravo G,
Ferrajoli A
,
Jabbour EJ
,
Jain N
,
Ohanian M
,
Takahashi K
, Thompson PA,
Loghavi S
, Montalbano KS, Pierce S,
Wierda WG
,
Kantarjian HM
,
Konopleva MY
. Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia. Blood Cancer J. 2021 02 01; 11(2):25.
PMID:
33563904
; PMCID:
PMC7873265
.
Citations:
11
Fields:
All
Allergy and Immunology
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Saberian C, Abdel-Wahab N,
Abudayyeh A
, Rafei H, Joseph J,
Rondon G
, Whited L, Gruschkus S, Fa'ak F, Daher M, Knape C, Safa H, Shoukier M,
Suarez-Almazor ME
, Marcotulli M, Ludford K, Gulbis AM,
Konopleva M
,
Ohanian M
, Ravandi F,
Garcia-Manero G
,
Oran B
,
Popat UR
, Mehta R,
Alousi AM
,
Daver N
,
Champlin R
,
Diab A
,
Al-Atrash G
. Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation. J Immunother Cancer. 2021 02; 9(2).
PMID:
33637601
; PMCID:
PMC7919586
.
Citations:
2
Fields:
Neo
Neoplasms
The
Therapeutics
Translation:
Humans
Bannon SA,
Routbort MJ
, Montalban-Bravo G,
Mehta RS
, Jelloul FZ,
Takahashi K
,
Daver N
,
Oran B
,
Pemmaraju N
,
Borthakur G
,
Naqvi K
, Issa G, Sasaki K,
Alvarado Y
,
Kadia TM
,
Konopleva M
, Shamanna RK,
Khoury JD
, Ravandi F,
Champlin R
,
Kantarjian HM
,
Bhalla K
,
Garcia-Manero G
,
Patel KP
,
DiNardo CD
. Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations. Front Oncol. 2020; 10:582213.
PMID:
33585199
; PMCID:
PMC7878971
.
Citations:
5
Gocho Y, Liu J, Hu J, Yang W, Dharia NV, Zhang J, Shi H, Du G, John A, Lin TN, Hunt J, Huang X, Ju B, Rowland L, Shi L, Maxwell D, Smart B, Crews KR, Yang W, Hagiwara K, Zhang Y, Roberts K, Wang H,
Jabbour E
, Stock W, Eisfelder B, Paietta E, Newman S, Roti G, Litzow M, Easton J, Zhang J, Peng J, Chi H, Pounds S, Relling MV, Inaba H, Zhu X,
Kornblau S
, Pui CH,
Konopleva M
, Teachey D, Mullighan CG, Stegmaier K, Evans WE, Yu J, Yang JJ. Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia. Nat Cancer. 2021 03; 2(3):284-299.
PMID:
34151288
; PMCID:
PMC8208590
.
Citations:
10
Translation:
Humans
Cells
DiNardo CD
,
Konopleva MY
. A venetoclax bench-to-bedside story. Nat Cancer. 2021 01; 2(1):3-5.
PMID:
35121895
.
Citations:
Maiti A, Qiao W, Sasaki K, Ravandi F,
Kadia TM
,
Jabbour EJ
,
Daver NG
,
Borthakur G
,
Garcia-Manero G
, Pierce SA, Montalbano KS,
Pemmaraju N
,
Naqvi K
,
Ohanian M
, Short NJ,
Alvarado Y
,
Takahashi K
, Yilmaz M,
Jain N
,
Kornblau SM
,
Andreeff M
,
Bose P
,
Ferrajoli A
, Issa GC, Masarova L, Thompson PA, Rausch CR,
Ning J
,
Kantarjian HM
,
DiNardo CD
,
Konopleva MY
. Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality. Am J Hematol. 2021 03 01; 96(3):282-291.
PMID:
33264443
; PMCID:
PMC8128145
.
Citations:
15
Fields:
Hem
Hematology
Translation:
Humans
Koller PB, Zhang H,
Kantarjian H
,
Jabbour E
, Pierce S, Gocho Y, Roberts KG, Yang W, Mullighan CG, Yang J,
Konopleva M
,
Jain N
. GATA3 rs3824662A allele in B-cell acute lymphoblastic leukemia in adults, adolescents and young adults: association with CRLF2 rearrangement and poor prognosis. Am J Hematol. 2021 03 01; 96(3):E71-E74.
PMID:
33275800
.
Citations:
2
Fields:
Hem
Hematology
Translation:
Humans
Short NJ, Rafei H,
Daver N
, Hwang H, Ning J,
Jorgensen JL
,
Kadia TM
,
DiNardo CD
, Wang SA,
Jabbour E
,
Popat U
,
Oran B
, Cortes J,
Konopleva M
, Yilmaz M, Issa GC,
Kantarjian H
, Ravandi F. Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML. Blood Adv. 2020 12 22; 4(24):6117-6126.
PMID:
33351107
; PMCID:
PMC7757010
.
Citations:
12
Fields:
Hem
Hematology
Translation:
Humans
Marques-Piubelli ML,
Schlette EJ
,
Khoury JD
, Furqan F, Vega F, Soto LMS,
Wistuba II
,
Wierda WG
,
Konopleva M
,
Ferrajoli A
, Strati P. Expression of BCL2 alternative proteins and association with outcome in CLL patients treated with venetoclax. Leuk Lymphoma. 2021 05; 62(5):1129-1135.
PMID:
33327833
.
Citations:
3
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Diao S, Nichols ED,
DiNardo C
,
Konopleva M
,
Ning J
, Qiao W, Maiti A, DiPippo AJ. Incidence of tumor lysis syndrome in patients with acute myeloid leukemia undergoing low-intensity induction with venetoclax. Am J Hematol. 2021 03 01; 96(3):E65-E68.
PMID:
33259075
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Alotaibi AS, Yilmaz M, Kanagal-Shamanna R,
Loghavi S
,
Kadia TM
,
DiNardo CD
,
Borthakur G
,
Konopleva M
, Pierce SA, Wang SA, Tang G, Guerra V, Samra B,
Pemmaraju N
,
Jabbour E
, Short NJ, Issa GC,
Ohanian M
,
Garcia-Manero G
,
Bhalla KN
,
Patel KP
,
Takahashi K
,
Andreeff M
,
Cortes JE
,
Kantarjian HM
, Ravandi F,
Daver N
. Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 inhibitors. Blood Cancer Discov. 2021 03; 2(2):125-134.
PMID:
33681815
; PMCID:
PMC7935111
.
Citations:
9
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Sasaki K,
Jabbour EJ
, Ravandi F,
Konopleva M
,
Borthakur G
,
Wierda WG
,
Daver N
,
Takahashi K
,
Naqvi K
,
DiNardo C
, Montalban-Bravo G, Kanagal-Shamanna R, Issa G, Jain P, Skinner J, Rios MB, Pierce S, Soltysiak KA, Sato J,
Garcia-Manero G
,
Cortes JE
. The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomes. Am J Hematol. 2021 02 01; 96(2):241-250.
PMID:
33180322
; PMCID:
PMC9022629
.
Citations:
4
Fields:
Hem
Hematology
Translation:
Humans
Yuan B, El Dana F, Ly S, Yan Y, Ruvolo V,
Shpall EJ
,
Konopleva M
,
Andreeff M
,
Battula VL
. Bone marrow stromal cells induce an ALDH+ stem cell-like phenotype and enhance therapy resistance in AML through a TGF-?-p38-ALDH2 pathway. PLoS One. 2020; 15(11):e0242809.
PMID:
33253299
; PMCID:
PMC7703975
.
Citations:
6
Fields:
Med
Medicine (General)
Sci
Science
Translation:
Humans
Cells
Samra B,
Kantarjian HM
, Sasaki K, Alotaibi AS,
Konopleva M
, O'Brien S,
Ferrajoli A
, Garris R,
Nunez CA
,
Kadia TM
, Short NJ,
Jabbour E
. Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant. Acta Haematol. 2021; 144(3):285-292.
PMID:
33238261
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
Cells
Short NJ, Montalban-Bravo G, Hwang H, Ning J, Franquiz MJ, Kanagal-Shamanna R,
Patel KP
,
DiNardo CD
, Ravandi F,
Garcia-Manero G
,
Takahashi K
,
Konopleva M
,
Daver N
, Issa GC,
Andreeff M
,
Kantarjian H
,
Kadia TM
. Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia. Blood Adv. 2020 11 24; 4(22):5681-5689.
PMID:
33211826
; PMCID:
PMC7686900
.
Citations:
11
Fields:
Hem
Hematology
Translation:
Humans
Montalban-Bravo G, Kanagal-Shamanna R, Guerra V, Ramos-Perez J, Hammond D, Shilpa P,
Naqvi K
, Sasaki K,
Jabbour E
,
DiNardo C
,
Takahashi K
,
Konopleva M
,
Pemmaraju N
,
Kadia T
, Ravandi F,
Daver N
,
Borthakur G
,
Estrov Z
,
Khoury JD
,
Loghavi S
, Pierce S,
Bueso-Ramos C
, Patel K,
Kantarjian H
,
Garcia-Manero G
. Clinical outcomes and influence of mutation clonal dominance in oligomonocytic and classical chronic myelomonocytic leukemia. Am J Hematol. 2021 02 01; 96(2):E50-E53.
PMID:
33156969
.
Citations:
3
Fields:
Hem
Hematology
Translation:
Humans
Morita K, Wang F, Jahn K, Hu T, Tanaka T, Sasaki Y, Kuipers J,
Loghavi S
, Wang SA, Yan Y, Furudate K, Matthews J, Little L, Gumbs C, Zhang J, Song X, Thompson E,
Patel KP
,
Bueso-Ramos CE
,
DiNardo CD
, Ravandi F,
Jabbour E
,
Andreeff M
, Cortes J,
Bhalla K
,
Garcia-Manero G
,
Kantarjian H
,
Konopleva M
,
Nakada D
,
Navin N
, Beerenwinkel N, Futreal PA,
Takahashi K
. Publisher Correction: Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nat Commun. 2020 Nov 19; 11(1):5996.
PMID:
33214561
; PMCID:
PMC7677309
.
Citations:
3
Fields:
Bio
Biology
Sci
Science
Pollyea DA, Pratz K, Letai A, Jonas BA, Wei AH, Pullarkat V,
Konopleva M
, Thirman MJ, Arellano M, Becker PS, Chyla B, Hong WJ, Jiang Q, Potluri J,
DiNardo CD
. Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow-up from a phase 1b study. Am J Hematol. 2021 02 01; 96(2):208-217.
PMID:
33119898
.
Citations:
19
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Chifotides HT, Masarova L, Alfayez M,
Daver N
,
Alvarado Y
,
Jabbour E
,
Konopleva M
,
Kantarjian HM
,
Patel KP
,
DiNardo CD
,
Verstovsek S
. Outcome of patients with IDH1/2-mutated post-myeloproliferative neoplasm AML in the era of IDH inhibitors. Blood Adv. 2020 11 10; 4(21):5336-5342.
PMID:
33112940
; PMCID:
PMC7656917
.
Citations:
9
Fields:
Hem
Hematology
Translation:
Humans
Samra B,
Konopleva M
, Isidori A,
Daver N
,
DiNardo C
. Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future Directions. Front Oncol. 2020; 10:562558.
PMID:
33251134
; PMCID:
PMC7675064
.
Citations:
10
Shoukier M,
Kadia T
,
Konopleva M
, Alotaibi AS, Alfayez M,
Loghavi S
,
Patel KP
, Kanagal-Shamanna R, Cortes J, Samra B,
Jabbour E
,
Garcia-Manero G
,
Takahashi K
, Pierce S, Short NJ, Yilmaz M, Sasaki K, Masarova L,
Pemmaraju N
,
Borthakur G
,
Kantarjian HM
, Ravandi F,
DiNardo CD
,
Daver N
. Clinical characteristics and outcomes in patients with acute myeloid leukemia with concurrent FLT3-ITD and IDH mutations. Cancer. 2021 02 01; 127(3):381-390.
PMID:
33119202
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Morita K, Wang F, Jahn K, Hu T, Tanaka T, Sasaki Y, Kuipers J,
Loghavi S
, Wang SA, Yan Y, Furudate K, Matthews J, Little L, Gumbs C, Zhang J, Song X, Thompson E,
Patel KP
,
Bueso-Ramos CE
,
DiNardo CD
, Ravandi F,
Jabbour E
,
Andreeff M
, Cortes J,
Bhalla K
,
Garcia-Manero G
,
Kantarjian H
,
Konopleva M
,
Nakada D
,
Navin N
, Beerenwinkel N, Futreal PA,
Takahashi K
. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nat Commun. 2020 10 21; 11(1):5327.
PMID:
33087716
; PMCID:
PMC7577981
.
Citations:
66
Fields:
Bio
Biology
Sci
Science
Translation:
Humans
Animals
Alotaibi AS, Yilmaz M,
Loghavi S
,
DiNardo C
,
Borthakur G
,
Kadia TM
,
Thakral B
,
Pemmaraju N
, Issa GC,
Konopleva M
, Short NJ, Patel K, Tang G, Ravandi F,
Daver N
. Emergence of BCR-ABL1 Fusion in AML Post-FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance - A Case Series. Front Oncol. 2020; 10:588876.
PMID:
33194747
; PMCID:
PMC7606916
.
Citations:
3
Lyapichev KA, Sukswai N, Angelova E, Kersh MJ, Pierce S,
Konopleva M
,
Jain N
,
Jabbour EJ
,
Jorgensen JL
, Wang SA, Medeiros LJ,
Khoury JD
,
Konoplev S
. CD123 Expression in Philadelphia Chromosome-like B Acute Lymphoblastic Leukemia/Lymphoma. Clin Lymphoma Myeloma Leuk. 2021 04; 21(4):e317-e320.
PMID:
33129747
.
Citations:
2
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Yilmaz M, Alfayez M,
DiNardo CD
,
Borthakur G
,
Kadia TM
,
Konopleva MY
,
Loghavi S
, Kanagal-Shamanna R,
Patel KP
,
Jabbour EJ
,
Garcia-Manero G
,
Pemmaraju N
, Pierce SA, Ghayas I, Short NJ, Montalban-Bravo G,
Takahashi K
, Assi R, Alotaibi AS,
Ohanian M
,
Andreeff M
,
Cortes JE
,
Kantarjian HM
, Ravandi F,
Daver NG
. Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML. J Hematol Oncol. 2020 10 08; 13(1):132.
PMID:
33032648
; PMCID:
PMC7542942
.
Citations:
7
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Sasaki K, Montalban-Bravo G, Kanagal-Shamanna R,
Jabbour E
, Ravandi F,
Kadia T
,
Daver N
,
Pemmaraju N
,
Konopleva M
,
Borthakur G
,
Takahashi K
, Patel K, Soltysiak KA, Chien KS, Sakurai K, Pierce S,
Kantarjian HM
,
Garcia-Manero G
. Natural history of newly diagnosed myelodysplastic syndrome with isolated inv(3)/t(3;3). Am J Hematol. 2020 12; 95(12):E326-E329.
PMID:
32886803
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
Cells
Yilmaz M,
Kantarjian HM
, Toruner G, Yin CC, Kanagal-Shamanna R,
Cortes JE
, Issa G, Short NJ,
Khoury JD
,
Garcia-Manero G
, Ravandi F,
Kadia T
,
Konopleva M
,
Wierda WG
,
Jain N
,
Estrov Z
, Sasaki K, Pierce S, O'Brien SM,
Jabbour EJ
. Translocation t(1;19)(q23;p13) in adult acute lymphoblastic leukemia - a distinct subtype with favorable prognosis. Leuk Lymphoma. 2021 01; 62(1):224-228.
PMID:
32955970
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Cells
DiNardo CD
, Maiti A, Rausch CR,
Pemmaraju N
,
Naqvi K
,
Daver NG
,
Kadia TM
,
Borthakur G
,
Ohanian M
,
Alvarado Y
, Issa GC, Montalban-Bravo G, Short NJ, Yilmaz M,
Bose P
,
Jabbour EJ
,
Takahashi K
,
Burger JA
,
Garcia-Manero G
,
Jain N
,
Kornblau SM
, Thompson PA,
Estrov Z
, Masarova L, Sasaki K,
Verstovsek S
,
Ferrajoli A
, Weirda WG, Wang SA,
Konoplev S
, Chen Z, Pierce SA,
Ning J
, Qiao W, Ravandi F,
Andreeff M
, Welch JS,
Kantarjian HM
,
Konopleva MY
. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial. Lancet Haematol. 2020 Oct; 7(10):e724-e736.
PMID:
32896301
; PMCID:
PMC7549397
.
Citations:
62
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Saxena K,
DiNardo C
,
Daver N
,
Konopleva M
. Harnessing Apoptosis in AML. Clin Lymphoma Myeloma Leuk. 2020 09; 20 Suppl 1:S61-S64.
PMID:
32862872
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Stoilova B, Moore R, Metzner M, Zheng Z,
Konopleva M
,
DiNardo C
, Vyas P. Mechanisms of Response and Resistance to AML Therapies. Clin Lymphoma Myeloma Leuk. 2020 09; 20 Suppl 1:S7.
PMID:
32862876
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Daver N
, Price A,
Benton CB
, Patel K, Zhang W,
Konopleva M
,
Pemmaraju N
,
Takahashi K
,
Andreeff M
,
Borthakur G
. First Report of Sorafenib in Patients With Acute Myeloid Leukemia Harboring Non-Canonical FLT3 Mutations. Front Oncol. 2020; 10:1538.
PMID:
32984009
; PMCID:
PMC7479234
.
Citations:
1
Pemmaraju N
,
Konopleva M
. Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm. Blood Adv. 2020 08 25; 4(16):4020-4027.
PMID:
32841341
; PMCID:
PMC7448601
.
Citations:
11
Fields:
Hem
Hematology
Translation:
Humans
Cells
CT
Clinical Trials
Borthakur G
,
Zeng Z
,
Cortes JE
, Chen HC, Huang X,
Konopleva M
, Ravandi F,
Kadia T
,
Patel KP
,
Daver N
, Kelly MA, McQueen T, Wang RY,
Kantarjian H
,
Andreeff M
. Phase 1 study of combinatorial sorafenib, G-CSF, and plerixafor treatment in relapsed/refractory, FLT3-ITD-mutated acute myelogenous leukemia patients. Am J Hematol. 2020 11; 95(11):1296-1303.
PMID:
32697348
.
Citations:
7
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Saxena K,
Konopleva M
. An expert overview of emerging therapies for acute myeloid leukemia: novel small molecules targeting apoptosis, p53, transcriptional regulation and metabolism. Expert Opin Investig Drugs. 2020 Sep; 29(9):973-988.
PMID:
32746655
.
Citations:
3
Fields:
Dru
Drug Therapy
Translation:
Humans
Animals
DiNardo CD
, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH,
Konopleva M
, Letai A, Fenaux P, Koller E, Havelange V, Leber B, Esteve J, Wang J, Pejsa V, Porkka K, Lavie D, Lemoli RM, Yamamoto K, Yoon SS, Jang JH, Yeh SP, Turgut M, Hong WJ, Zhou Y, Potluri J, Pratz KW, D?hner H, H?jek R, Ill?s ?. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia. N Engl J Med. 2020 08 13; 383(7):617-629.
PMID:
32786187
.
Citations:
306
Fields:
Med
Medicine (General)
Translation:
Humans
CT
Clinical Trials
Aung PP
,
Pemmaraju N
, Torres-Cabala CA,
Duvic M
,
Konopleva M
,
Khoury JD
,
Prieto VG
. Apparent partial loss of CD123 expression in blastic plasmacytoid dendritic cell neoplasm after treatment with CD123-targeted therapy: A novel finding and possible diagnostic pitfall. J Dermatol. 2020 Oct; 47(10):e354-e355.
PMID:
32770556
.
Citations:
Fields:
Der
Dermatology
Translation:
Humans
Cells
Major CK,
Kantarjian H
, Sasaki K,
Borthakur G
,
Kadia T
,
Pemmaraju N
,
DiNardo C
, Short NJ,
Daver N
,
Jabbour E
,
Champlin R
,
Garcia-Manero G
,
Konopleva M
,
Andreeff M
,
Kornblau S
,
Wierda W
, Pierce S, Ravandi F, Cortes J. Survivorship in AML - a landmark analysis on the outcomes of acute myelogenous leukemia patients after maintaining complete remission for at least 3 years. Leuk Lymphoma. 2020 12; 61(13):3120-3127.
PMID:
32755333
.
Citations:
2
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Samra B, Alotaibi AS, Short NJ,
Khoury JD
, Ravandi F, Garris R,
Jain N
,
Konopleva M
,
Kantarjian H
,
Jabbour E
. Outcome of adults with relapsed/refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma. Am J Hematol. 2020 09; 95(9):E245-E247.
PMID:
32501545
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Chen Z, Hu S, Wang SA,
Konopleva M
,
Tang Z
, Xu J, Li S, Toruner G,
Thakral B
,
Medeiros LJ
, Tang G. Chronic myeloid leukemia presenting in lymphoblastic crisis, a differential diagnosis with Philadelphia-positive B-lymphoblastic leukemia. Leuk Lymphoma. 2020 12; 61(12):2831-2838.
PMID:
32700989
.
Citations:
2
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Cells
Thakral B
,
Daver N
,
Tang Z
,
Patel KP
,
Ok CY
,
Loghavi S
,
Khoury JD
, Alotaibi AS,
Konopleva M
, Yilmaz M,
Medeiros LJ
. Clonal evolution with acquisition of BCR-ABL1 in refractory acute myeloid leukemia post therapy with FLT3-inhibitor. Leuk Lymphoma. 2020 12; 61(13):3243-3246.
PMID:
32696696
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Alotaibi AS, Abdulrazzaq M,
Patel KP
, Ravandi F,
Konoplev S
,
Bueso-Ramos C
, Yin CC,
Muzzafar T
, Tang G,
Futreal A
,
Jain N
,
Konopleva MY
,
Pemmaraju N
. Acute promyelocytic leukemia (APL) with an IRF2BP2-RARA fusion transcript: an aggressive APL variant. Leuk Lymphoma. 2020 12; 61(12):3018-3020.
PMID:
32657180
.
Citations:
2
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Konopleva M
, Martinelli G,
Daver N
, Wei A, Higgins B, Ott M, Mascarenhas J,
Andreeff M
, Papayannidis C. MDM2 inhibition: an important step forward in cancer therapy. Leukemia. 2020 11; 34(11):2858-2874.
PMID:
32651541
.
Citations:
62
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Animals
Cells
Jabbour E
, Richard-Carpentier G, Sasaki Y,
Konopleva M
, Patel K, Roberts K, Gu Z, Wang F, Huang X, Sasaki K, Short NJ,
Jain N
, Ravandi F,
Daver NG
,
Kadia TM
,
Alvarado Y
,
DiNardo CD
, Issa GC,
Pemmaraju N
,
Garcia-Manero G
,
Verstovsek S
, Wang S,
Khoury JD
,
Jorgensen J
,
Champlin R
,
Khouri I
,
Kebriaei P
, Schroeder H, Khouri M, Mullighan CG,
Takahashi K
, O'Brien SM,
Kantarjian H
. Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial. Lancet Haematol. 2020 Jul; 7(7):e523-e533.
PMID:
32589978
.
Citations:
10
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Cells
CT
Clinical Trials
Kim BR, Jung SH, Han AR, Park G, Kim HJ, Yuan B,
Battula VL
,
Andreeff M
,
Konopleva M
, Chung YJ, Cho BS. CXCR4 Inhibition Enhances Efficacy of FLT3 Inhibitors in FLT3-Mutated AML Augmented by Suppressed TGF-b Signaling. Cancers (Basel). 2020 Jun 30; 12(7).
PMID:
32629802
; PMCID:
PMC7407511
.
Citations:
3
Rytelewski M, Harutyunyan K, Baran N,
Mallampati S
, Zal MA, Cavazos A, Butler JM,
Konoplev S
, El Khatib M, Plunkett S, Marszalek JR,
Andreeff M
,
Zal T
,
Konopleva M
. Inhibition of Oxidative Phosphorylation Reverses Bone Marrow Hypoxia Visualized in Imageable Syngeneic B-ALL Mouse Model. Front Oncol. 2020; 10:991.
PMID:
32695673
; PMCID:
PMC7339962
.
Citations:
6
Short NJ,
Kantarjian H
, Kanagal-Shamanna R, Sasaki K, Ravandi F, Cortes J,
Konopleva M
, Issa GC,
Kornblau SM
,
Garcia-Manero G
, Garris R, Higgins J, Pratt G, Williams LN, Valentine CC,
Rivera VM
, Pritchard J, Salk JJ, Radich J,
Jabbour E
. Ultra-accurate Duplex Sequencing for the assessment of pretreatment ABL1 kinase domain mutations in Ph+ ALL. Blood Cancer J. 2020 05 26; 10(5):61.
PMID:
32457305
; PMCID:
PMC7250857
.
Citations:
3
Fields:
All
Allergy and Immunology
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Cells
Short NJ, Richard-Carpentier G, Kanagal-Shamanna R,
Patel KP
,
Konopleva M
, Papageorgiou I,
Pemmaraju N
,
Borthakur G
, Ravandi F,
DiNardo CD
,
Kadia TM
,
Kantarjian H
, Lamba JK,
Daver N
. Impact of CD33 and ABCB1 single nucleotide polymorphisms in patients with acute myeloid leukemia and advanced myeloid malignancies treated with decitabine plus gemtuzumab ozogamicin. Am J Hematol. 2020 09; 95(9):E225-E228.
PMID:
32356320
.
Citations:
3
Fields:
Hem
Hematology
Translation:
Humans
Paul S, Rausch CR,
Jain N
,
Kadia T
, Ravandi F,
DiNardo CD
, Welch MA,
Dabaja BS
,
Daver N
,
Garcia-Manero G
,
Wierda W
,
Pemmaraju N
, Montalban Bravo G, Thompson P,
Verstovsek S
,
Konopleva M
,
Kantarjian H
,
Jabbour E
. Treating Leukemia in the Time of COVID-19. Acta Haematol. 2021; 144(2):132-145.
PMID:
32392559
; PMCID:
PMC7270066
.
Citations:
18
Fields:
Hem
Hematology
Translation:
Humans
Cells
PH
Public Health
Samra B, Richard-Carpentier G,
Kadia TM
, Ravandi F,
Daver N
,
DiNardo CD
, Issa GC,
Bose P
,
Konopleva MY
, Yilmaz M,
Ohanian M
,
Borthakur G
,
Garcia-Manero G
, Pierce S,
Cortes JE
,
Kantarjian H
, Short NJ. Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype. Blood Cancer J. 2020 05 04; 10(5):47.
PMID:
32366832
; PMCID:
PMC7198507
.
Citations:
2
Fields:
All
Allergy and Immunology
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Maiti A,
Kantarjian HM
, Popat V,
Borthakur G
,
Garcia-Manero G
,
Konopleva MY
,
DiNardo CD
,
Verstovsek S
,
Andreeff M
,
Kadia TM
, Ajufo HO, Goswamy RV, Blanco C, Velasquez M,
Daver NG
,
Pemmaraju N
, Pierce SR,
Wierda WG
,
Kornblau SM
, Ravandi F,
Cortes JE
. Clinical value of event-free survival in acute myeloid leukemia. Blood Adv. 2020 04 28; 4(8):1690-1699.
PMID:
32330243
; PMCID:
PMC7189295
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Lachowiez CA,
Loghavi S
,
Kadia TM
,
Daver N
,
Borthakur G
,
Pemmaraju N
,
Naqvi K
,
Alvarado Y
, Yilmaz M, Short N,
Ohanian M
, Pierce SR,
Patel KP
, Qiao W, Ning J, Sasaki K,
Takahashi K
,
Jabbour E
,
Andreeff M
, Ravandi F,
Kantarjian HM
,
Konopleva M
,
DiNardo CD
. Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimens. Blood Adv. 2020 04 14; 4(7):1311-1320.
PMID:
32251497
; PMCID:
PMC7160266
.
Citations:
38
Fields:
Hem
Hematology
Translation:
Humans
Maiti A, Franquiz MJ, Ravandi F,
Cortes JE
,
Jabbour EJ
, Sasaki K, Marx K,
Daver NG
,
Kadia TM
,
Konopleva MY
, Masarova L,
Borthakur G
,
DiNardo CD
,
Naqvi K
, Pierce S,
Kantarjian HM
, Short NJ. Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias. Acta Haematol. 2020; 143(6):567-573.
PMID:
32289808
; PMCID:
PMC7839068
.
Citations:
18
Fields:
Hem
Hematology
Translation:
Humans
Panina SB, Pei J, Baran N,
Konopleva M
, Kirienko NV. Utilizing Synergistic Potential of Mitochondria-Targeting Drugs for Leukemia Therapy. Front Oncol. 2020; 10:435.
PMID:
32318340
; PMCID:
PMC7146088
.
Citations:
13
Montalban-Bravo G, Kanagal-Shamanna R, Class CA, Sasaki K, Ravandi F,
Cortes JE
,
Daver N
,
Takahashi K
, Short NJ,
DiNardo CD
,
Jabbour E
,
Borthakur G
,
Naqvi K
, Issa GC,
Konopleva M
,
Khoury JD
,
Routbort M
, Pierce S,
Do KA
,
Bueso-Ramos C
, Patel K,
Kantarjian H
,
Garcia-Manero G
,
Kadia TM
. Outcomes of acute myeloid leukemia with myelodysplasia related changes depend on diagnostic criteria and therapy. Am J Hematol. 2020 06; 95(6):612-622.
PMID:
32112433
.
Citations:
10
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Beckermann BM, Catalani O, Esteve J, Gamel K,
Konopleva MY
, Martinelli G, Monnet A, Park A, Vey N, Wei AH, Yoon SS, Montesinos P, Papayannidis C, R?cher C, Rodr?guez-Veiga R, R?llig C, Fenaux P. MIRROS: a randomized, placebo-controlled, Phase III trial of cytarabine ? idasanutlin in relapsed or refractory acute myeloid leukemia. Future Oncol. 2020 May; 16(13):807-815.
PMID:
32167393
.
Citations:
23
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
DiNardo CD, Tiong IS, Quaglieri A, MacRaild S,
Loghavi S
, Brown FC, Thijssen R, Pomilio G, Ivey A, Salmon JM, Glytsou C, Fleming SA, Zhang Q, Ma H, Patel KP,
Kornblau SM
, Xu Z, Chua CC, Chen X, Blombery P, Flensburg C, Cummings N, Aifantis I,
Kantarjian H
, Huang DCS, Roberts AW, Majewski IJ,
Konopleva M
, Wei AH. Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML. Blood. 2020 03 12; 135(11):791-803.
PMID:
31932844
; PMCID:
PMC7068032
.
Citations:
113
Fields:
Hem
Hematology
Translation:
Humans
Garcia-Manero G
,
Saliba RM
, Alfayez M,
Al-Atrash G
,
Ciurea SO
,
Jabbour EJ
,
Mehta RS
,
Popat UR
, Ravandi F,
Alousi AM
,
Kadia TM
,
Konopleva M
,
DiNardo CD
,
Rezvani K
,
Shpall EJ
,
Sharma P
,
Kantarjian HM
,
Champlin RE
,
Daver N
, Oran B. Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors. Cancer. 2020 05 15; 126(10):2193-2205.
PMID:
32125707
.
Citations:
12
Fields:
Neo
Neoplasms
Translation:
Humans
Tabe Y,
Konopleva M
,
Andreeff M
. Fatty Acid Metabolism, Bone Marrow Adipocytes, and AML. Front Oncol. 2020; 10:155.
PMID:
32133293
; PMCID:
PMC7040225
.
Citations:
12
Montalban-Bravo G, Kanagal-Shamanna R,
Benton CB
, Class CA, Chien KS, Sasaki K,
Naqvi K
,
Alvarado Y
,
Kadia TM
, Ravandi F,
Daver N
,
Takahashi K
,
Jabbour E
, Borthakur G,
Pemmaraju N
,
Konopleva M
, Soltysiak KA, Pierce SR,
Bueso-Ramos CE
,
Patel KP
,
Kantarjian H
,
Garcia-Manero G
. Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes. Blood Adv. 2020 02 11; 4(3):482-495.
PMID:
32027746
; PMCID:
PMC7013259
.
Citations:
20
Fields:
Hem
Hematology
Translation:
Humans
Lachowiez C,
DiNardo CD
,
Konopleva M
. Venetoclax in acute myeloid leukemia - current and future directions. Leuk Lymphoma. 2020 06; 61(6):1313-1322.
PMID:
32031033
.
Citations:
10
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Ciurea SO
, Kongtim P, Varma A,
Rondon G
, Chen J, Srour S,
Bashir Q
,
Alousi A
,
Mehta R
,
Oran B
,
Popat U
,
Hosing C
,
Olson A
,
Daver N
,
Konopleva M
,
Champlin RE
. Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation? Blood. 2020 02 06; 135(6):449-452.
PMID:
31826244
; PMCID:
PMC8212356
.
Citations:
9
Fields:
Hem
Hematology
Translation:
Humans
Short NJ,
Konopleva M
,
Kadia TM
,
Borthakur G
, Ravandi F,
DiNardo CD
,
Daver N
. Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges. Cancer Discov. 2020 04; 10(4):506-525.
PMID:
32014868
.
Citations:
71
Fields:
Neo
Neoplasms
Translation:
Humans
Masarova L,
Cortes JE
,
Patel KP
, O'Brien S, Nogueras-Gonzalez GM,
Konopleva M
,
Verstovsek S
,
Garcia-Manero G
,
Ferrajoli A
,
Kadia TM
,
Ravandi-Kashani F
,
Borthakur G
, DellaSala S,
Estrov Z
,
Jabbour EJ
,
Kantarjian HM
. Long-term results of a phase 2 trial of nilotinib 400?mg twice daily in newly diagnosed patients with chronic-phase chronic myeloid leukemia. Cancer. 2020 04 01; 126(7):1448-1459.
PMID:
31999850
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Pollyea DA, Amaya M, Strati P,
Konopleva MY
. Venetoclax for AML: changing the treatment paradigm. Blood Adv. 2019 12 23; 3(24):4326-4335.
PMID:
31869416
; PMCID:
PMC6929394
.
Citations:
38
Fields:
Hem
Hematology
Alfayez M,
Konopleva M
,
Pemmaraju N
. Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN). Expert Opin Biol Ther. 2020 02; 20(2):115-123.
PMID:
31801379
.
Citations:
1
Fields:
Bio
Biology
The
Therapeutics
Translation:
Humans
Cells
Jiang Y, Hu T, Wang T, Shi X, Kitano A, Eagle K, Hoegenauer KA,
Konopleva MY
, Lin CY,
Young NL
,
Nakada D
. AMP-activated protein kinase links acetyl-CoA homeostasis to BRD4 recruitment in acute myeloid leukemia. Blood. 2019 12 12; 134(24):2183-2194.
PMID:
31697807
; PMCID:
PMC6908829
.
Citations:
8
Fields:
Hem
Hematology
Translation:
Humans
Animals
Cells
Phillips DC, Jin S, Gregory GP, Zhang Q, Xue J, Zhao X, Chen J, Tong Y, Zhang H, Smith M, Tahir SK, Clark RF, Penning TD, Devlin JR, Shortt J, Hsi ED, Albert DH,
Konopleva M
, Johnstone RW, Leverson JD, Souers AJ. A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies. Leukemia. 2020 06; 34(6):1646-1657.
PMID:
31827241
; PMCID:
PMC7266741
.
Citations:
24
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Animals
Cells
Beird HC, Khan M, Wang F, Alfayez M, Cai T, Zhao L,
Khoury J
, Futreal PA,
Konopleva M
,
Pemmaraju N
. Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN). Blood Cancer J. 2019 12 06; 9(12):99.
PMID:
31811114
; PMCID:
PMC6898719
.
Citations:
9
Fields:
All
Allergy and Immunology
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Cells
Khan S, Zhang X, Lv D, Zhang Q, He Y, Zhang P, Liu X, Thummuri D, Yuan Y, Wiegand JS, Pei J, Zhang W, Sharma A, McCurdy CR, Kuruvilla VM, Baran N, Ferrando AA, Kim YM, Rogojina A, Houghton PJ, Huang G, Hromas R,
Konopleva M
, Zheng G, Zhou D. A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity. Nat Med. 2019 12; 25(12):1938-1947.
PMID:
31792461
; PMCID:
PMC6898785
.
Citations:
99
Fields:
Med
Medicine (General)
Mol
Molecular Biology
Translation:
Humans
Animals
Cells
Sekihara K, Saitoh K, Han L,
Ciurea S
, Yamamoto S, Kikkawa M, Kazuno S, Taka H, Kaga N, Arai H, Miida T,
Andreeff M
,
Konopleva M
, Tabe Y. Correction: Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1. Oncotarget. 2019 Nov 26; 10(63):6842.
PMID:
31827726
; PMCID:
PMC6887576
.
Citations:
Fields:
Neo
Neoplasms
Yilmaz M,
Kantarjian H
, Wang X,
Khoury JD
, Ravandi F,
Jorgensen J
, Short NJ,
Loghavi S
, Cortes J,
Garcia-Manero G
,
Kadia T
, Sasaki K,
Konopleva M
,
Takahashi K
,
Wierda W
,
Jain N
,
Verstovsek S
,
Estrov Z
,
Bose P
, Pierce S, Garris R, O'Brien S,
Jabbour E
. The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival. Am J Hematol. 2020 02; 95(2):144-150.
PMID:
31682008
.
Citations:
7
Fields:
Hem
Hematology
Translation:
Humans
Cells
CT
Clinical Trials
Abou Dalle I,
Kantarjian HM
, Short NJ,
Konopleva M
,
Jain N
,
Garcia-Manero G
, Garris R, Qiao W,
Cortes JE
, O'Brien S,
Kebriaei P
,
Kadia T
,
Jabbour E
, Ravandi F. Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors. Am J Hematol. 2019 12; 94(12):1388-1395.
PMID:
31595534
.
Citations:
7
Fields:
Hem
Hematology
Translation:
Humans
Cells
Srour SA,
Saliba RM
, Bittencourt MCB, Perez JMR, Kongtim P,
Alousi A
,
Al-Atrash G
,
Olson A
, Betul O,
Mehta R
,
Popat U
,
Hosing C
,
Bashir Q
,
Khouri I
,
Kebriaei P
, Masarova L, Short N,
Jabbour E
,
Daver N
,
Konopleva M
, Ravandi F,
Kantarjian H
,
Champlin RE
,
Ciurea SO
. Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation. Am J Hematol. 2019 12; 94(12):1382-1387.
PMID:
31595538
.
Citations:
5
Fields:
Hem
Hematology
Translation:
Humans
Zhu Y, He X, Lin YC, Dong H, Zhang L, Chen X, Wang Z, Shen Y, Li M, Wang H, Sun J, Nguyen LX, Zhang H, Jiang W, Yang Y, Chen J, Chen CW,
Konopleva MY
, Sun W, Jin J, Carlesso N, Marcucci G, Luo Y, Li L, M?schen M. Targeting PRMT1-mediated FLT3 methylation disrupts maintenance of MLL-rearranged acute lymphoblastic leukemia. Blood. 2019 10 10; 134(15):1257-1268.
PMID:
31395602
; PMCID:
PMC6788006
.
Citations:
6
Fields:
Hem
Hematology
Translation:
Humans
Animals
Cells
Sukswai N,
Aung PP
, Yin CC, Li S, Wang W, Wang SA, Ortega V, Lyapichev K,
Nagarajan P
, Alfattal R, Angelova E, Tang Z,
Loghavi S
, Kanagal-Shamanna R,
Miranda RN
,
Pemmaraju N
,
Bhalla K
,
Konopleva M
, Medeiros LJ,
Khoury JD
. Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm. Am J Surg Pathol. 2019 10; 43(10):1429-1437.
PMID:
31261288
.
Citations:
15
Fields:
Gen
General Surgery
Pat
Pathology
Translation:
Humans
Cells
Richard-Carpentier G,
Jabbour E
, Short NJ, Rausch CR, Savoy JM,
Bose P
, Yilmaz M,
Jain N
,
Borthakur G
,
Ohanian M
,
Alvarado Y
,
Rytting M
,
Kebriaei P
,
Konopleva M
,
Kantarjian H
, Ravandi F. Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk. 2020 04; 20(4):212-218.
PMID:
32035785
.
Citations:
18
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Economides MP,
Konopleva M
,
Pemmaraju N
. Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm. Ther Adv Hematol. 2019; 10:2040620719874733.
PMID:
31579499
; PMCID:
PMC6759709
.
Citations:
4
Tabe Y, Lorenzi PL,
Konopleva M
. Amino acid metabolism in hematologic malignancies and the era of targeted therapy. Blood. 2019 09 26; 134(13):1014-1023.
PMID:
31416801
; PMCID:
PMC6764269
.
Citations:
39
Fields:
Hem
Hematology
Translation:
Humans
Animals
Panina SB, Baran N, Brasil da Costa FH,
Konopleva M
, Kirienko NV. A mechanism for increased sensitivity of acute myeloid leukemia to mitotoxic drugs. Cell Death Dis. 2019 08 13; 10(8):617.
PMID:
31409768
; PMCID:
PMC6692368
.
Citations:
14
Fields:
Cel
Cell Biology
Int
Internal Medicine
Translation:
Humans
Cells
Potts J, Mohamed MO, Lopez Mattei JC,
Iliescu CA
,
Konopleva M
, Rashid M, Bagur R, Mamas MA. Percutaneous coronary intervention and in-hospital outcomes in patients with leukemia: a nationwide analysis. Catheter Cardiovasc Interv. 2020 07; 96(1):53-63.
PMID:
31410970
.
Citations:
4
Fields:
Car
Cardiology
Translation:
Humans
Ravandi F, Assi R,
Daver N
,
Benton CB
,
Kadia T
, Thompson PA,
Borthakur G
,
Alvarado Y
,
Jabbour EJ
,
Konopleva M
,
Takahashi K
,
Kornblau S
,
DiNardo CD
,
Estrov Z
, Flores W, Basu S,
Allison J
,
Sharma P
, Pierce S, Pike A,
Cortes JE
,
Garcia-Manero G
,
Kantarjian HM
. Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study. Lancet Haematol. 2019 Sep; 6(9):e480-e488.
PMID:
31400961
; PMCID:
PMC6778960
.
Citations:
31
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Zacharias NM, Baran N, Shanmugavelandy SS, Lee J, Lujan JV, Dutta P,
Millward SW
, Cai T,
Wood CG
,
Piwnica-Worms D
,
Konopleva M
,
Bhattacharya PK
. Assessing Metabolic Intervention with a Glutaminase Inhibitor in Real-Time by Hyperpolarized Magnetic Resonance in Acute Myeloid Leukemia. Mol Cancer Ther. 2019 11; 18(11):1937-1946.
PMID:
31387889
; PMCID:
PMC7080291
.
Citations:
7
Fields:
Ant
Antineoplastic Agents
Translation:
Humans
Animals
Cells
Lu X, Lodi A,
Konopleva M
, Tiziani S. Three-Dimensional Leukemia Co-Culture System for In Vitro High-Content Metabolomics Screening. SLAS Discov. 2019 09; 24(8):817-828.
PMID:
31345091
.
Citations:
5
Fields:
Mol
Molecular Biology
Translation:
Humans
Cells
Rafei H,
Jabbour EJ
,
Kantarjian H
, Sinicrope KD, Kamiya-Matsuoka C,
Mehta RS
,
Daver NG
,
Kadia TM
,
Naqvi K
, Cortes J,
Konopleva M
. Neurotoxic events associated with BCR-ABL1 tyrosine kinase inhibitors: a case series. Leuk Lymphoma. 2019 12; 60(13):3292-3295.
PMID:
31246142
.
Citations:
2
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Yalniz F, Abou Dalle I,
Kantarjian H
,
Borthakur G
,
Kadia T
, Patel K,
Loghavi S
,
Garcia-Manero G
, Sasaki K,
Daver N
,
DiNardo C
,
Pemmaraju N
, Short NJ, Yilmaz M,
Bose P
,
Naqvi K
, Pierce S,
Konopleva M
,
Andreeff M
, Cortes J, Ravandi F, Nogueras Gonz?lez GM. Prognostic significance of baseline FLT3-ITD mutant allele level in acute myeloid leukemia treated with intensive chemotherapy with/without sorafenib. Am J Hematol. 2019 09; 94(9):984-991.
PMID:
31237017
.
Citations:
13
Fields:
Hem
Hematology
Translation:
Humans
Cells
CT
Clinical Trials
Kannan S
, Aitken MJL, Herbrich SM, Golfman LS, Hall MG, Mak DH,
Burks JK
, Song G,
Konopleva M
, Mullighan CG,
Chandra J
, Zweidler-McKay PA. Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia. Mol Cancer Ther. 2019 09; 18(9):1615-1627.
PMID:
31227645
; PMCID:
PMC6726528
.
Citations:
4
Fields:
Ant
Antineoplastic Agents
Translation:
Humans
Animals
Cells
Chan WK, Horvath TD, Tan L,
Link T
, Harutyunyan KG, Pontikos MA, Anishkin A, Du D, Martin LA, Yin E, Rempe SB, Sukharev S,
Konopleva M
,
Weinstein JN
, Lorenzi PL. Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia. Mol Cancer Ther. 2019 09; 18(9):1587-1592.
PMID:
31209181
; PMCID:
PMC6726508
.
Citations:
20
Fields:
Ant
Antineoplastic Agents
Translation:
Humans
Animals
Cells
Chamoun K,
Kantarjian HM
, Wang X,
Naqvi K
,
Aung F
,
Garcia-Manero G
,
Borthakur G
,
Jabbour E
,
Kadia T
,
Daver N
,
DiNardo CD
,
Jain N
,
Konopleva M
, Cortes J, Ravandi F, Yilmaz M. Unrecognized fluid overload during induction therapy increases morbidity in patients with acute promyelocytic leukemia. Cancer. 2019 09 15; 125(18):3219-3224.
PMID:
31150121
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
Jain N
, Keating M, Thompson P,
Ferrajoli A
, Burger J,
Borthakur G
,
Takahashi K
,
Estrov Z
,
Fowler N
,
Kadia T
,
Konopleva M
,
Alvarado Y
, Yilmaz M,
DiNardo C
,
Bose P
,
Ohanian M
,
Pemmaraju N
,
Jabbour E
, Sasaki K, Kanagal-Shamanna R, Patel K,
Jorgensen J
,
Garg N
, Wang X, Sondermann K, Cruz N, Wei C, Ayala A, Plunkett W,
Kantarjian H
,
Gandhi V
,
Wierda W
. Ibrutinib and Venetoclax for First-Line Treatment of CLL. N Engl J Med. 2019 05 30; 380(22):2095-2103.
PMID:
31141631
.
Citations:
139
Fields:
Med
Medicine (General)
Translation:
Humans
CT
Clinical Trials
Guerra VA,
DiNardo C
,
Konopleva M
. Venetoclax-based therapies for acute myeloid leukemia. Best Pract Res Clin Haematol. 2019 06; 32(2):145-153.
PMID:
31203996
; PMCID:
PMC6581210
.
Citations:
36
Fields:
Hem
Hematology
Translation:
Humans
Han L, Zhang Q, Dail M, Shi C, Cavazos A, Ruvolo VR, Zhao Y, Kim E, Rahmani M, Mak DH, Jin SS, Chen J, Phillips DC, Koller PB,
Jacamo R
,
Burks JK
,
DiNardo C
,
Daver N
,
Jabbour E
, Wang J,
Kantarjian HM
,
Andreeff M
, Grant S, Leverson JD, Sampath D,
Konopleva M
. Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models. Haematologica. 2020 03; 105(3):697-707.
PMID:
31123034
; PMCID:
PMC7049339
.
Citations:
30
Fields:
Hem
Hematology
Translation:
Humans
Cells
Zeng Z
, Liu W,
Benton CB
,
Konoplev S
, Lu H, Wang RY, Chen J,
Shpall E
,
Baggerly KA
,
Champlin R
,
Konopleva M
. Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell Transplantation. Acta Haematol. 2019; 142(3):176-184.
PMID:
31112940
; PMCID:
PMC6792289
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Cells
CT
Clinical Trials
Aung PP
, Sukswai N, Nejati R,
Loghavi S
, Chen W, Torres-Cabala CA, Yin CC,
Konopleva M
, Zheng X, Wang J,
Tang Z
,
Medeiros LJ
,
Prieto VG
,
Pemmaraju N
,
Khoury JD
. PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers (Basel). 2019 May 19; 11(5).
PMID:
31109153
; PMCID:
PMC6562447
.
Citations:
1
Strati P,
Garcia-Manero G
, Zhao C,
Kadia T
,
Borthakur G
,
Konopleva M
,
Daver N
,
DiNardo CD
, Short NJ, Yilmaz M,
Naqvi K
,
Alvarado Y
, Pierce SA, Cortes J,
Bueso-Ramos C
,
Kantarjian H
, Ravandi F. Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts. Am J Hematol. 2019 07; 94(7):E188-E190.
PMID:
30977182
; PMCID:
PMC6566858
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Pemmaraju N
, Lane AA, Sweet KL, Stein AS, Vasu S, Blum W, Rizzieri DA, Wang ES,
Duvic M
, Sloan JM, Spence S, Shemesh S, Brooks CL, Balser J, Bergstein I, Lancet JE,
Kantarjian HM
,
Konopleva M
. Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm. N Engl J Med. 2019 04 25; 380(17):1628-1637.
PMID:
31018069
.
Citations:
83
Fields:
Med
Medicine (General)
Translation:
Humans
Cells
CT
Clinical Trials
Jabbour EJ
, Sasaki K, Ravandi F, Short NJ,
Garcia-Manero G
,
Daver N
,
Kadia T
,
Konopleva M
,
Jain N
, Cortes J, Issa GC, Jacob J, Kwari M, Thompson P, Garris R,
Pemmaraju N
, Yilmaz M, O'Brien SM,
Kantarjian HM
. Inotuzumab ozogamicin in combination with low-intensity chemotherapy (mini-HCVD) with or without blinatumomab versus standard intensive chemotherapy (HCVAD) as frontline therapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis. Cancer. 2019 08 01; 125(15):2579-2586.
PMID:
30985931
; PMCID:
PMC6625850
.
Citations:
20
Fields:
Neo
Neoplasms
Translation:
Humans
Ragon BK, Odenike O, Baer MR, Stock W,
Borthakur G
, Patel K, Han L, Chen H, Ma H, Joseph L, Zhao Y,
Baggerly K
,
Konopleva M
,
Jain N
. Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II Study. Clin Lymphoma Myeloma Leuk. 2019 07; 19(7):431-440.e13.
PMID:
31056348
; PMCID:
PMC6626580
.
Citations:
21
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Montalban-Bravo G, Kanagal-Shamanna R, Sasaki K, Patel K, Ganan-Gomez I,
Jabbour E
,
Kadia T
, Ravandi F,
DiNardo C
, Borthakur G,
Takahashi K
,
Konopleva M
, Komrokji RS, DeZern A, Kuzmanovic T, Maciejewski J, Pierce S,
Colla S
, Sekeres MA,
Kantarjian H
,
Bueso-Ramos C
,
Garcia-Manero G
. NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy. Blood Adv. 2019 03 26; 3(6):922-933.
PMID:
30902805
; PMCID:
PMC6436014
.
Citations:
21
Fields:
Hem
Hematology
Translation:
Humans
Abbas HA, Ravandi F,
Loghavi S
,
Patel KP
,
Borthakur G
,
Kadia TM
,
Jabbour E
,
Takahashi K
, Cortes J, Issa GC,
Konopleva M
,
Kantarjian HM
, Short NJ. NPM1 mutant variant allele frequency correlates with leukemia burden but does not provide prognostic information in NPM1-mutated acute myeloid leukemia. Am J Hematol. 2019 06; 94(6):E158-E160.
PMID:
30838674
; PMCID:
PMC6602057
.
Citations:
6
Fields:
Hem
Hematology
Translation:
Humans
Rytelewski M, Haryutyunan K, Nwajei F, Shanmugasundaram M, Wspanialy P, Zal MA, Chen CH, El Khatib M, Plunkett S, Vinogradov SA,
Konopleva M
,
Zal T
. Merger of dynamic two-photon and phosphorescence lifetime microscopy reveals dependence of lymphocyte motility on oxygen in solid and hematological tumors. J Immunother Cancer. 2019 03 18; 7(1):78.
PMID:
30885258
; PMCID:
PMC6423744
.
Citations:
15
Fields:
Neo
Neoplasms
The
Therapeutics
Translation:
Humans
Animals
Cells
Sasaki K,
Kantarjian HM
, O'Brien S, Ravandi F,
Konopleva M
,
Borthakur G
,
Garcia-Manero G
,
Wierda WG
,
Daver N
,
Ferrajoli A
,
Takahashi K
, Jain P, Rios MB, Pierce SA,
Jabbour EJ
,
Cortes JE
. Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors. Int J Hematol. 2019 May; 109(5):545-552.
PMID:
30830579
.
Citations:
13
Fields:
Hem
Hematology
Translation:
Humans
Benton CB
, Boddu PC,
DiNardo CD
,
Bose P
, Wang F, Assi R,
Pemmaraju N
, Kc D, Pierce S, Patel K,
Konopleva M
, Ravandi F,
Garcia-Manero G
,
Kadia TM
, Cortes J,
Kantarjian HM
,
Andreeff M
,
Verstovsek S
. Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia. Cancer. 2019 06 01; 125(11):1855-1866.
PMID:
30811597
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
Piya S
, Mu H, Bhattacharya S, Lorenzi PL, Davis RE, McQueen T, Ruvolo V, Baran N, Wang Z, Qian Y, Crews CM,
Konopleva M
, Ishizawa J, You MJ,
Kantarjian H
,
Andreeff M
,
Borthakur G
. BETP degradation simultaneously targets acute myelogenous leukemia stem cells and the microenvironment. J Clin Invest. 2019 05 01; 129(5):1878-1894.
PMID:
30829648
; PMCID:
PMC6486356
.
Citations:
23
Fields:
Med
Medicine (General)
Translation:
Humans
Animals
Cells
Wood C, Harutyunyan K, Sampaio DRT,
Konopleva M
,
Bouchard R
. Photoacoustic-based oxygen saturation assessment of murine femoral bone marrow in a preclinical model of leukemia. Photoacoustics. 2019 Jun; 14:31-36.
PMID:
31049286
; PMCID:
PMC6484208
.
Citations:
11
Swaminathan M,
Borthakur G
,
Kadia TM
,
Ferrajoli A
,
Alvarado Y
,
Pemmaraju N
, Bodden K, Yearby B,
Konopleva M
,
Khoury J
,
Bueso-Ramos C
,
Garcia-Manero G
,
DiNardo CD
. A phase 2 clinical trial of eltrombopag for treatment of patients with myelodysplastic syndromes after hypomethylating-agent failure. Leuk Lymphoma. 2019 09; 60(9):2207-2213.
PMID:
30773968
.
Citations:
3
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Cells
CT
Clinical Trials
Pemmaraju N
,
Konopleva M
, Lane AA. More on Blastic Plasmacytoid Dendritic-Cell Neoplasms. N Engl J Med. 2019 02 14; 380(7):695-6.
PMID:
30785714
.
Citations:
8
Fields:
Med
Medicine (General)
Translation:
Humans
Kadia TM
,
Kantarjian HM
,
Konopleva M
. Myeloid cell leukemia-1 dependence in acute myeloid leukemia: a novel approach to patient therapy. Oncotarget. 2019 Feb 08; 10(12):1250-1265.
PMID:
30815228
; PMCID:
PMC6383813
.
Citations:
6
Fields:
Neo
Neoplasms
Fiskus W
, Cai T,
DiNardo CD
,
Kornblau SM
,
Borthakur G
,
Kadia TM
,
Pemmaraju N
,
Bose P
, Masarova L, Rajapakshe K, Perera D,
Coarfa C
, Mill CP, Saenz DT, Saenz DN, Sun B,
Khoury JD
, Shen Y,
Konopleva M
,
Bhalla KN
. Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells. Blood Cancer J. 2019 01 15; 9(2):4.
PMID:
30647404
; PMCID:
PMC6333829
.
Citations:
29
Fields:
All
Allergy and Immunology
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Animals
Cells
Gu Z, Churchman ML, Roberts KG, Moore I, Zhou X, Nakitandwe J, Hagiwara K, Pelletier S, Gingras S, Berns H, Payne-Turner D, Hill A, Iacobucci I, Shi L, Pounds S, Cheng C, Pei D, Qu C, Newman S, Devidas M, Dai Y, Reshmi SC,
Gastier-Foster J
, Raetz EA, Borowitz MJ, Wood BL, Carroll WL, Zweidler-McKay PA,
Rabin KR
, Mattano LA, Maloney KW, Rambaldi A, Spinelli O, Radich JP, Minden MD, Rowe JM, Luger S, Litzow MR, Tallman MS, Racevskis J, Zhang Y, Bhatia R, Kohlschmidt J, Bloomfield CD, Stock W,
Kornblau S
,
Kantarjian HM
,
Konopleva M
, Evans WE, Jeha S, Pui CH, Yang J, Paietta E, Downing JR, Relling MV, Zhang J, Loh ML, Hunger SP, Mullighan CG, Mr?zek K. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet. 2019 02; 51(2):296-307.
PMID:
30643249
; PMCID:
PMC6525306
.
Citations:
141
Fields:
Gen
Genetics
Translation:
Humans
Animals
Cells
Horvath TD, Chan WK, Pontikos MA, Martin LA, Du D, Tan L,
Konopleva M
,
Weinstein JN
, Lorenzi PL. Assessment of l-Asparaginase Pharmacodynamics in Mouse Models of Cancer. Metabolites. 2019 Jan 09; 9(1).
PMID:
30634463
; PMCID:
PMC6359345
.
Citations:
3
Chamoun K,
Kantarjian H
, Atallah R, Gonzalez GN, Issa GC, Rios MB,
Garcia-Manero G
,
Borthakur G
, Ravandi F,
Jain N
,
Daver N
,
Konopleva M
,
DiNardo CD
,
Kadia T
,
Pemmaraju N
,
Jabbour E
, Cortes J. Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience. J Hematol Oncol. 2019 01 03; 12(1):1.
PMID:
30606227
; PMCID:
PMC6318861
.
Citations:
9
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Short NJ,
Kantarjian HM
,
Loghavi S
, Huang X, Qiao W,
Borthakur G
,
Kadia TM
,
Daver N
,
Ohanian M
,
Dinardo CD
,
Estrov Z
, Kanagal-Shamanna R, Maiti A,
Benton CB
,
Bose P
,
Alvarado Y
,
Jabbour E
,
Kornblau SM
,
Pemmaraju N
,
Jain N
, Gasior Y, Richie MA, Pierce S, Cortes J,
Konopleva M
,
Garcia-Manero G
, Ravandi F. Treatment with a 5-day versus a 10-day schedule of decitabine in older patients with newly diagnosed acute myeloid leukaemia: a randomised phase 2 trial. Lancet Haematol. 2019 Jan; 6(1):e29-e37.
PMID:
30545576
; PMCID:
PMC6563344
.
Citations:
32
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Boddu PC,
Kadia TM
,
Garcia-Manero G
, Cortes J, Alfayez M,
Borthakur G
,
Konopleva M
,
Jabbour EJ
,
Daver NG
,
DiNardo CD
,
Naqvi K
, Yilmaz M, Short NJ, Pierce S,
Kantarjian HM
, Ravandi F. Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3-internal tandem duplication genotypes. Cancer. 2019 04 01; 125(7):1091-1100.
PMID:
30521114
; PMCID:
PMC6561101
.
Citations:
20
Fields:
Neo
Neoplasms
Translation:
Humans
Jabbour E
, Short NJ, Ravandi F, Huang X,
Daver N
,
DiNardo CD
,
Konopleva M
,
Pemmaraju N
,
Wierda W
,
Garcia-Manero G
, Sasaki K, Cortes J, Garris R,
Khoury JD
,
Jorgensen J
,
Jain N
, Alvarez J, O'Brien S,
Kantarjian H
. Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study. Lancet Haematol. 2018 Dec; 5(12):e618-e627.
PMID:
30501869
; PMCID:
PMC10020885
.
Citations:
50
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Cells
CT
Clinical Trials
Williams P, Basu S,
Garcia-Manero G
, Hourigan CS, Oetjen KA,
Cortes JE
, Ravandi F,
Jabbour EJ
, Al-Hamal Z,
Konopleva M
,
Ning J
, Xiao L, Hidalgo Lopez J,
Kornblau SM
,
Andreeff M
, Flores W,
Bueso-Ramos C
, Blando J, Galera P, Calvo KR,
Al-Atrash G
,
Allison JP
,
Kantarjian HM
,
Sharma P
,
Daver NG
. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. 2019 05 01; 125(9):1470-1481.
PMID:
30500073
; PMCID:
PMC6467779
.
Citations:
84
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Herbrich SM,
Baggerly KA
,
Konopleva M
. Refining statistics clarifies leukaemic stem cell genomics. Br J Haematol. 2019 06; 185(5):1005-1007.
PMID:
30474856
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Animals
Tabe Y, Saitoh K, Yang H, Sekihara K, Yamatani K, Ruvolo V, Taka H, Kaga N, Kikkawa M, Arai H, Miida T,
Andreeff M
, Spagnuolo PA,
Konopleva M
. Inhibition of FAO in AML co-cultured with BM adipocytes: mechanisms of survival and chemosensitization to cytarabine. Sci Rep. 2018 11 15; 8(1):16837.
PMID:
30442990
; PMCID:
PMC6237992
.
Citations:
17
Fields:
Sci
Science
Translation:
Humans
Cells
Short NJ,
Jabbour E
,
Naqvi K
, Patel A,
Ning J
, Sasaki K, Nogueras-Gonzalez GM,
Bose P
,
Kornblau SM
,
Takahashi K
,
Andreeff M
, Sanchez-Petitto G,
Estrov Z
,
Dinardo CD
, Montalban-Bravo G,
Konopleva M
,
Alvarado Y
,
Bhalla KN
,
Fiskus W
, Khouri M, Islam R,
Kantarjian H
,
Garcia-Manero G
. A phase II study of omacetaxine mepesuccinate for patients with higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents. Am J Hematol. 2019 01; 94(1):74-79.
PMID:
30328139
; PMCID:
PMC6570401
.
Citations:
2
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Daver N
,
Garcia-Manero G
, Basu S, Boddu PC, Alfayez M,
Cortes JE
,
Konopleva M
,
Ravandi-Kashani F
,
Jabbour E
,
Kadia T
, Nogueras-Gonzalez GM,
Ning J
,
Pemmaraju N
,
DiNardo CD
,
Andreeff M
, Pierce SA, Gordon T,
Kornblau SM
, Flores W, Alhamal Z,
Bueso-Ramos C
,
Jorgensen JL
,
Patel KP
, Blando J,
Allison JP
,
Sharma P
,
Kantarjian H
. Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study. Cancer Discov. 2019 03; 9(3):370-383.
PMID:
30409776
; PMCID:
PMC6397669
.
Citations:
151
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
DiNardo CD
, Pratz K, Pullarkat V, Jonas BA, Arellano M, Becker PS, Frankfurt O,
Konopleva M
, Wei AH,
Kantarjian HM
, Xu T, Hong WJ, Chyla B, Potluri J, Pollyea DA, Letai A. Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia. Blood. 2019 01 03; 133(1):7-17.
PMID:
30361262
; PMCID:
PMC6318429
.
Citations:
444
Fields:
Hem
Hematology
Translation:
Humans
Angelova E, Audette C, Kovtun Y,
Daver N
, Wang SA, Pierce S,
Konoplev SN
, Khogeer H,
Jorgensen JL
,
Konopleva M
, Zweidler-McKay PA,
Medeiros LJ
,
Kantarjian HM
,
Jabbour EJ
,
Khoury JD
. CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia. Haematologica. 2019 04; 104(4):749-755.
PMID:
30361418
; PMCID:
PMC6442980
.
Citations:
22
Fields:
Hem
Hematology
Translation:
Humans
Cells
CT
Clinical Trials
Jabbour E
, Sasaki K, Ravandi F, Huang X, Short NJ, Khouri M,
Kebriaei P
,
Burger J
,
Khoury J
,
Jorgensen J
,
Jain N
,
Konopleva M
,
Garcia-Manero G
,
Kadia T
, Cortes J, Jacob J, Montalbano K, Garris R, O'Brien S,
Kantarjian HM
. Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage. Cancer. 2018 10 15; 124(20):4044-4055.
PMID:
30307611
; PMCID:
PMC6515924
.
Citations:
32
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Chamoun K,
Loghavi S
,
Pemmaraju N
,
Konopleva M
,
Kroll M
, Nguyen-Cao M, Hornbaker M,
DiNardo CD
,
Kadia T
,
Jorgensen J
,
Andreeff M
, Hu S,
Benton CB
. Early detection of transformation to BPDCN in a patient with MDS. Exp Hematol Oncol. 2018; 7:26.
PMID:
30323983
; PMCID:
PMC6174068
.
Citations:
4
Boddu P,
Borthakur G
, Koneru M, Huang X,
Naqvi K
,
Wierda W
,
Bose P
,
Jabbour E
,
Estrov Z
,
Burger J
,
Alvarado Y
, Deshmukh A, Patel A, Cavazos A, Han L,
Cortes JE
,
Kantarjian H
,
Andreeff M
,
Konopleva M
. Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia. Front Oncol. 2018; 8:369.
PMID:
30319961
; PMCID:
PMC6167965
.
Citations:
10
Assi R, Gur HD,
Loghavi S
,
Konoplev SN
,
Konopleva M
,
Daver N
, Tashakori M,
Kadia T
,
Routbort M
, Salem A, Kanagal-Shamanna R, Quesada A,
Jabbour EJ
,
Kornblau SM
,
Medeiros LJ
,
Kantarjian H
,
Khoury JD
. P53 protein overexpression in de novo acute myeloid leukemia patients with normal diploid karyotype correlates with FLT3 internal tandem duplication and worse relapse-free survival. Am J Hematol. 2018 11; 93(11):1376-1383.
PMID:
30117185
.
Citations:
8
Fields:
Hem
Hematology
Translation:
Humans
Cells
Ciurea SO
, Bittencourt MCB,
Cao K
, Kongtim P,
Rondon G
, Chen J,
Konopleva M
, Perez JMR, El Shazly MF, Aljadayeh M, Alvarez M, Im J,
Al-Atrash G
,
Mehta R
,
Popat U
,
Bashir Q
,
Oran B
,
Hosing CM
,
Khouri IF
,
Kebriaei P
,
Champlin RE
, Milton DR. Is a matched unrelated donor search needed for all allogeneic transplant candidates? Blood Adv. 2018 09 11; 2(17):2254-2261.
PMID:
30206098
; PMCID:
PMC6134218
.
Citations:
9
Fields:
Hem
Hematology
Translation:
Humans
Zeng Z
,
Konopleva M
. Targeting dihydroorotate dehydrogenase in acute myeloid leukemia. Haematologica. 2018 09; 103(9):1415-1417.
PMID:
30171015
; PMCID:
PMC6119147
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Kadia TM
, Cortes J, Ravandi F,
Jabbour E
,
Konopleva M
,
Benton CB
,
Burger J
, Sasaki K,
Borthakur G
,
DiNardo CD
,
Pemmaraju N
,
Daver N
,
Ferrajoli A
, Wang X, Patel K,
Jorgensen JL
, Wang S, O'Brien S, Pierce S, Tuttle C,
Estrov Z
,
Verstovsek S
,
Garcia-Manero G
,
Kantarjian H
. Cladribine and low-dose cytarabine alternating with decitabine as front-line therapy for elderly patients with acute myeloid leukaemia: a phase 2 single-arm trial. Lancet Haematol. 2018 Sep; 5(9):e411-e421.
PMID:
30115541
; PMCID:
PMC6775639
.
Citations:
19
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Abou Dalle I,
Cortes JE
, Pinnamaneni P,
Lamothe B
, Diaz Duque A, Randhawa J,
Pemmaraju N
,
Jabbour E
,
Ferrajoli A
,
Wierda WG
,
Estrov Z
,
Konopleva M
, Ravandi F,
Alvarado Y
,
Borthakur G
,
Gandhi V
,
Kantarjian HM
. A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia. Acta Haematol. 2018; 140(1):30-39.
PMID:
30071517
.
Citations:
5
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Konopleva M
, Letai A. BCL-2 inhibition in AML: an unexpected bonus? Blood. 2018 09 06; 132(10):1007-1012.
PMID:
30037885
; PMCID:
PMC6235069
.
Citations:
45
Fields:
Hem
Hematology
Translation:
Humans
Takahashi K
, Wang F, Morita K, Yan Y,
Hu P
, Zhao P, Zhar AA, Wu CJ, Gumbs C, Little L,
Tippen S
, Thornton R, Coyle M, Mendoza M, Thompson E, Zhang J,
DiNardo CD
,
Jain N
, Ravandi F,
Cortes JE
,
Garcia-Manero G
,
Kornblau S
,
Andreeff M
,
Jabbour E
,
Bueso-Ramos C
, Takaori-Kondo A,
Konopleva M
, Patel K,
Kantarjian H
, Futreal PA. Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes. Nat Commun. 2018 07 10; 9(1):2670.
PMID:
29991687
; PMCID:
PMC6039465
.
Citations:
26
Fields:
Bio
Biology
Sci
Science
Translation:
Humans
Cells
Yalniz FF,
Daver N
, Rezvani K,
Kornblau S
,
Ohanian M
,
Borthakur G
,
DiNardo CD
,
Konopleva M
, Burger J, Gasior Y, Pierce S,
Kantarjian H
,
Garcia-Manero G
. A Pilot Trial of Lirilumab With or Without Azacitidine for Patients With Myelodysplastic Syndrome. Clin Lymphoma Myeloma Leuk. 2018 10; 18(10):658-663.e2.
PMID:
30001986
; PMCID:
PMC6750214
.
Citations:
15
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Molina JR, Sun Y, Protopopova M, Gera S, Bandi M, Bristow C, McAfoos T, Morlacchi P, Ackroyd J, Agip AA,
Al-Atrash G
, Asara J, Bardenhagen J, Carrillo CC, Carroll C,
Chang E
,
Ciurea S
, Cross JB, Czako B, Deem A,
Daver N
,
de Groot JF
, Dong JW, Feng N, Gao G, Gay J, Do MG, Greer J, Giuliani V, Han J, Han L, Henry VK, Hirst J, Huang S, Jiang Y, Kang Z, Khor T,
Konoplev S
, Lin YH, Liu G, Lodi A, Lofton T, Ma H, Mahendra M, Matre P, Mullinax R, Peoples M, Petrocchi A, Rodriguez-Canale J, Serreli R, Shi T, Smith M, Tabe Y, Theroff J, Tiziani S, Xu Q, Zhang Q,
Muller F
,
DePinho RA
, Toniatti C,
Draetta GF
, Heffernan TP,
Konopleva M
, Jones P, Di Francesco ME, Marszalek JR. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat Med. 2018 07; 24(7):1036-1046.
PMID:
29892070
.
Citations:
261
Fields:
Med
Medicine (General)
Mol
Molecular Biology
Translation:
Humans
Animals
Cells
Chan LN, Chen Z, Braas D, Lee JW, Xiao G, Geng H, Cosgun KN, Hurtz C, Shojaee S, Cazzaniga V, Schjerven H,
Kornblau SM
,
Konopleva M
, Pufall MA, Liu GJ, Milne TA, Koeffler HP, Ross TS, Yamamoto KR, Dickins RA, Graeber TG, Ernst T, Hochhaus A, Cazzaniga G, S?nchez-Garc?a I, Borkhardt A, M?schen M. Author Correction: Metabolic gatekeeper function of B-lymphoid transcription factors. Nature. 2018 06; 558(7711):E5.
PMID:
29849140
.
Citations:
Fields:
Sci
Science
Chyla B,
Daver N
, Doyle K, McKeegan E, Huang X, Ruvolo V, Wang Z, Chen K, Souers A, Leverson J, Potluri J, Boghaert E, Bhathena A,
Konopleva M
, Popovic R. Genetic Biomarkers Of Sensitivity and Resistance to Venetoclax Monotherapy in Patients With Relapsed Acute Myeloid Leukemia. Am J Hematol. 2018 May 17.
PMID:
29770480
; PMCID:
PMC6120451
.
Citations:
53
Fields:
Hem
Hematology
Morita K,
Kantarjian HM
, Wang F, Yan Y,
Bueso-Ramos C
, Sasaki K, Issa GC, Wang S,
Jorgensen J
, Song X, Zhang J,
Tippen S
, Thornton R, Coyle M, Little L, Gumbs C,
Pemmaraju N
,
Daver N
,
DiNardo CD
,
Konopleva M
,
Andreeff M
, Ravandi F,
Cortes JE
,
Kadia T
,
Jabbour E
,
Garcia-Manero G
,
Patel KP
, Futreal PA,
Takahashi K
. Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia. J Clin Oncol. 2018 06 20; 36(18):1788-1797.
PMID:
29702001
; PMCID:
PMC6008108
.
Citations:
66
Fields:
Neo
Neoplasms
Translation:
Humans
Kantarjian HM
,
DiNardo CD
, Nogueras-Gonzalez GM,
Kadia TM
,
Jabbour E
,
Bueso-Ramos CE
, O'Brien SM,
Konopleva M
,
Jain NB
,
Daver NG
,
Shpall EJ
,
Champlin RE
, Simkins A,
Garcia-Manero G
, Keating MJ, Huang X,
Cortes JE
, Pierce SA, Ravandi F, Freireich EJ. Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000. Cancer. 2018 06 15; 124(12):2534-2540.
PMID:
29645075
.
Citations:
8
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Kornblau SM
,
Ruvolo PP
, Wang RY, Battula VL,
Shpall EJ
, Ruvolo VR, McQueen T, Qui Y, Zeng Z, Pierce S,
Jacamo R
, Yoo SY, Le PM, Sun J, Hail N,
Konopleva M
,
Andreeff M
. Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival. Haematologica. 2018 05; 103(5):810-821.
PMID:
29545342
; PMCID:
PMC5927978
.
Citations:
18
Fields:
Hem
Hematology
Translation:
Humans
Cells
Ohanian M
, Tari Ashizawa A,
Garcia-Manero G
,
Pemmaraju N
,
Kadia T
,
Jabbour E
, Ravandi F,
Borthakur G
,
Andreeff M
,
Konopleva M
, Lim M, Pierce S, O'Brien S,
Alvarado Y
,
Verstovsek S
,
Wierda W
,
Kantarjian H
, Cortes J. Liposomal Grb2 antisense oligodeoxynucleotide (BP1001) in patients with refractory or relapsed haematological malignancies: a single-centre, open-label, dose-escalation, phase 1/1b trial. Lancet Haematol. 2018 Apr; 5(4):e136-e146.
PMID:
29550383
.
Citations:
20
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Bose P
,
Konopleva MY
. ORY-1001: Overcoming the Differentiation Block in AML. Cancer Cell. 2018 03 12; 33(3):342-343.
PMID:
29533778
.
Citations:
8
Fields:
Neo
Neoplasms
Translation:
Humans
Jiang X, Mak PY, Mu H, Tao W, Mak DH,
Kornblau S
, Zhang Q,
Ruvolo P
,
Burks JK
, Zhang W, McQueen T, Pan R, Zhou H,
Konopleva M
, Cortes J, Liu Q,
Andreeff M
,
Carter BZ
. Disruption of Wnt/?-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in FLT3-Mutant Acute Myeloid Leukemia. Clin Cancer Res. 2018 05 15; 24(10):2417-2429.
PMID:
29463558
; PMCID:
PMC5955840
.
Citations:
29
Fields:
Neo
Neoplasms
Translation:
Humans
Animals
Cells
Jabbour E
, Ravandi F,
Kebriaei P
, Huang X, Short NJ, Thomas D, Sasaki K,
Rytting M
,
Jain N
,
Konopleva M
,
Garcia-Manero G
,
Champlin R
,
Marin D
,
Kadia T
, Cortes J,
Estrov Z
,
Takahashi K
, Patel Y, Khouri MR, Jacob J, Garris R, O'Brien S,
Kantarjian H
. Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Phase 2 Clinical Trial. JAMA Oncol. 2018 Feb 01; 4(2):230-234.
PMID:
28859185
; PMCID:
PMC5838597
.
Citations:
43
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
CT
Clinical Trials
Boddu P,
Kantarjian H
, Ravandi F,
Garcia-Manero G
,
Borthakur G
,
Andreeff M
,
Jabbour EJ
,
Benton CB
,
DiNardo CD
,
Konopleva M
,
Daver N
, Patel K,
Takahashi K
, Kanagal-Shamanna R, Cortes J,
Kadia T
. Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemia. Leuk Lymphoma. 2018 09; 59(9):2238-2241.
PMID:
29338567
.
Citations:
5
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Zhang Q, Shi C, Han L,
Jain N
, Roberts KG, Ma H, Cai T, Cavazos A, Tabe Y,
Jacamo RO
, Mu H, Zhao Y, Wang J, Wu SC, Cao F, Zeng Z, Zhou J, Mi Y,
Jabbour EJ
, Levine R, Tasian SK, Mullighan CG, Weinstock DM, Fruman DA,
Konopleva M
. Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in CRLF2 rearranged and/or JAK driven Philadelphia chromosome-like acute B-cell lymphoblastic leukemia. Oncotarget. 2018 Jan 30; 9(8):8027-8041.
PMID:
29487712
; PMCID:
PMC5814279
.
Citations:
18
Fields:
Neo
Neoplasms
Kantarjian H
, Ravandi F, Short NJ, Huang X,
Jain N
, Sasaki K,
Daver N
,
Pemmaraju N
,
Khoury JD
,
Jorgensen J
,
Alvarado Y
,
Konopleva M
,
Garcia-Manero G
,
Kadia T
, Yilmaz M, Bortakhur G,
Burger J
,
Kornblau S
,
Wierda W
,
DiNardo C
,
Ferrajoli A
, Jacob J, Garris R, O'Brien S,
Jabbour E
. Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study. Lancet Oncol. 2018 02; 19(2):240-248.
PMID:
29352703
.
Citations:
58
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
DiNardo CD
, Pratz KW, Letai A, Jonas BA, Wei AH, Thirman M, Arellano M, Frattini MG,
Kantarjian H
, Popovic R, Chyla B, Xu T, Dunbar M, Agarwal SK, Humerickhouse R, Mabry M, Potluri J,
Konopleva M
, Pollyea DA. Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study. Lancet Oncol. 2018 02; 19(2):216-228.
PMID:
29339097
.
Citations:
235
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Gotesman M, Vo TT, Herzog LO, Tea T, Mallya S, Tasian SK,
Konopleva M
, Fruman DA. mTOR inhibition enhances efficacy of dasatinib in ABL-rearranged Ph-like B-ALL. Oncotarget. 2018 Jan 19; 9(5):6562-6571.
PMID:
29464092
; PMCID:
PMC5814232
.
Citations:
6
Fields:
Neo
Neoplasms
Montalban-Bravo G,
Takahashi K
, Patel K, Wang F, Xingzhi S, Nogueras GM, Huang X, Pierola AA,
Jabbour E
,
Colla S
, Borthakur G,
Daver N
,
Estrov Z
,
Kadia T
,
Pemmaraju N
, Ravandi F,
Bueso-Ramos C
, Chamseddine A,
Konopleva M
, Zhang J,
Kantarjian H
,
Futreal A
,
Garcia-Manero G
, Ga?an-Gomez I. Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. Oncotarget. 2018 Feb 09; 9(11):9714-9727.
PMID:
29515765
; PMCID:
PMC5839396
.
Citations:
23
Fields:
Neo
Neoplasms
DiNardo CD
, Rausch CR, Benton C,
Kadia T
,
Jain N
,
Pemmaraju N
,
Daver N
, Covert W, Marx KR, Mace M,
Jabbour E
, Cortes J,
Garcia-Manero G
, Ravandi F,
Bhalla KN
,
Kantarjian H
,
Konopleva M
. Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies. Am J Hematol. 2018 03; 93(3):401-407.
PMID:
29218851
.
Citations:
126
Fields:
Hem
Hematology
Translation:
Humans
Cells
Jabbour E
, Yilmaz M,
Khoury JD
, Ravandi F,
Jain N
,
Garcia-Manero G
,
Konopleva M
, Short NJ, Thompson PA,
Wierda W
,
Daver N
, Cortes J, O'brien S,
Kantarjian H
, D?ll J, Einsele H, Topp MS. Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression. Am J Hematol. 2018 03; 93(3):371-374.
PMID:
29178361
.
Citations:
37
Fields:
Hem
Hematology
Translation:
Humans
Cells
Sasaki K,
Kantarjian H
, O'Brien S, Ravandi F,
Konopleva M
,
Borthakur G
,
Garcia-Manero G
,
Wierda W
,
Daver N
,
Ferrajoli A
,
Takahashi K
, Jain P, Rios MB, Pierce S,
Jabbour E
,
Cortes JE
. Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phase. Cancer. 2018 03 15; 124(6):1160-1168.
PMID:
29266206
; PMCID:
PMC5851790
.
Citations:
11
Fields:
Neo
Neoplasms
Translation:
Humans
Pan R, Ruvolo V, Mu H, Leverson JD, Nichols G, Reed JC,
Konopleva M
,
Andreeff M
. Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy. Cancer Cell. 2017 Dec 11; 32(6):748-760.e6.
PMID:
29232553
; PMCID:
PMC5730338
.
Citations:
99
Fields:
Neo
Neoplasms
Translation:
Humans
Animals
Cells
Bose P
,
Konopleva MY
. T-PLL: another check on the venetoclax list? Blood. 2017 12 07; 130(23):2447-2448.
PMID:
29217697
; PMCID:
PMC5721286
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
Cells
Leverson JD, Sampath D, Souers AJ, Rosenberg SH, Fairbrother WJ,
Konopleva M
, Letai A, Amiot M. Found in Translation: How Preclinical Research Is Guiding the Clinical Development of the BCL2-Selective Inhibitor Venetoclax. Cancer Discov. 2017 12; 7(12):1376-1393.
PMID:
29146569
; PMCID:
PMC5728441
.
Citations:
40
Fields:
Neo
Neoplasms
Translation:
Humans
Masarova L, Yin CC,
Cortes JE
,
Konopleva M
,
Borthakur G
, Newberry KJ,
Kantarjian HM
,
Bueso-Ramos CE
,
Verstovsek S
. Histomorphological responses after therapy with pegylated interferon a-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV). Exp Hematol Oncol. 2017; 6:30.
PMID:
29152412
; PMCID:
PMC5679503
.
Citations:
11
Abaza Y, M Kantarjian H, Faderl S,
Jabbour E
,
Jain N
, Thomas D,
Kadia T
,
Borthakur G
, D Khoury J,
Burger J
,
Wierda W
, O'Brien S,
Konopleva M
,
Ferrajoli A
,
Kebriaei P
,
Dabaja B
,
Kornblau S
,
Alvarado Y
,
Daver N
,
Pemmaraju N
,
Bose P
, Thompson P, Al Azzawi H, Kelly M, Garris R, Jain P,
Garcia-Manero G
, Cortes J, Ravandi F. Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma. Am J Hematol. 2018 01; 93(1):91-99.
PMID:
29047158
.
Citations:
21
Fields:
Hem
Hematology
Translation:
Humans
Gorskaya YF, Suslov AP, Semenova EN,
Konopleva MV
, Nesternko VG. Pretreatment with Antiviral Preparation Kagocel Normalizes the Content of Bone Marrow Multipotent Stromal Cells and TNFa in Blood Serum of CBA Mice Disturbed by Administration of S. typhimurium Antigen Complex In Vivo and Maintains High Concentration of IL-10 and Th1 Cytokines. Bull Exp Biol Med. 2017 Oct; 163(6):761-765.
PMID:
29063332
.
Citations:
Fields:
Bio
Biology
Med
Medicine (General)
Translation:
Animals
Cells
Boddu P, Yin CC, Kanagal-Shamanna R, Tang G,
Thakral B
,
Kadia T
,
Konopleva M
,
Jabbour E
,
Jain N
. An Unsuspected Finding of t(9;22): A Rare Case of Philadelphia Chromosome-Positive B-Lymphoblastic Lymphoma. Case Rep Hematol. 2017; 2017:2413587.
PMID:
29075538
; PMCID:
PMC5624137
.
Citations:
5
Boddu P,
Jorgensen J
,
Kantarjian H
, Borthakur G, Kadia T, Daver N, Alvarado Y, Pemmaraju N, Bose P, Naqvi K, Yilmaz M, Pierce S, Brandt M, DiNardo CD, Jabbour EJ,
Konopleva M
,
Garcia-Manero G
, Cortes J, Ravandi F. Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse. Leukemia. 2018 01; 32(1):241-244.
PMID:
28919634
.
Citations:
16
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Cells
Ciurea SO
, Shah MV,
Saliba RM
, Gaballa S, Kongtim P,
Rondon G
, Chen J, Wallis W,
Cao K
,
Konopleva M
,
Daver N
, Cortes J, Ravandi F,
Alousi A
,
Ahmed S
,
Popat U
,
Parmar S
,
Bashir Q
, Betul O,
Hosing C
,
Shpall EJ
, Rezvani K,
Khouri IF
,
Kebriaei P
,
Champlin RE
. Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome. Biol Blood Marrow Transplant. 2018 06; 24(6):1232-1236.
PMID:
28918304
; PMCID:
PMC7172017
.
Citations:
23
Fields:
Hem
Hematology
Tra
Transplantation
Translation:
Humans
Adam E, Kim HN, Gang EJ, Schnair C, Lee S, Lee S, Khazal S, Kosoyan O,
Konopleva M
, Parekh C, Bhojwani D, Wayne AS, Abdel-Azim H, Heisterkamp N, Kim YM. The PI3Kd Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALL. Cancers (Basel). 2017 Sep 10; 9(9).
PMID:
28891959
; PMCID:
PMC5615336
.
Citations:
7
Jain N
, Lu X,
Daver N
,
Thakral B
, Wang SA,
Konoplev S
, Patel K, Kanagal-Shamanna R, Valentine M, Tang G,
Pemmaraju N
,
Jorgensen J
,
Kebriaei P
,
Nunez CA
,
Wierda W
,
Jabbour E
, Roberts KG, Mullighan CG,
Kantarjian H
,
Konopleva M
. Co-occurrence of CRLF2-rearranged and Ph+ acute lymphoblastic leukemia: a report of four patients. Haematologica. 2017 12; 102(12):e514-e517.
PMID:
28860345
; PMCID:
PMC5709127
.
Citations:
5
Fields:
Hem
Hematology
Translation:
Humans
Cells
Abaza YM,
Kadia TM
,
Jabbour EJ
,
Konopleva MY
,
Borthakur G
,
Ferrajoli A
,
Estrov Z
,
Wierda WG
, Alfonso A, Chong TH, Chuah C, Koh LP, Goh BC, Chang JE, Durkes DE, Foudray MC,
Kantarjian HM
, Dong XQ,
Garcia-Manero G
. Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignancies. Cancer. 2017 Dec 15; 123(24):4851-4859.
PMID:
28841236
; PMCID:
PMC5901648
.
Citations:
15
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Naqvi K
,
Konopleva M
, Ravandi F. Targeted therapies in Acute Myeloid Leukemia: a focus on FLT-3 inhibitors and ABT199. Expert Rev Hematol. 2017 10; 10(10):863-874.
PMID:
28799432
.
Citations:
8
Fields:
Hem
Hematology
Translation:
Humans
Cells
Assi R,
Kantarjian H
, Short NJ,
Daver N
,
Takahashi K
,
Garcia-Manero G
,
DiNardo C
,
Burger J
, Cortes J,
Jain N
,
Wierda W
, Chamoun S,
Konopleva M
,
Jabbour E
. Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia. Clin Lymphoma Myeloma Leuk. 2017 Dec; 17(12):897-901.
PMID:
28927784
.
Citations:
45
Fields:
Neo
Neoplasms
Translation:
Humans
Jain P,
Kantarjian H
,
Jain N
, Short NJ, Yin CC, Kanagal-Shamanna R,
Khoury J
,
Konopleva M
, Sasaki K,
Kadia TM
, Garris R, Pierce S,
Estrov Z
,
Wierda W
, Cortes J, O'Brien S, Ravandi F,
Jabbour E
. Clinical characteristics and outcomes of previously untreated patients with adult onset T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma with hyper-CVAD based regimens. Am J Hematol. 2017 10; 92(10):E595-E597.
PMID:
28646517
; PMCID:
PMC5689471
.
Citations:
2
Fields:
Hem
Hematology
Translation:
Humans
Boddu P, Takahashi K, Pemmaraju N, Daver N, Benton CB, Pierce S,
Konopleva M
, Ravandi F, Cortes J,
Kantarjian H
, DiNardo CD. Influence of IDH on FLT3-ITD status in newly diagnosed AML. Leukemia. 2017 11; 31(11):2526-2529.
PMID:
28751773
.
Citations:
12
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Cells
Khan M, Cortes J,
Kadia T
,
Naqvi K
, Brandt M, Pierce S,
Patel KP
,
Borthakur G
, Ravandi F,
Konopleva M
,
Kornblau S
,
Kantarjian H
,
Bhalla K
,
DiNardo CD
. Clinical Outcomes and Co-Occurring Mutations in Patients with RUNX1-Mutated Acute Myeloid Leukemia. Int J Mol Sci. 2017 Jul 26; 18(8).
PMID:
28933735
; PMCID:
PMC5578010
.
Citations:
11
Fields:
Bio
Biochemistry
Che
Chemistry
Mol
Molecular Biology
Translation:
Humans
Cells
Jain P,
Kantarjian HM
, Ghorab A, Sasaki K,
Jabbour EJ
, Nogueras Gonzalez G, Kanagal-Shamanna R, Issa GC,
Garcia-Manero G
, Kc D, Dellasala S, Pierce S,
Konopleva M
,
Wierda WG
,
Verstovsek S
,
Daver NG
,
Kadia TM
,
Borthakur G
, O'Brien S,
Estrov Z
, Ravandi F,
Cortes JE
. Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients. Cancer. 2017 Nov 15; 123(22):4391-4402.
PMID:
28743165
; PMCID:
PMC5673547
.
Citations:
47
Fields:
Neo
Neoplasms
Translation:
Humans
Daver N
,
Kantarjian H
,
Garcia-Manero G
,
Jabbour E
,
Borthakur G
, Brandt M, Pierce S, Vaughan K, Ning J, Patel K, Jorgensen J,
Pemmaraju N
,
Kadia T
,
Konopleva M
,
Andreeff M
,
DiNardo C
, Cortes J, Ward R, Craig A, Ravandi F, Nogueras Gonz?lez GM. Vosaroxin in combination with decitabine in newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome. Haematologica. 2017 10; 102(10):1709-1717.
PMID:
28729302
; PMCID:
PMC5622855
.
Citations:
7
Fields:
Hem
Hematology
Translation:
Humans
Boddu P,
Kantarjian HM
,
Garcia-Manero G
, Ravandi F,
Verstovsek S
,
Jabbour E
,
Borthakur G
,
Konopleva M
,
Bhalla KN
,
Daver N
,
DiNardo CD
,
Benton CB
,
Takahashi K
,
Estrov Z
, Pierce SR,
Andreeff M
,
Cortes JE
,
Kadia TM
. Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis. Blood Adv. 2017 Jul 25; 1(17):1312-1323.
PMID:
29296774
; PMCID:
PMC5727976
.
Citations:
26
Fields:
Hem
Hematology
Short NJ,
Kantarjian H
, Ravandi F, Huang X, Xiao L,
Garcia-Manero G
, Plunkett W,
Gandhi V
, Sasaki K,
Pemmaraju N
,
Daver NG
,
Borthakur G
,
Jain N
,
Konopleva M
,
Estrov Z
,
Kadia TM
,
Wierda WG
,
DiNardo CD
, Brandt M, O'Brien SM,
Cortes JE
,
Jabbour E
. A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia. Leuk Lymphoma. 2018 04; 59(4):813-820.
PMID:
28718728
; PMCID:
PMC5773400
.
Citations:
7
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Jabbour E
, Short NJ, Ravandi F, Huang X, Xiao L,
Garcia-Manero G
, Plunkett W,
Gandhi V
, Sasaki K,
Pemmaraju N
,
Daver NG
,
Borthakur G
,
Jain N
,
Konopleva M
,
Estrov Z
,
Kadia TM
,
Wierda WG
,
DiNardo CD
, Brandt M, O'Brien SM,
Cortes JE
,
Kantarjian H
. A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia. Cancer. 2017 Nov 15; 123(22):4430-4439.
PMID:
28708931
; PMCID:
PMC5739034
.
Citations:
15
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Jacamo R
, Davis RE, Ling X, Sonnylal S, Wang Z, Ma W, Zhang M,
Ruvolo P
, Ruvolo V, Wang RY, McQueen T, Lowe S, Zuber J,
Kornblau SM
,
Konopleva M
,
Andreeff M
. Tumor Trp53 status and genotype affect the bone marrow microenvironment in acute myeloid leukemia. Oncotarget. 2017 Oct 13; 8(48):83354-83369.
PMID:
29137349
; PMCID:
PMC5663521
.
Citations:
4
Fields:
Neo
Neoplasms
Battula VL, Le PM, Sun JC, Nguyen K, Yuan B, Zhou X, Sonnylal S, McQueen T, Ruvolo V, Michel KA, Ling X,
Jacamo R
,
Shpall E
, Wang Z, Rao A,
Al-Atrash G
,
Konopleva M
, Davis RE, Harrington MA, Cahill CW,
Bueso-Ramos C
,
Andreeff M
. AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth. JCI Insight. 2017 Jul 06; 2(13).
PMID:
28679949
; PMCID:
PMC5499365
.
Citations:
48
Fields:
Med
Medicine (General)
Wells J,
Jain N
,
Konopleva M
. Philadelphia chromosome-like acute lymphoblastic leukemia: progress in a new cancer subtype. Clin Adv Hematol Oncol. 2017 Jul; 15(7):554-561.
PMID:
28749919
.
Citations:
8
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Animals
Cells
Zeng Z
, Liu W, Tsao T, Qiu Y, Zhao Y, Samudio I,
Sarbassov DD
,
Kornblau SM
,
Baggerly KA
,
Kantarjian HM
,
Konopleva M
,
Andreeff M
. High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemia. Haematologica. 2017 09; 102(9):1537-1548.
PMID:
28659338
; PMCID:
PMC5685227
.
Citations:
7
Fields:
Hem
Hematology
Translation:
Humans
Animals
Cells
Short NJ,
Kantarjian H
,
Jabbour E
,
Cortes JE
, Thomas DA,
Rytting ME
,
Daver N
,
Alvarado Y
,
Konopleva M
,
Kebriaei P
,
Wierda WG
,
DiNardo CD
, Bivins C, McCue D, Richie MA, Ravandi F. A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia. Br J Haematol. 2018 08; 182(3):442-444.
PMID:
28616864
; PMCID:
PMC6511975
.
Citations:
5
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Kanagal-Shamanna R, Jain P,
Takahashi K
, Short NJ, Tang G, Issa GC, Ravandi F,
Garcia-Manero G
, Yin CC,
Luthra R
,
Patel KP
,
Khoury JD
, Montalban-Bravo G, Sasaki K,
Kadia TM
,
Borthakur G
,
Konopleva M
,
Jain N
, Garris R, Pierce S,
Wierda W
,
Estrov Z
, Cortes J, O'Brien S,
Kantarjian HM
,
Jabbour E
. TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens. Cancer. 2017 Oct 01; 123(19):3717-3724.
PMID:
28608976
; PMCID:
PMC5689475
.
Citations:
7
Fields:
Neo
Neoplasms
Translation:
Humans
Daher M, Hidalgo Lopez JE, Randhawa JK, Jabbar KJ, Wei Y,
Pemmaraju N
,
Borthakur G
,
Kadia T
,
Konopleva M
,
Kantarjian HM
, Hearn K,
Estrov Z
, Reyes S,
Bueso-Ramos CE
,
Garcia-Manero G
. An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes. Am J Hematol. 2017 Jul; 92(7):674-682.
PMID:
28370157
; PMCID:
PMC5580683
.
Citations:
7
Fields:
Hem
Hematology
Translation:
Humans
Cells
CT
Clinical Trials
Tabe Y, Tafuri A, Sekihara K, Yang H,
Konopleva M
. Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia. Expert Opin Ther Targets. 2017 07; 21(7):705-714.
PMID:
28537457
.
Citations:
15
Fields:
The
Therapeutics
Translation:
Humans
Animals
Cells
Gleixner KV, Schneeweiss M, Eisenwort G, Berger D, Herrmann H, Blatt K, Greiner G, Byrgazov K, Hoermann G,
Konopleva M
, Waliul I, Cumaraswamy AA, Gunning PT, Maeda H, Moriggl R, Deininger M, Lion T,
Andreeff M
, Valent P. Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia. Haematologica. 2017 09; 102(9):1519-1529.
PMID:
28596283
; PMCID:
PMC5685220
.
Citations:
19
Fields:
Hem
Hematology
Translation:
Humans
Cells
Vo TT, Lee JS, Nguyen D, Lui B, Pandori W, Khaw A, Mallya S, Lu M,
Konopleva M
, Fruman DA, M?schen M. mTORC1 Inhibition Induces Resistance to Methotrexate and 6-Mercaptopurine in Ph+ and Ph-like B-ALL. Mol Cancer Ther. 2017 09; 16(9):1942-1953.
PMID:
28566433
; PMCID:
PMC5619649
.
Citations:
3
Fields:
Ant
Antineoplastic Agents
Translation:
Humans
Animals
Cells
Alfonso A, Montalban-Bravo G,
Takahashi K
,
Jabbour EJ
,
Kadia T
, Ravandi F, Cortes J,
Estrov Z
,
Borthakur G
,
Pemmaraju N
,
Konopleva M
,
Bueso-Ramos C
, Pierce S,
Kantarjian H
,
Garcia-Manero G
. Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents. Am J Hematol. 2017 Jul; 92(7):599-606.
PMID:
28370097
; PMCID:
PMC5553721
.
Citations:
17
Fields:
Hem
Hematology
Translation:
Humans
Cells
Sekihara K, Saitoh K, Han L,
Ciurea S
, Yamamoto S, Kikkawa M, Kazuno S, Taka H, Kaga N, Arai H, Miida T,
Andreeff M
,
Konopleva M
, Tabe Y. Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1. Oncotarget. 2017 May 23; 8(21):34552-34564.
PMID:
28388555
; PMCID:
PMC5470990
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Schito L, Rey S,
Konopleva M
. Integration of hypoxic HIF-a signaling in blood cancers. Oncogene. 2017 09 21; 36(38):5331-5340.
PMID:
28534514
.
Citations:
9
Fields:
Mol
Molecular Biology
Neo
Neoplasms
Translation:
Humans
Animals
Cells
Boddu PC,
Kantarjian HM
, Ravandi F,
Garcia-Manero G
,
Verstovsek S
,
Jabbour EJ
,
Takahashi K
,
Bhalla K
,
Konopleva M
,
DiNardo CD
,
Ohanian M
,
Pemmaraju N
,
Jain N
, Pierce S,
Wierda WG
,
Cortes JE
,
Kadia TM
. Characteristics and outcomes of older patients with secondary acute myeloid leukemia according to treatment approach. Cancer. 2017 Aug 15; 123(16):3050-3060.
PMID:
28387922
; PMCID:
PMC5544569
.
Citations:
15
Fields:
Neo
Neoplasms
Translation:
Humans
Konoplev S
, Lu X,
Konopleva M
,
Jain N
, Ouyang J, Goswami M, Roberts KG, Valentine M, Mullighan CG,
Bueso-Ramos C
, Zweidler-McKay PA,
Jorgensen JL
, Wang SA. CRLF2-Positive B-Cell Acute Lymphoblastic Leukemia in Adult Patients: A Single-Institution Experience. Am J Clin Pathol. 2017 04 01; 147(4):357-363.
PMID:
28340183
.
Citations:
10
Fields:
Pat
Pathology
Translation:
Humans
Cells
Montalban-Bravo G, Huang X, Naqvi K, Jabbour E, Borthakur G, DiNardo CD, Pemmaraju N, Cortes J,
Verstovsek S
, Kadia T, Daver N,
Wierda W
, Alvarado Y,
Konopleva M
, Ravandi F,
Estrov Z
, Jain N, Alfonso A, Brandt M, Sneed T, Chen HC, Yang H,
Bueso-Ramos C
, Pierce S, Estey E, Bohannan Z,
Kantarjian HM
,
Garcia-Manero G
. A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials. Leukemia. 2017 07; 31(7):1659.
PMID:
28338082
.
Citations:
3
Fields:
Hem
Hematology
Neo
Neoplasms
Sandulache VC
, Chen Y, Feng L, William WN,
Skinner HD
,
Myers JN
, Meyn RE, Li J, Mijiti A,
Bankson JA
,
Fuller CD
,
Konopleva MY
,
Lai SY
. Metabolic interrogation as a tool to optimize chemotherapeutic regimens. Oncotarget. 2017 Mar 14; 8(11):18154-18165.
PMID:
28184025
; PMCID:
PMC5392315
.
Citations:
6
Fields:
Neo
Neoplasms
Translation:
Humans
Animals
Cells
Masarova L,
Patel KP
, Newberry KJ, Cortes J,
Borthakur G
,
Konopleva M
,
Estrov Z
,
Kantarjian H
,
Verstovsek S
. Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial. Lancet Haematol. 2017 Apr; 4(4):e165-e175.
PMID:
28291640
; PMCID:
PMC5421384
.
Citations:
42
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Uy GL, Rettig MP, Stone RM,
Konopleva MY
,
Andreeff M
, McFarland K, Shannon W, Fletcher TR, Reineck T, Eades W, Stockerl-Goldstein K, Abboud CN, Jacoby MA, Westervelt P, DiPersio JF. A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia. Blood Cancer J. 2017 03 10; 7(3):e542.
PMID:
28282031
; PMCID:
PMC5380905
.
Citations:
27
Fields:
All
Allergy and Immunology
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Khan M, Siddiqi R,
Konopleva M
, Bhatti MM,
Benton CB
. Increased peripheral leukemia blasts leading to false-positive blood culture. Blood Cells Mol Dis. 2017 05; 64:8-9.
PMID:
28285097
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Cells
Montalban-Bravo G,
Benton CB
, Wang SA, Ravandi F,
Kadia T
, Cortes J,
Daver N
,
Takahashi K
,
DiNardo C
,
Jabbour E
,
Borthakur G
,
Konopleva M
, Pierce S,
Bueso-Ramos C
, Patel K,
Kornblau S
,
Kantarjian H
,
Young KH
,
Garcia-Manero G
,
Andreeff M
. More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia. Blood. 2017 05 04; 129(18):2584-2587.
PMID:
28246192
; PMCID:
PMC5418636
.
Citations:
16
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Cho BS, Kim HJ,
Konopleva M
. Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside. Korean J Intern Med. 2017 Mar; 32(2):248-257.
PMID:
28219003
; PMCID:
PMC5339474
.
Citations:
35
Fields:
Int
Internal Medicine
Translation:
Humans
Animals
Cells
Milella M, Falcone I, Conciatori F, Matteoni S, Sacconi A, De Luca T, Bazzichetto C, Corbo V, Simbolo M, Sperduti I, Benfante A, Del Curatolo A, Cesta Incani U, Malusa F, Sette G, Scarpa A,
Konopleva M
,
Andreeff M
, McCubrey JA, Blandino G, Todaro M, Stassi G, De Maria R, Cognetti F, Del Bufalo D, Ciuffreda L, Eramo A. PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer. Sci Rep. 2017 02 21; 7:43013.
PMID:
28220839
; PMCID:
PMC5318947
.
Citations:
25
Fields:
Sci
Science
Translation:
Humans
Animals
Cells
Chan LN, Chen Z, Braas D, Lee JW, Xiao G, Geng H, Cosgun KN, Hurtz C, Shojaee S, Cazzaniga V, Schjerven H,
Kornblau SM
,
Konopleva M
, Pufall MA, Liu GJ, Milne TA, Koeffler HP, Ross TS, Yamamoto KR, Dickins RA, Graeber TG, Ernst T, Hochhaus A, Cazzaniga G, S?nchez-Garc?a I, Borkhardt A, M?schen M. Metabolic gatekeeper function of B-lymphoid transcription factors. Nature. 2017 02 23; 542(7642):479-483.
PMID:
28192788
; PMCID:
PMC5621518
.
Citations:
82
Fields:
Sci
Science
Translation:
Humans
Animals
Cells
Short NJ,
Kantarjian HM
, Sasaki K, Ravandi F, Ko H, Cameron Yin C,
Garcia-Manero G
,
Cortes JE
, Garris R, O'Brien SM, Patel K, Khouri M, Thomas D,
Jain N
,
Kadia TM
,
Daver NG
,
Benton CB
, Issa GC,
Konopleva M
,
Jabbour E
. Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor. Am J Hematol. 2017 Mar; 92(3):238-243.
PMID:
28006851
; PMCID:
PMC5495018
.
Citations:
12
Fields:
Hem
Hematology
Translation:
Humans
Cells
Agarwal SK,
DiNardo CD
, Potluri J, Dunbar M,
Kantarjian HM
, Humerickhouse RA, Wong SL, Menon RM,
Konopleva MY
, Salem AH. Management of Venetoclax-Posaconazole Interaction in Acute Myeloid Leukemia Patients: Evaluation of Dose Adjustments. Clin Ther. 2017 Feb; 39(2):359-367.
PMID:
28161120
.
Citations:
51
Fields:
Dru
Drug Therapy
The
Therapeutics
Translation:
Humans
CT
Clinical Trials
Pemmaraju N
,
Kantarjian H
,
Jorgensen JL
,
Jabbour E
,
Jain N
, Thomas D, O'Brien S, Wang X, Huang X, Wang SA,
Konopleva M
,
Konoplev S
,
Kadia T
, Garris R, Pierce S,
Garcia-Manero G
, Cortes J, Ravandi F. Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remission. Am J Hematol. 2017 Mar; 92(3):279-285.
PMID:
28052371
; PMCID:
PMC5851443
.
Citations:
11
Fields:
Hem
Hematology
Translation:
Humans
Dinardo CD
, Luskin MR, Carroll M, Smith C, Harrison J, Pierce S,
Kornblau S
,
Konopleva M
,
Kadia T
,
Kantarjian H
, Wertheim GB, Master SR. Validation of a clinical assay of multi-locus DNA methylation for prognosis of newly diagnosed AML. Am J Hematol. 2017 Feb; 92(2):E14-E15.
PMID:
27804182
; PMCID:
PMC5915352
.
Citations:
5
Fields:
Hem
Hematology
Translation:
Humans
Cells
Pinnix CC
, Chi L,
Jabbour EJ
,
Milgrom SA
, Smith GL,
Daver N
,
Garg N
,
Cykowski MD
,
Fuller G
, Cachia D, Kamiya-Matsuoka C,
Woodman K
,
Dinardo C
,
Jain N
,
Kadia TM
,
Pemmaraju N
,
Ohanian M
,
Konopleva M
,
Kantarjian HM
,
Dabaja BS
. Dorsal column myelopathy after intrathecal chemotherapy for leukemia. Am J Hematol. 2017 Feb; 92(2):155-160.
PMID:
27874212
; PMCID:
PMC5338569
.
Citations:
1
Fields:
Hem
Hematology
Translation:
Humans
Bose P
,
Gandhi V
,
Konopleva M
. Pathways and mechanisms of venetoclax resistance. Leuk Lymphoma. 2017 09; 58(9):1-17.
PMID:
28140720
; PMCID:
PMC5478500
.
Citations:
69
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Animals
Baran N,
Konopleva M
. Molecular Pathways: Hypoxia-Activated Prodrugs in Cancer Therapy. Clin Cancer Res. 2017 May 15; 23(10):2382-2390.
PMID:
28137923
; PMCID:
PMC5433896
.
Citations:
51
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Tabe Y, Yamamoto S, Saitoh K, Sekihara K, Monma N, Ikeo K, Mogushi K, Shikami M, Ruvolo V, Ishizawa J, Hail N, Kazuno S, Igarashi M, Matsushita H, Yamanaka Y, Arai H, Nagaoka I, Miida T, Hayashizaki Y,
Konopleva M
,
Andreeff M
. Bone Marrow Adipocytes Facilitate Fatty Acid Oxidation Activating AMPK and a Transcriptional Network Supporting Survival of Acute Monocytic Leukemia Cells. Cancer Res. 2017 03 15; 77(6):1453-1464.
PMID:
28108519
; PMCID:
PMC5354955
.
Citations:
59
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Han L,
Jorgensen JL
, Brooks C, Shi C, Zhang Q, Cavazos A, Pan R, Mu H, Wang SA, Zhou J, Ai-Atrash G,
Ciurea SO
, Rettig M, DiPersio JF, Cortes J, Huang X,
Kantarjian HM
,
Andreeff M
, Ravandi F,
Konopleva M
, Nogueras Gonz?lez GM. Antileukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody Conjugate, in Acute Myeloid Leukemia. Clin Cancer Res. 2017 07 01; 23(13):3385-3395.
PMID:
28096272
; PMCID:
PMC5496806
.
Citations:
23
Fields:
Neo
Neoplasms
Translation:
Humans
Animals
Cells
Kerry J, Godfrey L, Repapi E, Tapia M, Blackledge NP, Ma H, Ballabio E, O'Byrne S, Ponthan F, Heidenreich O, Roy A, Roberts I,
Konopleva M
, Klose RJ, Geng H, Milne TA. MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. Cell Rep. 2017 01 10; 18(2):482-495.
PMID:
28076791
; PMCID:
PMC5263239
.
Citations:
36
Fields:
Cel
Cell Biology
Mol
Molecular Biology
Translation:
Humans
Cells
Zeng Z
,
Konopleva M
,
Andreeff M
. Single-Cell Mass Cytometry of Acute Myeloid Leukemia and Leukemia Stem/Progenitor Cells. Methods Mol Biol. 2017; 1633:75-86.
PMID:
28735481
.
Citations:
11
Fields:
Mol
Molecular Biology
Translation:
Humans
Cells
Tabe Y,
Konopleva M
. Leukemia Stem Cells Microenvironment. Adv Exp Med Biol. 2017; 1041:19-32.
PMID:
29204827
.
Citations:
11
Fields:
Bio
Biology
Med
Medicine (General)
Translation:
Humans
Animals
Cells
Abaza Y,
Kantarjian H
,
Garcia-Manero G
, Estey E,
Borthakur G
,
Jabbour E
, Faderl S, O'Brien S,
Wierda W
, Pierce S, Brandt M, McCue D,
Luthra R
, Patel K,
Kornblau S
,
Kadia T
,
Daver N
,
DiNardo C
,
Jain N
,
Verstovsek S
,
Ferrajoli A
,
Andreeff M
,
Konopleva M
,
Estrov Z
, Foudray M, McCue D, Cortes J, Ravandi F. Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab. Blood. 2017 03 09; 129(10):1275-1283.
PMID:
28003274
; PMCID:
PMC5413297
.
Citations:
73
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials